Patent Grant
11666913
In biosciences and related fields, it can be useful to have the ability to re-configure the flow region of a microfluidic device in real time. Some embodiments of the present invention include apparatuses and processes for in situ-generation of microfluidic isolation structures.
In one aspect, a microfluidic device is provided which includes an enclosure having: a substrate; a flow region located within the enclosure; and at least one in situ-generated isolation structure disposed on the substrate, where the at least one in situ-generated isolation structure includes a solidified polymer network. In some embodiments, the solidified polymer network does not include a silicone polymer. In some embodiments, the solidified polymer network does not include silicon. The solidified polymer network may include a photoinitiated polymer. All or at least part of the at least one in situ-generated isolation structure may consist of the solidified polymer network.
In another aspect, a microfluidic device is provided which includes an enclosure having: a substrate; a microfluidic channel; at least one sequestration pen; and an in situ-generated barrier. The sequestration pen may include an isolation region and a connection region, the connection region having a proximal opening to the microfluidic channel and a distal opening to the isolation region. The in situ-generated barrier may be disposed to provide at least a partial blockade of the microfluidic channel and/or the sequestration pen. In various embodiments, the in situ-generated barrier may include a solidified polymer network. The solidified polymer network may include a photoinitiated polymer.
In yet another aspect, a microfluidic device is provided which includes an enclosure having: a substrate; a flow region including a microfluidic channel configured to contain a fluidic medium; a first plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the first plurality opens off a first side of the microfluidic channel; and a second plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the second plurality opens off a second opposing side of the microfluidic channel. The first side of the microfluidic channel may be configured to receive a first fluidic medium, and the second side of the microfluidic channel may be configured to receive a second fluidic medium. In various embodiments, the enclosure may further comprise a barrier. The barrier may be configured to divide the microfluidic channel into a first sub-channel and a second sub-channel, wherein the first sub-channel is configured to provide a first sub-flow of fluidic medium past the first plurality of sequestration pens, and wherein the second sub-channel is configured to provide a second sub-flow of fluidic medium past the second plurality of sequestration pens. The barrier may comprise, consist of, or consist essentially of an in situ-generated barrier. Thus, in certain embodiments, the barrier may comprise a portion that is not an in situ-generated barrier. In various embodiments, the barrier may be punctuated by at least one gap. The gap may be aligned between a proximal opening of a first pen of the first plurality of pens and a proximal opening of a corresponding first pen of the second plurality of pens. In various embodiments, the in situ-generated barrier may prevent cells from moving from the first sub-channel to the second sub-channel, and vice versa.
In another aspect, a method of isolating a micro-object in a microfluidic device is provided, including the steps of: introducing a first fluidic medium including a plurality of micro-objects into an enclosure of the microfluidic device, the enclosure including a substrate and a flow region; introducing a solution including a flowable polymer into the enclosure; activating solidification of the flowable polymer at at least one selected area of the flow region, thereby forming an in situ-generated isolation structure; and isolating at least one of the plurality of micro-objects with the in situ-generated isolation structure. In some embodiments, the step of initiating solidification of the flowable polymer may include optically illuminating the at least one selected area of the flow region. In some embodiments, the solidification of the flowable polymer may include the polymerization of polymers of the flowable polymer into a polymer network. The step of introducing a flowable polymer may further include introducing a photoactivatable polymerization initiator.
In another aspect, a method of isolating a micro-object in a microfluidic device is provided, including the steps of: providing a microfluidic device including an enclosure having a substrate, a flow region including a microfluidic channel, and a plurality of sequestration pens; introducing a first fluidic medium including a plurality of micro-objects into the microfluidic channel of the microfluidic device; disposing ones of the plurality of micro-objects in at least a portion of the plurality of sequestration pens, thereby forming a plurality of populated sequestration pens each containing at least one micro-object; introducing a second fluidic medium into the microfluidic channel, wherein the second fluidic medium comprises a flowable polymer; selecting at least one of the plurality of populated sequestration pens; initiating polymerization of the flowable polymer at at least a first selected point within or adjacent to at least one selected sequestration pen, where the polymerized polymer of the flowable polymer generates at least a partial in situ-generated barrier that prevents the at least one micro-object from exiting the at least one selected sequestration pen. Each of the plurality of sequestration pens may include an isolation region and a connection region, the connection region having a proximal opening to the microfluidic channel and a distal opening to the isolation region. In certain embodiments, initiating polymerization of the flowable polymer at a selected point within or adjacent to a sequestration pen comprises: initiating polymerization within the connection region or isolation region of the sequestration pen; and/or initiating polymerization at or adjacent to an edge of the proximal opening of the connection region.
In another aspect, a method of concentrating micro-objects in a microfluidic device may be provided, including the steps of: providing a microfluidic device including an enclosure having a substrate and a flow region configured to contain a fluidic medium; introducing an in situ-generated isolation structure in a first sector of the flow region, where the in situ-generated isolation structure is configured to permit the fluidic medium to flow through the in situ-generated isolation structure while preventing at least one micro-object in the fluidic medium from passing into, out of, and/or through the in situ-generated isolation structure; introducing a first plurality of micro-objects in a first volume of the fluidic medium into the first sector of the flow region; and concentrating at least a first subset of the first plurality of micro-objects in the first sector of the flow region. In various embodiments, the first volume of the fluidic medium may be larger than a volume of the first sector of the flow region.
In another aspect, a method of assaying a cell of a clonal population in a microfluidic device is provided, the method including the steps of: introducing a first fluidic medium comprising a plurality of cells into an enclosure of the microfluidic device, the enclosure comprising a substrate, a flow region comprising a microfluidic channel configured to contain a fluidic medium, a first plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the first plurality opens off a first side of the microfluidic channel, and a second plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the second plurality opens off a second opposing side of the microfluidic channel; flowing the first fluidic medium and the plurality of cells into the microfluidic channel of the microfluidic device; introducing a clonal population of cells in each of the sequestration pens of the first plurality of sequestration pens; for each clonal population of cells in the first plurality of sequestration pens, moving at least one cell to a respective sequestration pen of the second plurality of sequestration pens; introducing a flowable polymer into the microfluidic channel; activating solidification of the flowable polymer along a length of the microfluidic channel, thereby forming an in situ-generated barrier dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of sequestration pens, wherein the in situ-generated barrier prevents cells from moving from the first sub-channel to the second sub-channel, and vice versa; flowing a second fluidic medium into the second sub-channel, wherein the second fluidic medium comprises reagents for assaying the cells in the second plurality of sequestration pens; and assaying the cell(s) in each sequestration pen of the second plurality. The step of introducing the clonal population may include introducing a single cell into each of the first plurality of sequestration pens, and may further include expanding the single cell to a clonal population of cells.
In another aspect, a kit for isolating a micro-object within a microfluidic device is provided, the kit including a microfluidic device comprising an enclosure having: a substrate and a flow region located within the enclosure; and a flowable polymer solution, where the polymer may be capable of polymerization and/or thermally-induced gelling. In some embodiments, flowable polymer may be configured to be polymerized by photoinitiation. In some embodiments, the kit may further include a photoactivatable polymerization initiator. In some embodiments, the microfluidic device may further include at least one sequestration pen. In various embodiments, the at least one sequestration pen may include an isolation region and a connection region, the connection region having a proximal opening to the flow region and a distal opening to the isolation region.
In another aspect, a kit for assaying cells of a clonal population is provided, the kit including: a microfluidic device comprising an enclosure having a substrate, a flow region including a channel located within the enclosure, a first plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the first plurality opens off a first side of the microfluidic channel, and a second plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the second plurality opens off a second opposing side of the microfluidic channel; and a flowable polymer solution, wherein the polymer is capable of polymerization and/or thermally-induced gelling. In some embodiments, the microfluidic device may further include a barrier separating the first side of the microfluidic channel from the second side of the microfluidic channel. In some embodiments, the barrier is punctuated by at least one gap aligned between a proximal opening to the microfluidic channel of a first pen of the first plurality of pens and a proximal opening to the microfluidic channel of a first pen of the second plurality of pens.
This specification describes exemplary embodiments and applications of the invention. The invention, however, is not limited to these exemplary embodiments and applications or to the manner in which the exemplary embodiments and applications operate or are described herein. Moreover, the Figures may show simplified or partial views, and the dimensions of elements in the Figures may be exaggerated or otherwise not in proportion for clarity. In addition, as the terms “on,” “attached to,” or “coupled to” are used herein, one element (e.g., a material, a layer, a substrate, etc.) can be “on,” “attached to,” or “coupled to” another element regardless of whether the one element is directly on, attached, or coupled to the other element or there are one or more intervening elements between the one element and the other element. Also, directions (e.g., above, below, top, bottom, side, up, down, under, over, upper, lower, horizontal, vertical, “x,” “y,” “z,” etc.), if provided, are relative and provided solely by way of example and for ease of illustration and discussion and not by way of limitation. In addition, where reference is made to a list of elements (e.g., elements a, b, c), such reference is intended to include any one of the listed elements by itself, any combination of less than all of the listed elements, and/or a combination of all of the listed elements.
Section divisions in the specification are for ease of review only and do not limit any combination of elements discussed.
As used herein, “substantially” means sufficient to work for the intended purpose. The term “substantially” thus allows for minor, insignificant variations from an absolute or perfect state, dimension, measurement, result, or the like such as would be expected by a person of ordinary skill in the field but that do not appreciably affect overall performance. When used with respect to numerical values or parameters or characteristics that can be expressed as numerical values, “substantially” means within ten percent.
As used herein, the term “ones” means more than one. As used herein, the term “plurality” can be 2, 3, 4, 5, 6, 7, 8, 9, 10, or more.
As used herein: μm means micrometer, μm3 means cubic micrometer, pL means picoliter, nL means nanoliter, and μL (or uL) means microliter.
As used herein, the term “transparent” refers to a material which allows visible light to pass through without substantially altering the light as is passes through.
As used herein, the term “disposed” encompasses within its meaning “located.”
As used herein, a “nanofluidic device” or “nanofluidic apparatus” is a type of microfluidic device having a microfluidic circuit that contains at least one circuit element, including but not limited to region(s), flow path(s), channel(s), chamber(s), and/or pen(s), configured to hold a volume of fluid of less than about 1 μL, e.g., less than about 750, 500, 250, 200, 150, 100, 75, 50, 25, 20, 15, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1 nL or less. A nanofluidic device may comprise a plurality of circuit elements (e.g., at least 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 50, 75, 100, 150, 200, 250, 300, 400, 500, 600, 700, 800, 900, 1000, 1500, 2000, 2500, 3000, 3500, 4000, 4500, 5000, 6000, 7000, 8000, 9000, 10,000, or more). In certain embodiments, one or more (e.g., all) of the at least one circuit elements is configured to hold a volume of fluid of about 100 pL to 1 nL, 100 pL to 2 nL, 100 pL to 5 nL, 250 pL to 2 nL, 250 pL to 5 nL, 250 pL to 10 nL, 500 pL to 5 nL, 500 pL to 10 nL, 500 pL to 15 nL, 750 pL to 10 nL, 750 pL to 15 nL, 750 pL to 20 nL, 1 to 10 nL, 1 to 15 nL, 1 to 20 nL, 1 to 25 nL, or 1 to 50 nL. In other embodiments, one or more (e.g., all) of the at least one circuit elements is configured to hold a volume of fluid of about 20 nL to 200 nL, 100 to 200 nL, 100 to 300 nL, 100 to 400 nL, 100 to 500 nL, 200 to 300 nL, 200 to 400 nL, 200 to 500 nL, 200 to 600 nL, 200 to 700 nL, 250 to 400 nL, 250 to 500 nL, 250 to 600 nL, or 250 to 750 nL.
As used herein, a “flow path” refers to one or more fluidically connected circuit elements (e.g. channel(s), region(s), chamber(s) and the like) that define, and are subject to, the trajectory of a flow of medium. A flow path is thus an example of a swept region of a microfluidic device. Other circuit elements (e.g., unswept regions) may be fluidically connected with the circuit elements that comprise the flow path without being subject to the flow of medium in the flow path.
A “microfluidic channel” or “flow channel” as used herein refers to flow region of a microfluidic device having a length that is significantly longer than both the horizontal and vertical dimensions. For example, the flow channel can be at least 5 times the length of either the horizontal or vertical dimension, e.g., at least 10 times the length, at least 25 times the length, at least 100 times the length, at least 200 times the length, at least 500 times the length, at least 1,000 times the length, at least 5,000 times the length, or longer. In some embodiments, the length of a flow channel is in the range of from about 100,000 microns to about 500,000 microns, including any range therebetween. In some embodiments, the horizontal dimension is in the range of from about 100 microns to about 1000 microns (e.g., about 150 to about 500 microns) and the vertical dimension is in the range of from about 25 microns to about 200 microns, e.g., from about 40 to about 150 microns. It is noted that a flow channel may have a variety of different spatial configurations in a microfluidic device, and thus is not restricted to a perfectly linear element. For example, a flow channel may be, or include one or more sections having, the following configurations: curve, bend, spiral, incline, decline, fork (e.g., multiple different flow paths), and any combination thereof. In addition, a flow channel may have different cross-sectional areas along its path, widening and constricting to provide a desired fluid flow therein.
As used herein, the term “obstruction” refers generally to a bump or similar type of structure that is sufficiently large so as to partially (but not completely) impede movement of target micro-objects between two different regions or circuit elements in a microfluidic device. The two different regions/circuit elements can be, for example, the connection region and the isolation region of a microfluidic sequestration pen.
As used herein, the term “constriction” refers generally to a narrowing of a width of a circuit element (or an interface between two circuit elements) in a microfluidic device. The constriction can be located, for example, at the interface between the isolation region and the connection region of a microfluidic sequestration pen of the instant invention.
As used herein in reference to a fluidic medium, “diffuse” and “diffusion” refer to thermodynamic movement of a component of the fluidic medium down a concentration gradient.
The phrase “flow of a medium” means bulk movement of a fluidic medium primarily due to any mechanism other than diffusion. For example, flow of a medium can involve movement of the fluidic medium from one point to another point due to a pressure differential between the points. Such flow can include a continuous, pulsed, periodic, random, intermittent, or reciprocating flow of the liquid, or any combination thereof. When one fluidic medium flows into another fluidic medium, turbulence and mixing of the media can result.
The phrase “substantially no flow” refers to a rate of flow of a fluidic medium that, averaged over time, is less than the rate of diffusion of components of a material (e.g., an analyte of interest) into or within the fluidic medium. The rate of diffusion of components of such a material can depend on, for example, temperature, the size of the components, and the strength of interactions between the components and the fluidic medium.
As used herein in reference to different regions within a microfluidic device, the phrase “fluidically connected” means that, when the different regions are substantially filled with fluid, such as fluidic media, the fluid in each of the regions is connected so as to form a single body of fluid. This does not mean that the fluids (or fluidic media) in the different regions are necessarily identical in composition. Rather, the fluids in different fluidically connected regions of a microfluidic device can have different compositions (e.g., different concentrations of solutes, such as proteins, carbohydrates, ions, or other molecules) which are in flux as solutes move down their respective concentration gradients and/or fluids flow through the device.
A microfluidic (or nanofluidic) device can comprise “swept” regions and “unswept” regions. As used herein, a “swept” region is comprised of one or more fluidically interconnected circuit elements of a microfluidic circuit, each of which experiences a flow of medium when fluid is flowing through the microfluidic circuit. The circuit elements of a swept region can include, for example, regions, channels, and all or parts of chambers. As used herein, an “unswept” region is comprised of one or more fluidically interconnected circuit element of a microfluidic circuit, each of which experiences substantially no flux of fluid when fluid is flowing through the microfluidic circuit. An unswept region can be fluidically connected to a swept region, provided the fluidic connections are structured to enable diffusion but substantially no flow of media between the swept region and the unswept region. The microfluidic device can thus be structured to substantially isolate an unswept region from a flow of medium in a swept region, while enabling substantially only diffusive fluidic communication between the swept region and the unswept region. For example, a flow channel of a micro-fluidic device is an example of a swept region while an isolation region (described in further detail below) of a microfluidic device is an example of an unswept region.
The capability of biological micro-objects (e.g., biological cells) to produce specific biological materials (e.g., proteins, such as antibodies) can be assayed in such a microfluidic device. In a specific embodiment of an assay, sample material comprising biological micro-objects (e.g., cells) to be assayed for production of an analyte of interest can be loaded into a swept region of the microfluidic device. Ones of the biological micro-objects (e.g., mammalian cells, such as human cells) can be selected for particular characteristics and disposed in unswept regions. The remaining sample material can then be flowed out of the swept region and an assay material flowed into the swept region. Because the selected biological micro-objects are in unswept regions, the selected biological micro-objects are not substantially affected by the flowing out of the remaining sample material or the flowing in of the assay material. The selected biological micro-objects can be allowed to produce the analyte of interest, which can diffuse from the unswept regions into the swept region, where the analyte of interest can react with the assay material to produce localized detectable reactions, each of which can be correlated to a particular unswept region. Any unswept region associated with a detected reaction can be analyzed to determine which, if any, of the biological micro-objects in the unswept region are sufficient producers of the analyte of interest.
As used herein, the term “micro-object” refers generally to any microscopic object that may be isolated and/or manipulated in accordance with the present invention. Non-limiting examples of micro-objects include: inanimate micro-objects such as microparticles; microbeads (e.g., polystyrene beads, Luminex™ beads, or the like); magnetic beads; microrods; microwires; quantum dots, and the like; biological micro-objects such as cells; biological organelles; vesicles, or complexes; synthetic vesicles; liposomes (e.g., synthetic or derived from membrane preparations); lipid nanorafts, and the like; or a combination of inanimate micro-objects and biological micro-objects (e.g., microbeads attached to cells, liposome-coated micro-beads, liposome-coated magnetic beads, or the like). Beads may include moieties/molecules covalently or non-covalently attached, such as fluorescent labels, proteins, carbohydrates, antigens, small molecule signaling moieties, or other chemical/biological species capable of use in an assay. Lipid nanorafts have been described, for example, in Ritchie et al. (2009) “Reconstitution of Membrane Proteins in Phospholipid Bilayer Nanodiscs,” Methods Enzymol., 464:211-231.
As used herein, the term “cell” is used interchangeably with the term “biological cell.” Non-limiting examples of biological cells include eukaryotic cells, plant cells, animal cells, such as mammalian cells, reptilian cells, avian cells, fish cells, or the like, prokaryotic cells, bacterial cells, fungal cells, protozoan cells, or the like, cells dissociated from a tissue, such as muscle, cartilage, fat, skin, liver, lung, neural tissue, and the like, immunological cells, such as T cells, B cells, natural killer cells, macrophages, and the like, embryos (e.g., zygotes), oocytes, ova, sperm cells, hybridomas, cultured cells, cells from a cell line, cancer cells, infected cells, transfected and/or transformed cells, reporter cells, and the like. A mammalian cell can be, for example, from a human, a mouse, a rat, a horse, a goat, a sheep, a cow, a primate, or the like.
A colony of biological cells is “clonal” if all of the living cells in the colony that are capable of reproducing are daughter cells derived from a single parent cell. In certain embodiments, all the daughter cells in a clonal colony are derived from the single parent cell by no more than 10 divisions. In other embodiments, all the daughter cells in a clonal colony are derived from the single parent cell by no more than 14 divisions. In other embodiments, all the daughter cells in a clonal colony are derived from the single parent cell by no more than 17 divisions. In other embodiments, all the daughter cells in a clonal colony are derived from the single parent cell by no more than 20 divisions. The term “clonal cells” refers to cells of the same clonal colony.
As used herein, a “colony” of biological cells refers to 2 or more cells (e.g. about 2 to about 20, about 4 to about 40, about 6 to about 60, about 8 to about 80, about 10 to about 100, about 20 about 200, about 40 about 400, about 60 about 600, about 80 about 800, about 100 about 1000, or greater than 1000 cells).
As used herein, the term “maintaining (a) cell(s)” refers to providing an environment comprising both fluidic and gaseous components and, optionally a surface, that provides the conditions necessary to keep the cells viable and/or expanding.
As used herein, the term “expanding” when referring to cells, refers to increasing in cell number.
As used herein, the term “processing” when referring to processing cells, may include culturing or continuing to culture the cells, assaying the cells using one or more assays, and/or preparing the cells for a procedure such as, but not limited to, lysis, fusion, transfection, gene editing of any kind (e.g., targeted gene editing) and/or genotyping.
As used herein, “isolating a micro-object” means confining a micro-object to a defined area within the microfluidic device. The micro-object may still be capable of motion within the defined area (e.g., within an in situ-generated isolation structure).
As used herein, “antibody” refers to an immunoglobulin (Ig) and includes both polyclonal and monoclonal antibodies; primatized (e.g., humanized); murine; mouse-human; mouse-primate; and chimeric; and may be an intact molecule, a fragment thereof (such as scFv, Fv, Fd, Fab, Fab′ and F(ab)′2 fragments), or multimers or aggregates of intact molecules and/or fragments; and may occur in nature or be produced, e.g., by immunization, synthesis or genetic engineering. An “antibody fragment,” as used herein, refers to fragments, derived from or related to an antibody, which bind antigen and which in some embodiments may be derivatized to exhibit structural features that facilitate clearance and uptake, e.g., by the incorporation of galactose residues. This includes, e.g., F(ab), F(ab)′2, scFv, light chain variable region (VL), heavy chain variable region (VH), and combinations thereof.
A “component” of a fluidic medium is any chemical or biochemical molecule present in the medium, including solvent molecules, ions, small molecules, antibiotics, nucleotides and nucleosides, nucleic acids, amino acids, peptides, proteins, sugars, carbohydrates, lipids, fatty acids, cholesterol, metabolites, or the like.
As used herein, “capture moiety” is a chemical or biological species, functionality, or motif that provides a recognition site for a micro-object. A selected class of micro-objects may recognize the capture moiety and may bind or have an affinity for the capture moiety. Non-limiting examples include antigens, antibodies, and cell surface binding motifs.
As used herein, “flowable polymer” is a polymer monomer or macromer that is soluble or dispersible within a fluidic medium. The flowable polymer may be input into a microfluidic flow region and flow with other components of a fluidic medium therein.
As used herein, “photoinitiated polymer” refers to a polymer (or a monomeric molecule that can be used to generate the polymer) that upon exposure to light, is capable of crosslinking covalently, forming specific covalent bonds, changing regiochemistry around a rigidified chemical motif, or forming ion pairs which cause a change in physical state, and thereby forming a polymer network. In some instances, a photoinitiated polymer may include a polymer segment bound to one or more chemical moieties capable of crosslinking covalently, forming specific covalent bonds, changing regiochemistry around a rigidified chemical motif, or forming ion pairs which cause a change in physical state. In some instances, a photoinitiated polymer may require a photoactivatable radical initiator to initiate formation of the polymer network (e.g., via polymerization of the polymer).
Microfluidic Devices and Systems for Operating and Observing Such Devices.
As generally illustrated in
The support structure 104 can be at the bottom and the cover 110 at the top of the microfluidic circuit 120 as illustrated in
The support structure 104 can comprise one or more electrodes (not shown) and a substrate or a plurality of interconnected substrates. For example, the support structure 104 can comprise one or more semiconductor substrates, each of which is electrically connected to an electrode (e.g., all or a subset of the semiconductor substrates can be electrically connected to a single electrode). The support structure 104 can further comprise a printed circuit board assembly (“PCBA”). For example, the semiconductor substrate(s) can be mounted on a PCBA.
The microfluidic circuit structure 108 can define circuit elements of the microfluidic circuit 120. Such circuit elements can comprise spaces or regions that can be fluidly interconnected when microfluidic circuit 120 is filled with fluid, such as flow regions (which may include or be one or more flow channels), chambers, pens, traps, and the like. In the microfluidic circuit 120 illustrated in
The microfluidic circuit material 116 can be patterned with cavities or the like to define circuit elements and interconnections of the microfluidic circuit 120. The microfluidic circuit material 116 can comprise a flexible material, such as a flexible polymer (e.g. rubber, plastic, elastomer, silicone, polydimethylsiloxane (“PDMS”), or the like), which can be gas permeable. Other examples of materials that can compose microfluidic circuit material 116 include molded glass, an etchable material such as silicone (e.g. photo-patternable silicone or “PPS”), photo-resist (e.g., SU8), or the like. In some embodiments, such materials—and thus the microfluidic circuit material 116—can be rigid and/or substantially impermeable to gas. Regardless, microfluidic circuit material 116 can be disposed on the support structure 104 and inside the frame 114.
The cover 110 can be an integral part of the frame 114 and/or the microfluidic circuit material 116. Alternatively, the cover 110 can be a structurally distinct element, as illustrated in
In some embodiments, the cover 110 can comprise a rigid material. The rigid material may be glass or a material with similar properties. In some embodiments, the cover 110 can comprise a deformable material. The deformable material can be a polymer, such as PDMS. In some embodiments, the cover 110 can comprise both rigid and deformable materials. For example, one or more portions of cover 110 (e.g., one or more portions positioned over sequestration pens 124, 126, 128, 130) can comprise a deformable material that interfaces with rigid materials of the cover 110. In some embodiments, the cover 110 can further include one or more electrodes. The one or more electrodes can comprise a conductive oxide, such as indium-tin-oxide (ITO), which may be coated on glass or a similarly insulating material. Alternatively, the one or more electrodes can be flexible electrodes, such as single-walled nanotubes, multi-walled nanotubes, nanowires, clusters of electrically conductive nanoparticles, or combinations thereof, embedded in a deformable material, such as a polymer (e.g., PDMS). Flexible electrodes that can be used in microfluidic devices have been described, for example, in U.S. 2012/0325665 (Chiou et al.), the contents of which are incorporated herein by reference. In some embodiments, the cover 110 can be modified (e.g., by conditioning all or part of a surface that faces inward toward the microfluidic circuit 120) to support cell adhesion, viability and/or growth. The modification may include a coating of a synthetic or natural polymer. In some embodiments, the cover 110 and/or the support structure 104 can be transparent to light. The cover 110 may also include at least one material that is gas permeable (e.g., PDMS or PPS).
The electrical power source 192 can provide electric power to the microfluidic device 100 and/or tilting device 190, providing biasing voltages or currents as needed. The electrical power source 192 can, for example, comprise one or more alternating current (AC) and/or direct current (DC) voltage or current sources. The imaging device 194 (part of imaging module 164, discussed below) can comprise a device, such as a digital camera, for capturing images inside microfluidic circuit 120. In some instances, the imaging device 194 further comprises a detector having a fast frame rate and/or high sensitivity (e.g. for low light applications). The imaging device 194 can also include a mechanism for directing stimulating radiation and/or light beams into the microfluidic circuit 120 and collecting radiation and/or light beams reflected or emitted from the microfluidic circuit 120 (or micro-objects contained therein). The emitted light beams may be in the visible spectrum and may, e.g., include fluorescent emissions. The reflected light beams may include reflected emissions originating from an LED or a wide spectrum lamp, such as a mercury lamp (e.g. a high pressure mercury lamp) or a Xenon arc lamp. As discussed with respect to
System 150 further comprises a tilting device 190 (part of tilting module 166, discussed below) configured to rotate a microfluidic device 100 about one or more axes of rotation. In some embodiments, the tilting device 190 is configured to support and/or hold the enclosure 102 comprising the microfluidic circuit 120 about at least one axis such that the microfluidic device 100 (and thus the microfluidic circuit 120) can be held in a level orientation (i.e. at 0° relative to x- and y-axes), a vertical orientation (i.e. at 90° relative to the x-axis and/or the y-axis), or any orientation therebetween. The orientation of the microfluidic device 100 (and the microfluidic circuit 120) relative to an axis is referred to herein as the “tilt” of the microfluidic device 100 (and the microfluidic circuit 120). For example, the tilting device 190 can tilt the microfluidic device 100 at 0.1°, 0.2°, 0.3°, 0.4°, 0.5°, 0.6°, 0.7°, 0.8°, 0.9°, 1°, 2°, 3°, 4°, 5°, 10°, 15°, 20°, 25°, 30°, 35°, 40°, 45°, 50°, 55°, 60°, 65°, 70°, 75°, 80°, 90° relative to the x-axis or any degree therebetween. The level orientation (and thus the x- and y-axes) is defined as normal to a vertical axis defined by the force of gravity. The tilting device can also tilt the microfluidic device 100 (and the microfluidic circuit 120) to any degree greater than 90° relative to the x-axis and/or y-axis, or tilt the microfluidic device 100 (and the microfluidic circuit 120) 180° relative to the x-axis or the y-axis in order to fully invert the microfluidic device 100 (and the microfluidic circuit 120). Similarly, in some embodiments, the tilting device 190 tilts the microfluidic device 100 (and the microfluidic circuit 120) about an axis of rotation defined by flow path 106 or some other portion of microfluidic circuit 120.
In some instances, the microfluidic device 100 is tilted into a vertical orientation such that the flow path 106 is positioned above or below one or more sequestration pens. The term “above” as used herein denotes that the flow path 106 is positioned higher than the one or more sequestration pens on a vertical axis defined by the force of gravity (i.e. an object in a sequestration pen above a flow path 106 would have a higher gravitational potential energy than an object in the flow path). The term “below” as used herein denotes that the flow path 106 is positioned lower than the one or more sequestration pens on a vertical axis defined by the force of gravity (i.e. an object in a sequestration pen below a flow path 106 would have a lower gravitational potential energy than an object in the flow path).
In some instances, the tilting device 190 tilts the microfluidic device 100 about an axis that is parallel to the flow path 106. Moreover, the microfluidic device 100 can be tilted to an angle of less than 90° such that the flow path 106 is located above or below one or more sequestration pens without being located directly above or below the sequestration pens. In other instances, the tilting device 190 tilts the microfluidic device 100 about an axis perpendicular to the flow path 106. In still other instances, the tilting device 190 tilts the microfluidic device 100 about an axis that is neither parallel nor perpendicular to the flow path 106.
System 150 can further include a media source 178. The media source 178 (e.g., a container, reservoir, or the like) can comprise multiple sections or containers, each for holding a different fluidic medium 180. Thus, the media source 178 can be a device that is outside of and separate from the microfluidic device 100, as illustrated in
The master controller 154 can comprise a control module 156 and a digital memory 158. The control module 156 can comprise, for example, a digital processor configured to operate in accordance with machine executable instructions (e.g., software, firmware, source code, or the like) stored as non-transitory data or signals in the memory 158. Alternatively, or in addition, the control module 156 can comprise hardwired digital circuitry and/or analog circuitry. The media module 160, motive module 162, imaging module 164, tilting module 166, and/or other modules 168 can be similarly configured. Thus, functions, processes acts, actions, or steps of a process discussed herein as being performed with respect to the microfluidic device 100 or any other microfluidic apparatus can be performed by any one or more of the master controller 154, media module 160, motive module 162, imaging module 164, tilting module 166, and/or other modules 168 configured as discussed above. Similarly, the master controller 154, media module 160, motive module 162, imaging module 164, tilting module 166, and/or other modules 168 may be communicatively coupled to transmit and receive data used in any function, process, act, action or step discussed herein.
The media module 160 controls the media source 178. For example, the media module 160 can control the media source 178 to input a selected fluidic medium 180 into the enclosure 102 (e.g., through an inlet port 107). The media module 160 can also control removal of media from the enclosure 102 (e.g., through an outlet port (not shown)). One or more media can thus be selectively input into and removed from the microfluidic circuit 120. The media module 160 can also control the flow of fluidic medium 180 in the flow path 106 inside the microfluidic circuit 120. For example, in some embodiments media module 160 stops the flow of media 180 in the flow path 106 and through the enclosure 102 prior to the tilting module 166 causing the tilting device 190 to tilt the microfluidic device 100 to a desired angle of incline.
The motive module 162 can be configured to control selection, trapping, and movement of micro-objects (not shown) in the microfluidic circuit 120. As discussed below with respect to
The imaging module 164 can control the imaging device 194. For example, the imaging module 164 can receive and process image data from the imaging device 194. Image data from the imaging device 194 can comprise any type of information captured by the imaging device 194 (e.g., the presence or absence of micro-objects, droplets of medium, accumulation of label, such as fluorescent label, etc.). Using the information captured by the imaging device 194, the imaging module 164 can further calculate the position of objects (e.g., micro-objects, droplets of medium) and/or the rate of motion of such objects within the microfluidic device 100.
The tilting module 166 can control the tilting motions of tilting device 190. Alternatively, or in addition, the tilting module 166 can control the tilting rate and timing to optimize transfer of micro-objects to the one or more sequestration pens via gravitational forces. The tilting module 166 is communicatively coupled with the imaging module 164 to receive data describing the motion of micro-objects and/or droplets of medium in the microfluidic circuit 120. Using this data, the tilting module 166 may adjust the tilt of the microfluidic circuit 120 in order to adjust the rate at which micro-objects and/or droplets of medium move in the microfluidic circuit 120. The tilting module 166 may also use this data to iteratively adjust the position of a micro-object and/or droplet of medium in the microfluidic circuit 120.
In the example shown in
The microfluidic circuit 120 may comprise any number of microfluidic sequestration pens. Although five sequestration pens are shown, microfluidic circuit 120 may have fewer or more sequestration pens. As shown, microfluidic sequestration pens 124, 126, 128, and 130 of microfluidic circuit 120 each comprise differing features and shapes which may provide one or more benefits useful in producing an embryo, such as isolating one ovum from an adjacent ovum. Testing, stimulating and fertilizing may all be performed on an individual basis and, in some embodiments, may be performed on an individual time scale. In some embodiments, the microfluidic circuit 120 comprises a plurality of identical microfluidic sequestration pens.
In some embodiments, the microfluidic circuit 120 comprises a plurality of microfluidic sequestration pens, wherein two or more of the sequestration pens comprise differing structures and/or features which provide differing benefits in producing embryos. One non-limiting example may include maintaining ova in one type of pen while maintaining sperm in a different type of pen. In another embodiment, at least one of the sequestration pens is configured to have electrical contacts suitable for providing electrical activation for an ovum. In yet another embodiment, differing types of cells (such as, for example, uterine cells, endometrial cells, PEG (intercalary) cells derived from the uterine tube (e.g., oviduct or Fallopian tube), cumulus cells, or a combination thereof) may be disposed in sequestration pens adjacent to a sequestration pen containing an ovum, such that secretions from the surrounding sequestration pens may diffuse out of each respective pen and into the pen containing an ovum, which is not possible with macroscale in-vitro culturing and fertilization. Microfluidic devices useful for producing an embryo may include any of the sequestration pens 124, 126, 128, and 130 or variations thereof, and/or may include pens configured like those shown in
In the embodiment illustrated in
In some instances, microfluidic circuit 120 comprises a plurality of parallel channels 122 and flow paths 106, wherein the fluidic medium 180 within each flow path 106 flows in the same direction. In some instances, the fluidic medium within each flow path 106 flows in at least one of a forward or reverse direction. In some instances, a plurality of sequestration pens is configured (e.g., relative to a channel 122) such that the sequestration pens can be loaded with target micro-objects in parallel.
In some embodiments, microfluidic circuit 120 further comprises one or more micro-object traps 132. The traps 132 are generally formed in a wall forming the boundary of a channel 122, and may be positioned opposite an opening of one or more of the microfluidic sequestration pens 124, 126, 128, 130. In some embodiments, the traps 132 are configured to receive or capture a single micro-object from the flow path 106. In some embodiments, the traps 132 are configured to receive or capture a plurality of micro-objects from the flow path 106. In some instances, the traps 132 comprise a volume approximately equal to the volume of a single target micro-object.
The traps 132 may further comprise an opening which is configured to assist the flow of targeted micro-objects into the traps 132. In some instances, the traps 132 comprise an opening having a height and width that is approximately equal to the dimensions of a single target micro-object, whereby larger micro-objects are prevented from entering into the micro-object trap. The traps 132 may further comprise other features configured to assist in retention of targeted micro-objects within the trap 132. In some instances, the trap 132 is aligned with and situated on the opposite side of a channel 122 relative to the opening of a microfluidic sequestration pen, such that upon tilting the microfluidic device 100 about an axis parallel to the channel 122, the trapped micro-object exits the trap 132 at a trajectory that causes the micro-object to fall into the opening of the sequestration pen. In some instances, the trap 132 comprises a side passage 134 that is smaller than the target micro-object in order to facilitate flow through the trap 132 and thereby increase the likelihood of capturing a micro-object in the trap 132.
In some embodiments, dielectrophoretic (DEP) forces are applied across the fluidic medium 180 (e.g., in the flow path and/or in the sequestration pens) via one or more electrodes (not shown) to manipulate, transport, separate and sort micro-objects located therein. For example, in some embodiments, DEP forces are applied to one or more portions of microfluidic circuit 120 in order to transfer a single micro-object from the flow path 106 into a desired microfluidic sequestration pen. In some embodiments, DEP forces are used to prevent a micro-object within a sequestration pen (e.g., sequestration pen 124, 126, 128, or 130) from being displaced therefrom. Further, in some embodiments, DEP forces are used to selectively remove a micro-object from a sequestration pen that was previously collected in accordance with the teachings of the instant invention. In some embodiments, the DEP forces comprise optoelectronic tweezer (OET) forces.
In other embodiments, optoelectrowetting (OEW) forces are applied to one or more positions in the support structure 104 (and/or the cover 110) of the microfluidic device 100 (e.g., positions helping to define the flow path and/or the sequestration pens) via one or more electrodes (not shown) to manipulate, transport, separate and sort droplets located in the microfluidic circuit 120. For example, in some embodiments, OEW forces are applied to one or more positions in the support structure 104 (and/or the cover 110) in order to transfer a single droplet from the flow path 106 into a desired microfluidic sequestration pen. In some embodiments, OEW forces are used to prevent a droplet within a sequestration pen (e.g., sequestration pen 124, 126, 128, or 130) from being displaced therefrom. Further, in some embodiments, OEW forces are used to selectively remove a droplet from a sequestration pen that was previously collected in accordance with the teachings of the instant invention.
In some embodiments, DEP and/or OEW forces are combined with other forces, such as flow and/or gravitational force, so as to manipulate, transport, separate and sort micro-objects and/or droplets within the microfluidic circuit 120. For example, the enclosure 102 can be tilted (e.g., by tilting device 190) to position the flow path 106 and micro-objects located therein above the microfluidic sequestration pens, and the force of gravity can transport the micro-objects and/or droplets into the pens. In some embodiments, the DEP and/or OEW forces can be applied prior to the other forces. In other embodiments, the DEP and/or OEW forces can be applied after the other forces. In still other instances, the DEP and/or OEW forces can be applied at the same time as the other forces or in an alternating manner with the other forces.
Examples of microfluidic devices having pens in which oocytes, ova, or embryos can be placed, cultured, and/or monitored have been described, for example, in US 2014/0116881 (application Ser. No. 14/060,117, filed Oct. 22, 2013), US 2015/0151298 (application Ser. No. 14/520,568, filed Oct. 22, 2014), and US 2015/0165436 (application Ser. No. 14/521,447, filed Oct. 22, 2014), each of which is incorporated herein by reference in its entirety. U.S. application Ser. Nos. 14/520,568 and 14/521,447 also describe exemplary methods of analyzing secretions of cells cultured in a microfluidic device. Each of the foregoing applications further describes microfluidic devices configured to produce dielectrophoretic (DEP) forces, such as optoelectronic tweezers (OET) or configured to provide opto-electro wetting (OEW). For example, the optoelectronic tweezers device illustrated in FIG. 2 of US 2014/0116881 is an example of a device that can be utilized in embodiments of the present invention to select and move an individual biological micro-object or a group of biological micro-objects.
Microfluidic Device Motive Configurations.
As described above, the control and monitoring equipment of the system can comprise a motive module for selecting and moving objects, such as micro-objects or droplets, in the microfluidic circuit of a microfluidic device. The microfluidic device can have a variety of motive configurations, depending upon the type of object being moved and other considerations. For example, a dielectrophoresis (DEP) configuration can be utilized to select and move micro-objects in the microfluidic circuit. Thus, the support structure 104 and/or cover 110 of the microfluidic device 100 can comprise a DEP configuration for selectively inducing DEP forces on micro-objects in a fluidic medium 180 in the microfluidic circuit 120 and thereby select, capture, and/or move individual micro-objects or groups of micro-objects. Alternatively, the support structure 104 and/or cover 110 of the microfluidic device 100 can comprise an electrowetting (EW) configuration for selectively inducing EW forces on droplets in a fluidic medium 180 in the microfluidic circuit 120 and thereby select, capture, and/or move individual droplets or groups of droplets.
One example of a microfluidic device 200 comprising a DEP configuration is illustrated in
As seen in
In certain embodiments, the microfluidic device 200 illustrated in
With the power source 212 activated, the foregoing DEP configuration creates an electric field gradient in the fluidic medium 180 between illuminated DEP electrode regions 214a and adjacent dark DEP electrode regions 214, which in turn creates local DEP forces that attract or repel nearby micro-objects (not shown) in the fluidic medium 180. DEP electrodes that attract or repel micro-objects in the fluidic medium 180 can thus be selectively activated and deactivated at many different such DEP electrode regions 214 at the inner surface 208 of the region/chamber 202 by changing light patterns 218 projected from a light source 216 into the microfluidic device 200. Whether the DEP forces attract or repel nearby micro-objects can depend on such parameters as the frequency of the power source 212 and the dielectric properties of the medium 180 and/or micro-objects (not shown).
The square pattern 220 of illuminated DEP electrode regions 214a illustrated in
In some embodiments, the electrode activation substrate 206 can comprise or consist of a photoconductive material. In such embodiments, the inner surface 208 of the electrode activation substrate 206 can be featureless. For example, the electrode activation substrate 206 can comprise or consist of a layer of hydrogenated amorphous silicon (a-Si:H). The a-Si:H can comprise, for example, about 8% to 40% hydrogen (calculated as 100*the number of hydrogen atoms/the total number of hydrogen and silicon atoms). The layer of a-Si:H can have a thickness of about 500 nm to about 2.0 μm. In such embodiments, the DEP electrode regions 214 can be created anywhere and in any pattern on the inner surface 208 of the electrode activation substrate 206, in accordance with the light pattern 218. The number and pattern of the DEP electrode regions 214 thus need not be fixed, but can correspond to the light pattern 218. Examples of microfluidic devices having a DEP configuration comprising a photoconductive layer such as discussed above have been described, for example, in U.S. Pat. No. RE 44,711 (Wu et al.) (originally issued as U.S. Pat. No. 7,612,355), the entire contents of which are incorporated herein by reference.
In other embodiments, the electrode activation substrate 206 can comprise a substrate comprising a plurality of doped layers, electrically insulating layers (or regions), and electrically conductive layers that form semiconductor integrated circuits, such as is known in semiconductor fields. For example, the electrode activation substrate 206 can comprise a plurality of phototransistors, including, for example, lateral bipolar phototransistors, each phototransistor corresponding to a DEP electrode region 214. Alternatively, the electrode activation substrate 206 can comprise electrodes (e.g., conductive metal electrodes) controlled by phototransistor switches, with each such electrode corresponding to a DEP electrode region 214. The electrode activation substrate 206 can include a pattern of such phototransistors or phototransistor-controlled electrodes. The pattern, for example, can be an array of substantially square phototransistors or phototransistor-controlled electrodes arranged in rows and columns, such as shown in
Examples of microfluidic devices having electrode activation substrates that comprise phototransistors have been described, for example, in U.S. Pat. No. 7,956,339 (Ohta et al.) (see, e.g., device 300 illustrated in
In some embodiments of a DEP configured microfluidic device, the top electrode 210 is part of a first wall (or cover 110) of the enclosure 102, and the electrode activation substrate 206 and bottom electrode 204 are part of a second wall (or support structure 104) of the enclosure 102. The region/chamber 202 can be between the first wall and the second wall. In other embodiments, the electrode 210 is part of the second wall (or support structure 104) and one or both of the electrode activation substrate 206 and/or the electrode 210 are part of the first wall (or cover 110). Moreover, the light source 216 can alternatively be used to illuminate the enclosure 102 from below.
With the microfluidic device 200 of
In other embodiments, the microfluidic device 200 can have a DEP configuration that does not rely upon light activation of DEP electrodes at the inner surface 208 of the electrode activation substrate 206. For example, the electrode activation substrate 206 can comprise selectively addressable and energizable electrodes positioned opposite to a surface including at least one electrode (e.g., cover 110). Switches (e.g., transistor switches in a semiconductor substrate) may be selectively opened and closed to activate or inactivate DEP electrodes at DEP electrode regions 214, thereby creating a net DEP force on a micro-object (not shown) in region/chamber 202 in the vicinity of the activated DEP electrodes. Depending on such characteristics as the frequency of the power source 212 and the dielectric properties of the medium (not shown) and/or micro-objects in the region/chamber 202, the DEP force can attract or repel a nearby micro-object. By selectively activating and deactivating a set of DEP electrodes (e.g., at a set of DEP electrodes regions 214 that forms a square pattern 220), one or more micro-objects in region/chamber 202 can be trapped and moved within the region/chamber 202. The motive module 162 in
As yet another example, the microfluidic device 200 can have an electrowetting (EW) configuration, which can be in place of the DEP configuration or can be located in a portion of the microfluidic device 200 that is separate from the portion which has the DEP configuration. The EW configuration can be an opto-electrowetting configuration or an electrowetting on dielectric (EWOD) configuration, both of which are known in the art. In some EW configurations, the support structure 104 has an electrode activation substrate 206 sandwiched between a dielectric layer (not shown) and the bottom electrode 204. The dielectric layer can comprise a hydrophobic material and/or can be coated with a hydrophobic material, as described below. For microfluidic devices 200 that have an EW configuration, the inner surface 208 of the support structure 104 is the inner surface of the dielectric layer or its hydrophobic coating.
The dielectric layer (not shown) can comprise one or more oxide layers, and can have a thickness of about 50 nm to about 250 nm (e.g., about 125 nm to about 175 nm). In certain embodiments, the dielectric layer may comprise a layer of oxide, such as a metal oxide (e.g., aluminum oxide or hafnium oxide). In certain embodiments, the dielectric layer can comprise a dielectric material other than a metal oxide, such as silicon oxide or a nitride. Regardless of the exact composition and thickness, the dielectric layer can have an impedance of about 10 kOhms to about 50 kOhms.
In some embodiments, the surface of the dielectric layer that faces inward toward region/chamber 202 is coated with a hydrophobic material. The hydrophobic material can comprise, for example, fluorinated carbon molecules. Examples of fluorinated carbon molecules include perfluoro-polymers such as polytetrafluoroethylene (e.g., TEFLON®) or poly(2,3-difluoromethylenyl-perfluorotetrahydrofuran) (e.g., CYTOP™). Molecules that make up the hydrophobic material can be covalently bonded to the surface of the dielectric layer. For example, molecules of the hydrophobic material can be covalently bound to the surface of the dielectric layer by means of a linker such as a siloxane group, a phosphonic acid group, or a thiol group. Thus, in some embodiments, the hydrophobic material can comprise alkyl-terminated siloxane, alkyl-termination phosphonic acid, or alkyl-terminated thiol. The alkyl group can be long-chain hydrocarbons (e.g., having a chain of at least 10 carbons, or at least 16, 18, 20, 22, or more carbons). Alternatively, fluorinated (or perfluorinated) carbon chains can be used in place of the alkyl groups. Thus, for example, the hydrophobic material can comprise fluoroalkyl-terminated siloxane, fluoroalkyl-terminated phosphonic acid, or fluoroalkyl-terminated thiol. In some embodiments, the hydrophobic coating has a thickness of about 10 nm to about 50 nm. In other embodiments, the hydrophobic coating has a thickness of less than 10 nm (e.g., less than 5 nm, or about 1.5 to 3.0 nm).
In some embodiments, the cover 110 of a microfluidic device 200 having an electrowetting configuration is coated with a hydrophobic material (not shown) as well. The hydrophobic material can be the same hydrophobic material used to coat the dielectric layer of the support structure 104, and the hydrophobic coating can have a thickness that is substantially the same as the thickness of the hydrophobic coating on the dielectric layer of the support structure 104. Moreover, the cover 110 can comprise an electrode activation substrate 206 sandwiched between a dielectric layer and the top electrode 210, in the manner of the support structure 104. The electrode activation substrate 206 and the dielectric layer of the cover 110 can have the same composition and/or dimensions as the electrode activation substrate 206 and the dielectric layer of the support structure 104. Thus, the microfluidic device 200 can have two electrowetting surfaces.
In some embodiments, the electrode activation substrate 206 can comprise a photoconductive material, such as described above. Accordingly, in certain embodiments, the electrode activation substrate 206 can comprise or consist of a layer of hydrogenated amorphous silicon (a-Si:H). The a-Si:H can comprise, for example, about 8% to 40% hydrogen (calculated as 100*the number of hydrogen atoms/the total number of hydrogen and silicon atoms). The layer of a-Si:H can have a thickness of about 500 nm to about 2.0 μm. Alternatively, the electrode activation substrate 206 can comprise electrodes (e.g., conductive metal electrodes) controlled by phototransistor switches, as described above. Microfluidic devices having an opto-electrowetting configuration are known in the art and/or can be constructed with electrode activation substrates known in the art. For example, U.S. Pat. No. 6,958,132 (Chiou et al.), the entire contents of which are incorporated herein by reference, discloses opto-electrowetting configurations having a photoconductive material such as a-Si:H, while U.S. Patent Publication No. 2014/0124370 (Short et al.), referenced above, discloses electrode activation substrates having electrodes controlled by phototransistor switches.
The microfluidic device 200 thus can have an opto-electrowetting configuration, and light patterns 218 can be used to activate photoconductive EW regions or photoresponsive EW electrodes in the electrode activation substrate 206. Such activated EW regions or EW electrodes of the electrode activation substrate 206 can generate an electrowetting force at the inner surface 208 of the support structure 104 (i.e., the inner surface of the overlaying dielectric layer or its hydrophobic coating). By changing the light patterns 218 (or moving microfluidic device 200 relative to the light source 216) incident on the electrode activation substrate 206, droplets (e.g., containing an aqueous medium, solution, or solvent) contacting the inner surface 208 of the support structure 104 can be moved through an immiscible fluid (e.g., an oil medium) present in the region/chamber 202.
In other embodiments, microfluidic devices 200 can have an EWOD configuration, and the electrode activation substrate 206 can comprise selectively addressable and energizable electrodes that do not rely upon light for activation. The electrode activation substrate 206 thus can include a pattern of such electrowetting (EW) electrodes. The pattern, for example, can be an array of substantially square EW electrodes arranged in rows and columns, such as shown in
Regardless of the configuration of the microfluidic device 200, a power source 212 can be used to provide a potential (e.g., an AC voltage potential) that powers the electrical circuits of the microfluidic device 200. The power source 212 can be the same as, or a component of, the power source 192 referenced in
Sequestration Pens.
Non-limiting examples of generic sequestration pens 224, 226, and 228 are shown within the microfluidic device 230 depicted in
The sequestration pens 224, 226, and 228 of
The channel 122 can thus be an example of a swept region, and the isolation regions 240 of the sequestration pens 224, 226, 228 can be examples of unswept regions. As noted, the channel 122 and sequestration pens 224, 226, 228 can be configured to contain one or more fluidic media 180. In the example shown in
As is known, a flow 242 of fluidic medium 180 in a microfluidic channel 122 past a proximal opening 234 of sequestration pen 224 can cause a secondary flow 244 of the medium 180 into and/or out of the sequestration pen 224. To isolate micro-objects 246 in the isolation region 240 of a sequestration pen 224 from the secondary flow 244, the length Lcon of the connection region 236 of the sequestration pen 224 (i.e., from the proximal opening 234 to the distal opening 238) should be greater than the penetration depth Dp of the secondary flow 244 into the connection region 236. The penetration depth Dp of the secondary flow 244 depends upon the velocity of the fluidic medium 180 flowing in the channel 122 and various parameters relating to the configuration of the channel 122 and the proximal opening 234 of the connection region 236 to the channel 122. For a given microfluidic device, the configurations of the channel 122 and the opening 234 will be fixed, whereas the rate of flow 242 of fluidic medium 180 in the channel 122 will be variable. Accordingly, for each sequestration pen 224, a maximal velocity Vmax for the flow 242 of fluidic medium 180 in channel 122 can be identified that ensures that the penetration depth Dp of the secondary flow 244 does not exceed the length Lcon of the connection region 236. As long as the rate of the flow 242 of fluidic medium 180 in the channel 122 does not exceed the maximum velocity Vmax, the resulting secondary flow 244 can be limited to the channel 122 and the connection region 236 and kept out of the isolation region 240. The flow 242 of medium 180 in the channel 122 will thus not draw micro-objects 246 out of the isolation region 240. Rather, micro-objects 246 located in the isolation region 240 will stay in the isolation region 240 regardless of the flow 242 of fluidic medium 180 in the channel 122.
Moreover, as long as the rate of flow 242 of medium 180 in the channel 122 does not exceed Vmax, the flow 242 of fluidic medium 180 in the channel 122 will not move miscellaneous particles (e.g., microparticles and/or nanoparticles) from the channel 122 into the isolation region 240 of a sequestration pen 224. Having the length Lcon of the connection region 236 be greater than the maximum penetration depth Dp of the secondary flow 244 can thus prevent contamination of one sequestration pen 224 with miscellaneous particles from the channel 122 or another sequestration pen (e.g., sequestration pens 226, 228 in
Because the channel 122 and the connection regions 236 of the sequestration pens 224, 226, 228 can be affected by the flow 242 of medium 180 in the channel 122, the channel 122 and connection regions 236 can be deemed swept (or flow) regions of the microfluidic device 230. The isolation regions 240 of the sequestration pens 224, 226, 228, on the other hand, can be deemed unswept (or non-flow) regions. For example, components (not shown) in a first fluidic medium 180 in the channel 122 can mix with a second fluidic medium 248 in the isolation region 240 substantially only by diffusion of components of the first medium 180 from the channel 122 through the connection region 236 and into the second fluidic medium 248 in the isolation region 240. Similarly, components (not shown) of the second medium 248 in the isolation region 240 can mix with the first medium 180 in the channel 122 substantially only by diffusion of components of the second medium 248 from the isolation region 240 through the connection region 236 and into the first medium 180 in the channel 122. In some embodiments, the extent of fluidic medium exchange between the isolation region of a sequestration pen and the flow region by diffusion is greater than about 90%, 91%, 92%, 93%, 94% 95%, 96%, 97%, 98%, or greater than about 99% of fluidic exchange. The first medium 180 can be the same medium or a different medium than the second medium 248. Moreover, the first medium 180 and the second medium 248 can start out being the same, then become different (e.g., through conditioning of the second medium 248 by one or more cells in the isolation region 240, or by changing the medium 180 flowing through the channel 122).
The maximum penetration depth Dp of the secondary flow 244 caused by the flow 242 of fluidic medium 180 in the channel 122 can depend on a number of parameters, as mentioned above. Examples of such parameters include: the shape of the channel 122 (e.g., the channel can direct medium into the connection region 236, divert medium away from the connection region 236, or direct medium in a direction substantially perpendicular to the proximal opening 234 of the connection region 236 to the channel 122); a width Wch (or cross-sectional area) of the channel 122 at the proximal opening 234; and a width Wcon (or cross-sectional area) of the connection region 236 at the proximal opening 234; the velocity V of the flow 242 of fluidic medium 180 in the channel 122; the viscosity of the first medium 180 and/or the second medium 248, or the like.
In some embodiments, the dimensions of the channel 122 and sequestration pens 224, 226, 228 can be oriented as follows with respect to the vector of the flow 242 of fluidic medium 180 in the channel 122: the channel width Wch (or cross-sectional area of the channel 122) can be substantially perpendicular to the flow 242 of medium 180; the width Wcon (or cross-sectional area) of the connection region 236 at opening 234 can be substantially parallel to the flow 242 of medium 180 in the channel 122; and/or the length Lcon of the connection region can be substantially perpendicular to the flow 242 of medium 180 in the channel 122. The foregoing are examples only, and the relative position of the channel 122 and sequestration pens 224, 226, 228 can be in other orientations with respect to each other.
As illustrated in
As illustrated in
The microfluidic device 250 of
Each sequestration pen 266 can comprise an isolation structure 272, an isolation region 270 within the isolation structure 272, and a connection region 268. From a proximal opening 274 at the channel 264 to a distal opening 276 at the isolation structure 272, the connection region 268 fluidically connects the channel 264 to the isolation region 270. Generally, in accordance with the above discussion of
As illustrated in
As illustrated in
In various embodiments of sequestration pens (e.g. 124, 126, 128, 130, 224, 226, 228, or 266), the isolation region (e.g. 240 or 270) is configured to contain a plurality of micro-objects. In other embodiments, the isolation region can be configured to contain only one, two, three, four, five, or a similar relatively small number of micro-objects. Accordingly, the volume of an isolation region can be, for example, at least 1×106, 2×106, 4×106, 6×106 cubic microns, or more.
In various embodiments of sequestration pens, the width Wch of the channel (e.g., 122) at a proximal opening (e.g. 234) can be within any of the following ranges: about 50-1000 microns, 50-500 microns, 50-400 microns, 50-300 microns, 50-250 microns, 50-200 microns, 50-150 microns, 50-100 microns, 70-500 microns, 70-400 microns, 70-300 microns, 70-250 microns, 70-200 microns, 70-150 microns, 90-400 microns, 90-300 microns, 90-250 microns, 90-200 microns, 90-150 microns, 100-300 microns, 100-250 microns, 100-200 microns, 100-150 microns, and 100-120 microns. In some other embodiments, the width Wch of the channel (e.g., 122) at a proximal opening (e.g. 234) can be in a range of about 200-800 microns, 200-700 microns, or 200-600 microns. The foregoing are examples only, and the width Wch of the channel 122 can be in other ranges (e.g., a range defined by any of the endpoints listed above). Moreover, the Wch of the channel 122 can be selected to be in any of these ranges in regions of the channel other than at a proximal opening of a sequestration pen.
In some embodiments, a sequestration pen has a height of about 30 to about 200 microns, or about 50 to about 150 microns. In some embodiments, the sequestration pen has a cross-sectional area of about 1×104-3×106 square microns, 2×104-2×106 square microns, 4×104-1×106 square microns, 2×104-5×105 square microns, 2×104-1×105 square microns or about 2×105-2×106 square microns.
In various embodiments of sequestration pens, the height Hch of the channel (e.g., 122) at a proximal opening (e.g., 234) can be within any of the following ranges: 20-100 microns, 20-90 microns, 20-80 microns, 20-70 microns, 20-60 microns, 20-50 microns, 30-100 microns, 30-90 microns, 30-80 microns, 30-70 microns, 30-60 microns, 30-50 microns, 40-100 microns, 40-90 microns, 40-80 microns, 40-70 microns, 40-60 microns, or 40-50 microns. The foregoing are examples only, and the height Hch of the channel (e.g., 122) can be in other ranges (e.g., a range defined by any of the endpoints listed above). The height Hch of the channel 122 can be selected to be in any of these ranges in regions of the channel other than at a proximal opening of an sequestration pen.
In various embodiments of sequestration pens a cross-sectional area of the channel (e.g., 122) at a proximal opening (e.g., 234) can be within any of the following ranges: 500-50,000 square microns, 500-40,000 square microns, 500-30,000 square microns, 500-25,000 square microns, 500-20,000 square microns, 500-15,000 square microns, 500-10,000 square microns, 500-7,500 square microns, 500-5,000 square microns, 1,000-25,000 square microns, 1,000-20,000 square microns, 1,000-15,000 square microns, 1,000-10,000 square microns, 1,000-7,500 square microns, 1,000-5,000 square microns, 2,000-20,000 square microns, 2,000-15,000 square microns, 2,000-10,000 square microns, 2,000-7,500 square microns, 2,000-6,000 square microns, 3,000-20,000 square microns, 3,000-15,000 square microns, 3,000-10,000 square microns, 3,000-7,500 square microns, or 3,000 to 6,000 square microns. The foregoing are examples only, and the cross-sectional area of the channel (e.g., 122) at a proximal opening (e.g., 234) can be in other ranges (e.g., a range defined by any of the endpoints listed above).
In various embodiments of sequestration pens, the length Lcon of the connection region (e.g., 236) can be in any of the following ranges: about 1-600 microns, 5-550 microns, 10-500 microns, 15-400 microns, 20-300 microns, 20-500 microns, 40-400 microns, 60-300 microns, 80-200 microns, or about 100-150 microns. The foregoing are examples only, and length Lcon of a connection region (e.g., 236) can be in a different range than the foregoing examples (e.g., a range defined by any of the endpoints listed above).
In various embodiments of sequestration pens the width Wcon of a connection region (e.g., 236) at a proximal opening (e.g., 234) can be in any of the following ranges: 20-500 microns, 20-400 microns, 20-300 microns, 20-200 microns, 20-150 microns, 20-100 microns, 20-80 microns, 20-60 microns, 30-400 microns, 30-300 microns, 30-200 microns, 30-150 microns, 30-100 microns, 30-80 microns, 30-60 microns, 40-300 microns, 40-200 microns, 40-150 microns, 40-100 microns, 40-80 microns, 40-60 microns, 50-250 microns, 50-200 microns, 50-150 microns, 50-100 microns, 50-80 microns, 60-200 microns, 60-150 microns, 60-100 microns, 60-80 microns, 70-150 microns, 70-100 microns, and 80-100 microns. The foregoing are examples only, and the width Wcon of a connection region (e.g., 236) at a proximal opening (e.g., 234) can be different than the foregoing examples (e.g., a range defined by any of the endpoints listed above).
In various embodiments of sequestration pens, the width Wcon of a connection region (e.g., 236) at a proximal opening (e.g., 234) can be at least as large as the largest dimension of a micro-object (e.g., biological cell which may be a T cell, B cell, or an ovum or embryo) that the sequestration pen is intended for. For example, the width Wcon a connection region 236 at a proximal opening 234 of an sequestration pen that an oocyte, ovum, or embryo will be placed into can be in any of the following ranges: about 100 microns, about 110 microns, about 120 microns, about 130 microns, about 140 microns, about 150 microns, about 160 microns, about 170 microns, about 180 microns, about 190 microns, about 200 microns, about 225 microns, about 250 microns, about 300 microns or about 100-400 microns, about 120-350 microns, about 140-200-200 300 microns, or about 140-200 microns. The foregoing are examples only, and the width Wcon of a connection region (e.g., 236) at a proximal opening (e.g., 234) can be different than the foregoing examples (e.g., a range defined by any of the endpoints listed above).
In various embodiments of sequestration pens, the width Wpr of a proximal opening of a connection region may be at least as large as the largest dimension of a micro-object (e.g., a biological micro-object such as a cell) that the sequestration pen is intended for. For example, the width Wpr may be about 50 microns, about 60 microns, about 100 microns, about 200 microns, about 300 microns or may be in a range of about 50-300 microns, about 50-200 microns, about 50-100 microns, about 75-150 microns, about 75-100 microns, or about 200-300 microns
In various embodiments of sequestration pens, a ratio of the length Lcon of a connection region (e.g., 236) to a width Wcon of the connection region (e.g., 236) at the proximal opening 234 can be greater than or equal to any of the following ratios: 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0, or more. The foregoing are examples only, and the ratio of the length Lcon of a connection region 236 to a width Wcon of the connection region 236 at the proximal opening 234 can be different than the foregoing examples.
In various embodiments of microfluidic devices 100, 200, 230, 250, 280, 290, 300, 400, 500, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2100, 2200, Vmax can be set around 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, or 1.5 microliters/sec.
In various embodiments of microfluidic devices having sequestration pens, the volume of an isolation region (e.g., 240) of a sequestration pen can be, for example, at least 5×105, 8×105, 1×106, 2×106, 4×106, 6×106, 8×106, 1×107, 5×107, 1×108, 5×108, or 8×108 cubic microns, or more. In various embodiments of microfluidic devices having sequestration pens, the volume of a sequestration pen may be about 5×105, 6×105, 8×105, 1×106, 2×106, 4×106, 8×106, 1×107, 3×107, 5×107, or about 8×107 cubic microns, or more. In some other embodiments, the volume of a sequestration pen may be about 1 nanoliter to about 50 nanoliters, 2 nanoliters to about 25 nanoliters, 2 nanoliters to about 20 nanoliters, about 2 nanoliters to about 15 nanoliters, or about 2 nanoliters to about 10 nanoliters.
In various embodiment, the microfluidic device has sequestration pens configured as in any of the embodiments discussed herein where the microfluidic device has about 5 to about 10 sequestration pens, about 10 to about 50 sequestration pens, about 100 to about 500 sequestration pens; about 200 to about 1000 sequestration pens, about 500 to about 1500 sequestration pens, about 1000 to about 2000 sequestration pens, or about 1000 to about 3500 sequestration pens. The sequestration pens need not all be the same size and may include a variety of configurations (e.g., different widths, different features within the sequestration pen.
As illustrated in
Typically, the electrical signal generation subsystem 304 will include a waveform generator (not shown). The electrical signal generation subsystem 304 can further include an oscilloscope (not shown) and/or a waveform amplification circuit (not shown) configured to amplify a waveform received from the waveform generator. The oscilloscope, if present, can be configured to measure the waveform supplied to the microfluidic device 320 held by the socket 302. In certain embodiments, the oscilloscope measures the waveform at a location proximal to the microfluidic device 320 (and distal to the waveform generator), thus ensuring greater accuracy in measuring the waveform actually applied to the device. Data obtained from the oscilloscope measurement can be, for example, provided as feedback to the waveform generator, and the waveform generator can be configured to adjust its output based on such feedback. An example of a suitable combined waveform generator and oscilloscope is the Red Pitaya™.
In certain embodiments, the nest 300 further comprises a controller 308, such as a microprocessor used to sense and/or control the electrical signal generation subsystem 304. Examples of suitable microprocessors include the Arduino™ microprocessors, such as the Arduino Nano™. The controller 308 may be used to perform functions and analysis or may communicate with an external master controller 154 (shown in
In some embodiments, the nest 300 can comprise an electrical signal generation subsystem 304 comprising a Red Pitaya™ waveform generator/oscilloscope unit (“Red Pitaya unit”) and a waveform amplification circuit that amplifies the waveform generated by the Red Pitaya unit and passes the amplified voltage to the microfluidic device 100. In some embodiments, the Red Pitaya unit is configured to measure the amplified voltage at the microfluidic device 320 and then adjust its own output voltage as needed such that the measured voltage at the microfluidic device 320 is the desired value. In some embodiments, the waveform amplification circuit can have a +6.5V to −6.5V power supply generated by a pair of DC-DC converters mounted on the PCBA 322, resulting in a signal of up to 13 Vpp at the microfluidic device 100.
As illustrated in
In some embodiments, the nest 300 can include a thermal control subsystem 306 with a feedback circuit that is an analog voltage divider circuit (not shown) which includes a resistor (e.g., with resistance 1 kOhm+/−0.1%, temperature coefficient +/−0.02 ppm/C0) and a NTC thermistor (e.g., with nominal resistance 1 kOhm+/−0.01%). In some instances, the thermal control subsystem 306 measures the voltage from the feedback circuit and then uses the calculated temperature value as input to an on-board PID control loop algorithm. Output from the PID control loop algorithm can drive, for example, both a directional and a pulse-width-modulated signal pin on a Pololu™ motor drive (not shown) to actuate the thermoelectric power supply, thereby controlling the Peltier thermoelectric device.
The nest 300 can include a serial port 324 which allows the microprocessor of the controller 308 to communicate with an external master controller 154 via the interface 310 (not shown). In addition, the microprocessor of the controller 308 can communicate (e.g., via a Plink tool (not shown)) with the electrical signal generation subsystem 304 and thermal control subsystem 306. Thus, via the combination of the controller 308, the interface 310, and the serial port 324, the electrical signal generation subsystem 304 and the thermal control subsystem 306 can communicate with the external master controller 154. In this manner, the master controller 154 can, among other things, assist the electrical signal generation subsystem 304 by performing scaling calculations for output voltage adjustments. A Graphical User Interface (GUI) (not shown) provided via a display device 170 coupled to the external master controller 154, can be configured to plot temperature and waveform data obtained from the thermal control subsystem 306 and the electrical signal generation subsystem 304, respectively. Alternatively, or in addition, the GUI can allow for updates to the controller 308, the thermal control subsystem 306, and the electrical signal generation subsystem 304.
As discussed above, system 150 can include an imaging device 194. In some embodiments, the imaging device 194 comprises a light modulating subsystem 330 (See
In certain embodiments, the imaging device 194 further comprises a microscope 350. In such embodiments, the nest 300 and light modulating subsystem 330 can be individually configured to be mounted on the microscope 350. The microscope 350 can be, for example, a standard research-grade light microscope or fluorescence microscope. Thus, the nest 300 can be configured to be mounted on the stage 344 of the microscope 350 and/or the light modulating subsystem 330 can be configured to mount on a port of microscope 350. In other embodiments, the nest 300 and the light modulating subsystem 330 described herein can be integral components of microscope 350.
In certain embodiments, the microscope 350 can further include one or more detectors 348. In some embodiments, the detector 348 is controlled by the imaging module 164. The detector 348 can include an eye piece, a charge-coupled device (CCD), a camera (e.g., a digital camera), or any combination thereof. If at least two detectors 348 are present, one detector can be, for example, a fast-frame-rate camera while the other detector can be a high sensitivity camera. Furthermore, the microscope 350 can include an optical train configured to receive reflected and/or emitted light from the microfluidic device 320 and focus at least a portion of the reflected and/or emitted light on the one or more detectors 348. The optical train of the microscope can also include different tube lenses (not shown) for the different detectors, such that the final magnification on each detector can be different.
In certain embodiments, imaging device 194 is configured to use at least two light sources. For example, a first light source 332 can be used to produce structured light (e.g., via the light modulating subsystem 330) and a second light source 334 can be used to provide unstructured light. The first light source 332 can produce structured light for optically-actuated electrokinesis and/or fluorescent excitation, and the second light source 334 can be used to provide bright field illumination. In these embodiments, the motive module 164 can be used to control the first light source 332 and the imaging module 164 can be used to control the second light source 334. The optical train of the microscope 350 can be configured to (1) receive structured light from the light modulating subsystem 330 and focus the structured light on at least a first region in a microfluidic device, such as an optically-actuated electrokinetic device, when the device is being held by the nest 300, and (2) receive reflected and/or emitted light from the microfluidic device and focus at least a portion of such reflected and/or emitted light onto detector 348. The optical train can be further configured to receive unstructured light from a second light source and focus the unstructured light on at least a second region of the microfluidic device, when the device is held by the nest 300. In certain embodiments, the first and second regions of the microfluidic device can be overlapping regions. For example, the first region can be a subset of the second region.
In
In some embodiments, the second light source 334 emits blue light. With an appropriate dichroic filter 346, blue light reflected from the sample plane 342 is able to pass through dichroic filter 346 and reach the detector 348. In contrast, structured light coming from the light modulating subsystem 330 gets reflected from the sample plane 342, but does not pass through the dichroic filter 346. In this example, the dichroic filter 346 is filtering out visible light having a wavelength longer than 495 nm. Such filtering out of the light from the light modulating subsystem 330 would only be complete (as shown) if the light emitted from the light modulating subsystem did not include any wavelengths shorter than 495 nm. In practice, if the light coming from the light modulating subsystem 330 includes wavelengths shorter than 495 nm (e.g., blue wavelengths), then some of the light from the light modulating subsystem would pass through filter 346 to reach the detector 348. In such an embodiment, the filter 346 acts to change the balance between the amount of light that reaches the detector 348 from the first light source 332 and the second light source 334. This can be beneficial if the first light source 332 is significantly stronger than the second light source 334. In other embodiments, the second light source 334 can emit red light, and the dichroic filter 346 can filter out visible light other than red light (e.g., visible light having a wavelength shorter than 650 nm).
Coating Solutions and Coating Agents.
Without intending to be limited by theory, maintenance of a biological micro-object (e.g., a biological cell) within a microfluidic device (e.g., a DEP-configured and/or EW-configured microfluidic device) may be facilitated (i.e., the biological micro-object exhibits increased viability, greater expansion and/or greater portability within the microfluidic device) when at least one or more inner surfaces of the microfluidic device have been conditioned or coated so as to present a layer of organic and/or hydrophilic molecules that provides the primary interface between the microfluidic device and biological micro-object(s) maintained therein. In some embodiments, one or more of the inner surfaces of the microfluidic device (e.g. the inner surface of the electrode activation substrate of a DEP-configured microfluidic device, the cover of the microfluidic device, and/or the surfaces of the circuit material) may be treated with or modified by a coating solution and/or coating agent to generate the desired layer of organic and/or hydrophilic molecules.
The coating may be applied before or after introduction of biological micro-object(s), or may be introduced concurrently with the biological micro-object(s). In some embodiments, the biological micro-object(s) may be imported into the microfluidic device in a fluidic medium that includes one or more coating agents. In other embodiments, the inner surface(s) of the microfluidic device (e.g., a DEP-configured microfluidic device) are treated or “primed” with a coating solution comprising a coating agent prior to introduction of the biological micro-object(s) into the microfluidic device.
In some embodiments, at least one surface of the microfluidic device includes a coating material that provides a layer of organic and/or hydrophilic molecules suitable for maintenance and/or expansion of biological micro-object(s) (e.g. provides a conditioned surface as described below). In some embodiments, substantially all the inner surfaces of the microfluidic device include the coating material. The coated inner surface(s) may include the surface of a flow region (e.g., channel), chamber, or sequestration pen, or a combination thereof. In some embodiments, each of a plurality of sequestration pens has at least one inner surface coated with coating materials. In other embodiments, each of a plurality of flow regions or channels has at least one inner surface coated with coating materials. In some embodiments, at least one inner surface of each of a plurality of sequestration pens and each of a plurality of channels is coated with coating materials.
Coating Agent/Solution.
Any convenient coating agent/coating solution can be used, including but not limited to: serum or serum factors, bovine serum albumin (BSA), polymers, detergents, enzymes, and any combination thereof.
Polymer-Based Coating Materials.
The at least one inner surface may include a coating material that comprises a polymer. The polymer may be covalently or non-covalently bound (or may be non-specifically adhered) to the at least one surface. The polymer may have a variety of structural motifs, such as found in block polymers (and copolymers), star polymers (star copolymers), and graft or comb polymers (graft copolymers), all of which may be suitable for the methods disclosed herein.
The polymer may include a polymer including alkylene ether moieties. A wide variety of alkylene ether containing polymers may be suitable for use in the microfluidic devices described herein. One non-limiting exemplary class of alkylene ether containing polymers are amphiphilic nonionic block copolymers which include blocks of polyethylene oxide (PEO) and polypropylene oxide (PPO) subunits in differing ratios and locations within the polymer chain. Pluronic® polymers (BASF) are block copolymers of this type and are known in the art to be suitable for use when in contact with living cells. The polymers may range in average molecular mass Mw from about 2000 Da to about 20 KDa. In some embodiments, the PEO-PPO block copolymer can have a hydrophilic-lipophilic balance (HLB) greater than about 10 (e.g. 12-18). Specific Pluronic® polymers useful for yielding a coated surface include Pluronic® L44, L64, P85, and F127 (including F127NF). Another class of alkylene ether containing polymers is polyethylene glycol (PEG Mw<100,000 Da) or alternatively polyethylene oxide (PEO, Mw>100,000). In some embodiments, a PEG may have an Mw of about 1000 Da, 5000 Da, 10,000 Da or 20,000 Da.
In other embodiments, the coating material may include a polymer containing carboxylic acid moieties. The carboxylic acid subunit may be an alkyl, alkenyl or aromatic moiety containing subunit. One non-limiting example is polylactic acid (PLA). In other embodiments, the coating material may include a polymer containing phosphate moieties, either at a terminus of the polymer backbone or pendant from the backbone of the polymer. In yet other embodiments, the coating material may include a polymer containing sulfonic acid moieties. The sulfonic acid subunit may be an alkyl, alkenyl or aromatic moiety containing subunit. One non-limiting example is polystyrene sulfonic acid (PSSA) or polyanethole sulfonic acid. In further embodiments, the coating material may include a polymer including amine moieties. The polyamino polymer may include a natural polyamine polymer or a synthetic polyamine polymer. Examples of natural polyamines include spermine, spermidine, and putrescine.
In other embodiments, the coating material may include a polymer containing saccharide moieties. In a non-limiting example, polysaccharides such as xanthan gum or dextran may be suitable to form a material which may reduce or prevent cell sticking in the microfluidic device. For example, a dextran polymer having a size about 3 kDa may be used to provide a coating material for a surface within a microfluidic device.
In other embodiments, the coating material may include a polymer containing nucleotide moieties, i.e. a nucleic acid, which may have ribonucleotide moieties or deoxyribonucleotide moieties, providing a polyelectrolyte surface. The nucleic acid may contain only natural nucleotide moieties or may contain unnatural nucleotide moieties which comprise nucleobase, ribose or phosphate moiety analogs such as 7-deazaadenine, pentose, methyl phosphonate or phosphorothioate moieties without limitation.
In yet other embodiments, the coating material may include a polymer containing amino acid moieties. The polymer containing amino acid moieties may include a natural amino acid containing polymer or an unnatural amino acid containing polymer, either of which may include a peptide, a polypeptide or a protein. In one non-limiting example, the protein may be bovine serum albumin (BSA) and/or serum (or a combination of multiple different sera) comprising albumin and/or one or more other similar proteins as coating agents. The serum can be from any convenient source, including but not limited to fetal calf serum, sheep serum, goat serum, horse serum, and the like. In certain embodiments, BSA in a coating solution is present in a range of form about 1 mg/mL to about 100 mg/mL, including 5 mg/mL, 10 mg/mL, 20 mg/mL, 30 mg/mL, 40 mg/mL, 50 mg/mL, 60 mg/mL, 70 mg/mL, 80 mg/mL, 90 mg/mL, or more or anywhere in between. In certain embodiments, serum in a coating solution may be present in a range of from about 20% (v/v) to about 50% v/v, including 25%, 30%, 35%, 40%, 45%, or more or anywhere in between. In some embodiments, BSA may be present as a coating agent in a coating solution at 5 mg/mL, whereas in other embodiments, BSA may be present as a coating agent in a coating solution at 70 mg/mL. In certain embodiments, serum is present as a coating agent in a coating solution at 30%. In some embodiments, an extracellular matrix (ECM) protein may be provided within the coating material for optimized cell adhesion to foster cell growth. A cell matrix protein, which may be included in a coating material, can include, but is not limited to, a collagen, an elastin, an RGD-containing peptide (e.g. a fibronectin), or a laminin. In yet other embodiments, growth factors, cytokines, hormones or other cell signaling species may be provided within the coating material of the microfluidic device.
In some embodiments, the coating material may include a polymer containing more than one of alkylene oxide moieties, carboxylic acid moieties, sulfonic acid moieties, phosphate moieties, saccharide moieties, nucleotide moieties, or amino acid moieties. In other embodiments, the polymer conditioned surface may include a mixture of more than one polymer each having alkylene oxide moieties, carboxylic acid moieties, sulfonic acid moieties, phosphate moieties, saccharide moieties, nucleotide moieties, and/or amino acid moieties, which may be independently or simultaneously incorporated into the coating material.
Covalently Linked Coating Materials.
In some embodiments, the at least one inner surface includes covalently linked molecules that provide a layer of organic and/or hydrophilic molecules suitable for maintenance/expansion of biological micro-object(s) within the microfluidic device, providing a conditioned surface for such cells.
The covalently linked molecules include a linking group, wherein the linking group is covalently linked to one or more surfaces of the microfluidic device, as described below. The linking group is also covalently linked to a moiety configured to provide a layer of organic and/or hydrophilic molecules suitable for maintenance/expansion of biological micro-object(s).
In some embodiments, the covalently linked moiety configured to provide a layer of organic and/or hydrophilic molecules suitable for maintenance/expansion of biological micro-object(s) may include alkyl or fluoroalkyl (which includes perfluoroalkyl) moieties; mono- or polysaccharides (which may include but is not limited to dextran); alcohols (including but not limited to propargyl alcohol); polyalcohols, including but not limited to polyvinyl alcohol; alkylene ethers, including but not limited to polyethylene glycol; polyelectrolytes (including but not limited to polyacrylic acid or polyvinyl phosphonic acid); amino groups (including derivatives thereof, such as, but not limited to alkylated amines, hydroxyalkylated amino group, guanidinium, and heterocylic groups containing an unaromatized nitrogen ring atom, such as, but not limited to morpholinyl or piperazinyl); carboxylic acids including but not limited to propiolic acid (which may provide a carboxylate anionic surface); phosphonic acids, including but not limited to ethynyl phosphonic acid (which may provide a phosphonate anionic surface); sulfonate anions; carboxybetaines; sulfobetaines; sulfamic acids; or amino acids.
In various embodiments, the covalently linked moiety configured to provide a layer of organic and/or hydrophilic molecules suitable for maintenance/expansion of biological micro-object(s) in the microfluidic device may include non-polymeric moieties such as an alkyl moiety, a substituted alkyl moiety, such as a fluoroalkyl moiety (including but not limited to a perfluoroalkyl moiety), amino acid moiety, alcohol moiety, amino moiety, carboxylic acid moiety, phosphonic acid moiety, sulfonic acid moiety, sulfamic acid moiety, or saccharide moiety. Alternatively, the covalently linked moiety may include polymeric moieties, which may be any of the moieties described above.
In some embodiments, the covalently linked alkyl moiety may comprises carbon atoms forming a linear chain (e.g., a linear chain of at least 10 carbons, or at least 14, 16, 18, 20, 22, or more carbons) and may be an unbranched alkyl moiety. In some embodiments, the alkyl group may include a substituted alkyl group (e.g., some of the carbons in the alkyl group can be fluorinated or perfluorinated). In some embodiments, the alkyl group may include a first segment, which may include a perfluoroalkyl group, joined to a second segment, which may include a non-substituted alkyl group, where the first and second segments may be joined directly or indirectly (e.g., by means of an ether linkage). The first segment of the alkyl group may be located distal to the linking group, and the second segment of the alkyl group may be located proximal to the linking group.
In other embodiments, the covalently linked moiety may include at least one amino acid, which may include more than one type of amino acid. Thus, the covalently linked moiety may include a peptide or a protein. In some embodiments, the covalently linked moiety may include an amino acid which may provide a zwitterionic surface to support cell growth, viability, portability, or any combination thereof.
In other embodiments, the covalently linked moiety may include at least one alkylene oxide moiety, and may include any alkylene oxide polymer as described above. One useful class of alkylene ether containing polymers is polyethylene glycol (PEG Mw<100,000 Da) or alternatively polyethylene oxide (PEO, Mw>100,000). In some embodiments, a PEG may have an Mw of about 1000 Da, 5000 Da, 10,000 Da or 20,000 Da.
The covalently linked moiety may include one or more saccharides. The covalently linked saccharides may be mono-, di-, or polysaccharides. The covalently linked saccharides may be modified to introduce a reactive pairing moiety which permits coupling or elaboration for attachment to the surface. Exemplary reactive pairing moieties may include aldehyde, alkyne or halo moieties. A polysaccharide may be modified in a random fashion, wherein each of the saccharide monomers may be modified or only a portion of the saccharide monomers within the polysaccharide are modified to provide a reactive pairing moiety that may be coupled directly or indirectly to a surface. One exemplar may include a dextran polysaccharide, which may be coupled indirectly to a surface via an unbranched linker.
The covalently linked moiety may include one or more amino groups. The amino group may be a substituted amine moiety, guanidine moiety, nitrogen-containing heterocyclic moiety or heteroaryl moiety. The amino containing moieties may have structures permitting pH modification of the environment within the microfluidic device, and optionally, within the sequestration pens and/or flow regions (e.g., channels).
The coating material providing a conditioned surface may comprise only one kind of covalently linked moiety or may include more than one different kind of covalently linked moiety. For example, the fluoroalkyl conditioned surfaces (including perfluoroalkyl) may have a plurality of covalently linked moieties which are all the same, e.g., having the same linking group and covalent attachment to the surface, the same overall length, and the same number of fluoromethylene units comprising the fluoroalkyl moiety. Alternatively, the coating material may have more than one kind of covalently linked moiety attached to the surface. For example, the coating material may include molecules having covalently linked alkyl or fluoroalkyl moieties having a specified number of methylene or fluoromethylene units and may further include a further set of molecules having charged moieties covalently attached to an alkyl or fluoroalkyl chain having a greater number of methylene or fluoromethylene units, which may provide capacity to present bulkier moieties at the coated surface. In this instance, the first set of molecules having different, less sterically demanding termini and fewer backbone atoms can help to functionalize the entire substrate surface and thereby prevent undesired adhesion or contact with the silicon/silicon oxide, hafnium oxide or alumina making up the substrate itself. In another example, the covalently linked moieties may provide a zwitterionic surface presenting alternating charges in a random fashion on the surface.
Conditioned Surface Properties.
Aside from the composition of the conditioned surface, other factors such as physical thickness of the hydrophobic material can impact DEP force. Various factors can alter the physical thickness of the conditioned surface, such as the manner in which the conditioned surface is formed on the substrate (e.g. vapor deposition, liquid phase deposition, spin coating, flooding, and electrostatic coating). In some embodiments, the conditioned surface has a thickness in the range of about 1 nm to about 10 nm; about 1 nm to about 7 nm; about 1 nm to about 5 nm; or any individual value therebetween. In other embodiments, the conditioned surface formed by the covalently linked moieties may have a thickness of about 10 nm to about 50 nm. In various embodiments, the conditioned surface prepared as described herein has a thickness of less than 10 nm. In some embodiments, the covalently linked moieties of the conditioned surface may form a monolayer when covalently linked to the surface of the microfluidic device (e.g., a DEP configured substrate surface) and may have a thickness of less than 10 nm (e.g., less than 5 nm, or about 1.5 to 3.0 nm). These values are in contrast to that of a CYTOP® (Asahi Glass Co., Ltd. JP) fluoropolymer spin coating, which has a thickness in the range of about 30 nm. In some embodiments, the conditioned surface does not require a perfectly formed monolayer to be suitably functional for operation within a DEP-configured microfluidic device.
In various embodiments, the coating material providing a conditioned surface of the microfluidic device may provide desirable electrical properties. Without intending to be limited by theory, one factor that impacts robustness of a surface coated with a particular coating material is intrinsic charge trapping. Different coating materials may trap electrons, which can lead to breakdown of the coating material. Defects in the coating material may increase charge trapping and lead to further breakdown of the coating material. Similarly, different coating materials have different dielectric strengths (i.e. the minimum applied electric field that results in dielectric breakdown), which may impact charge trapping. In certain embodiments, the coating material can have an overall structure (e.g., a densely-packed monolayer structure) that reduces or limits that amount of charge trapping.
In addition to its electrical properties, the conditioned surface may also have properties that are beneficial in use with biological molecules. For example, a conditioned surface that contains fluorinated (or perfluorinated) carbon chains may provide a benefit relative to alkyl-terminated chains in reducing the amount of surface fouling. Surface fouling, as used herein, refers to the amount of indiscriminate material deposition on the surface of the microfluidic device, which may include permanent or semi-permanent deposition of biomaterials such as protein and its degradation products, nucleic acids and respective degradation products and the like.
Unitary or Multi-Part Conditioned Surface.
The covalently linked coating material may be formed by reaction of a molecule which already contains the moiety configured to provide a layer of organic and/or hydrophilic molecules suitable for maintenance/expansion of biological micro-object(s) in the microfluidic device, as is described below. Alternatively, the covalently linked coating material may be formed in a two-part sequence by coupling the moiety configured to provide a layer of organic and/or hydrophilic molecules suitable for maintenance/expansion of biological micro-object(s) to a surface modifying ligand that itself has been covalently linked to the surface.
Methods of Preparing a Covalently Linked Coating Material.
In some embodiments, a coating material that is covalently linked to the surface of a microfluidic device (e.g., including at least one surface of the sequestration pens and/or flow regions) has a structure of Formula 1 or Formula 2. When the coating material is introduced to the surface in one step, it has a structure of Formula 1, while when the coating material is introduced in a multiple step process, it has a structure of Formula 2.
The coating material may be linked covalently to oxides of the surface of a DEP-configured or EW-configured substrate. The DEP- or EW-configured substrate may comprise silicon, silicon oxide, alumina, or hafnium oxide. Oxides may be present as part of the native chemical structure of the substrate or may be introduced as discussed below.
The coating material may be attached to the oxides via a linking group (“LG”), which may be a siloxy or phosphonate ester group formed from the reaction of a siloxane or phosphonic acid group with the oxides. The moiety configured to provide a layer of organic and/or hydrophilic molecules suitable for maintenance/expansion of biological micro-object(s) in the microfluidic device can be any of the moieties described herein. The linking group LG may be directly or indirectly connected to the moiety configured to provide a layer of organic and/or hydrophilic molecules suitable for maintenance/expansion of biological micro-object(s) in the microfluidic device. When the linking group LG is directly connected to the moiety, optional linker (“L”) is not present and n is 0. When the linking group LG is indirectly connected to the moiety, linker L is present and n is 1. The linker L may have a linear portion where a backbone of the linear portion may include 1 to 200 non-hydrogen atoms selected from any combination of silicon, carbon, nitrogen, oxygen, sulfur and phosphorus atoms, subject to chemical bonding limitations as is known in the art. It may be interrupted with any combination of one or more moieties selected from the group consisting of ether, amino, carbonyl, amido, or phosphonate groups, arylene, heteroarylene, or heterocyclic groups. In some embodiments, the backbone of the linker L may include 10 to 20 atoms. In other embodiments, the backbone of the linker L may include about 5 atoms to about 200 atoms; about 10 atoms to about 80 atoms; about 10 atoms to about 50 atoms; or about 10 atoms to about 40 atoms. In some embodiments, the backbone atoms are all carbon atoms.
In some embodiments, the moiety configured to provide a layer of organic and/or hydrophilic molecules suitable for maintenance/expansion of biological micro-object(s) may be added to the surface of the substrate in a multi-step process, and has a structure of Formula 2, as shown above. The moiety may be any of the moieties described above.
In some embodiments, the coupling group CG represents the resultant group from reaction of a reactive moiety Rx and a reactive pairing moiety Rpx (i.e., a moiety configured to react with the reactive moiety Rx). For example, one typical coupling group CG may include a carboxamidyl group, which is the result of the reaction of an amino group with a derivative of a carboxylic acid, such as an activated ester, an acid chloride or the like. Other CG may include a triazolylene group, a carboxamidyl, thioamidyl, an oxime, a mercaptyl, a disulfide, an ether, or alkenyl group, or any other suitable group that may be formed upon reaction of a reactive moiety with its respective reactive pairing moiety. The coupling group CG may be located at the second end (i.e., the end proximal to the moiety configured to provide a layer of organic and/or hydrophilic molecules suitable for maintenance/expansion of biological micro-object(s) in the microfluidic device) of linker L, which may include any combination of elements as described above. In some other embodiments, the coupling group CG may interrupt the backbone of the linker L. When the coupling group CG is triazolylene, it may be the product resulting from a Click coupling reaction and may be further substituted (e.g., a dibenzocylcooctenyl fused triazolylene group).
In some embodiments, the coating material (or surface modifying ligand) is deposited on the inner surfaces of the microfluidic device using chemical vapor deposition. The vapor deposition process can be optionally improved, for example, by pre-cleaning the cover 110, the microfluidic circuit material 116, and/or the substrate (e.g., the inner surface 208 of the electrode activation substrate 206 of a DEP-configured substrate, or a dielectric layer of the support structure 104 of an EW-configured substrate), by exposure to a solvent bath, sonication or a combination thereof. Alternatively, or in addition, such pre-cleaning can include treating the cover 110, the microfluidic circuit material 116, and/or the substrate in an oxygen plasma cleaner, which can remove various impurities, while at the same time introducing an oxidized surface (e.g. oxides at the surface, which may be covalently modified as described herein). Alternatively, liquid-phase treatments, such as a mixture of hydrochloric acid and hydrogen peroxide or a mixture of sulfuric acid and hydrogen peroxide (e.g., piranha solution, which may have a ratio of sulfuric acid to hydrogen peroxide in a range from about 3:1 to about 7:1) may be used in place of an oxygen plasma cleaner.
In some embodiments, vapor deposition is used to coat the inner surfaces of the microfluidic device 200 after the microfluidic device 200 has been assembled to form an enclosure 102 defining a microfluidic circuit 120. Without intending to be limited by theory, depositing such a coating material on a fully-assembled microfluidic circuit 120 may be beneficial in preventing delamination caused by a weakened bond between the microfluidic circuit material 116 and the electrode activation substrate 206 dielectric layer and/or the cover 110. In embodiments where a two-step process is employed the surface modifying ligand may be introduced via vapor deposition as described above, with subsequent introduction of the moiety configured provide a layer of organic and/or hydrophilic molecules suitable for maintenance/expansion of biological micro-object(s). The subsequent reaction may be performed by exposing the surface modified microfluidic device to a suitable coupling reagent in solution.
In the embodiment shown in
In other embodiments, the coating material 298 used to coat the inner surface(s) 292, 294 of the microfluidic device 290 can include anionic, cationic, or zwitterionic moieties, or any combination thereof. Without intending to be limited by theory, by presenting cationic moieties, anionic moieties, and/or zwitterionic moieties at the inner surfaces of the enclosure 284 of the microfluidic circuit 120, the coating material 298 can form strong hydrogen bonds with water molecules such that the resulting water of hydration acts as a layer (or “shield”) that separates the biological micro-objects from interactions with non-biological molecules (e.g., the silicon and/or silicon oxide of the substrate). In addition, in embodiments in which the coating material 298 is used in conjunction with coating agents, the anions, cations, and/or zwitterions of the coating material 298 can form ionic bonds with the charged portions of non-covalent coating agents (e.g. proteins in solution) that are present in a medium 180 (e.g. a coating solution) in the enclosure 284.
In still other embodiments, the coating material may comprise or be chemically modified to present a hydrophilic coating agent at its enclosure-facing terminus. In some embodiments, the coating material may include an alkylene ether containing polymer, such as PEG. In some embodiments, the coating material may include a polysaccharide, such as dextran. Like the charged moieties discussed above (e.g., anionic, cationic, and zwitterionic moieties), the hydrophilic coating agent can form strong hydrogen bonds with water molecules such that the resulting water of hydration acts as a layer (or “shield”) that separates the biological micro-objects from interactions with non-biological molecules (e.g., the silicon and/or silicon oxide of the substrate).
Further details of appropriate coating treatments and modifications may be found at U.S. application Ser. No. 15/135,707, filed on Apr. 22, 2016, and is incorporated by reference in its entirety.
Additional System Components for Maintenance of Viability of Cells within the Sequestration Pens of the Microfluidic Device.
In order to promote growth and/or expansion of cell populations, environmental conditions conducive to maintaining functional cells may be provided by additional components of the system. For example, such additional components can provide nutrients, cell growth signaling species, pH modulation, gas exchange, temperature control, and removal of waste products from cells.
In Situ-Generated Isolation Structures.
In many applications of microfluidic cell manipulation, it is useful to have the ability to alter structures within the microfluidic environment, based upon optical feedback of the microfluidic contents such micro-objects, cells, beads and the like. It had been difficult within the microfluidics field to make changes to a microfluidic device to alter valving function, to direct flows of media, to direct cells to selected portions of the microfluidic chip, and to select cells using real-time information. In addition, it can be desirable to remove structures as part of a method of processing micro-objects. While optically actuated dielectrophoresis or opto-electrowetting cell and fluid manipulation modes are highly useful for many of these functions, having yet another mode of micro-object and media flow manipulation that provides real-time ability to change the microfluidic flow region and pen environment within the microfluidic device, and to select, isolate and direct cells and fluidic flow therein, is desirable.
It has been surprisingly discovered that a wide variety of isolation structures can be generated in situ within a microfluidic (or nanofluidic) device as described herein. In many embodiments, in situ-generated isolation structures may be fabricated in the presence of biological cells without disturbing general viability. These in situ-generated isolation structures may be used for selectively isolating one cell from a set of cells within a microfluidic device; for selective and reversible valving of media flows, sample-containing flows, or reagent flows; concentration of cells from a dilute input source; assaying cells from a clonal population within the same device; controlled laminar flows; selectively mixed laminar flows; or directed cell line development, amongst other uses. Applicant describes microfluidic devices, compositions and methods of use for these classes of devices having in situ-generated isolation structures.
A microfluidic (or nanofluidic) device is provided which includes an enclosure comprising a substrate, a flow region located within the enclosure, and at least one in situ-generated isolation structure disposed on the substrate. The in situ-generated isolation structure may include a solidified polymer network. The solidified polymer network may include a photoinitiated polymer. In some embodiments, the solidified polymer network does not include a silicone polymer. In some embodiments, the solidified polymer network does not include silicon. In some embodiments, the solidified polymer network may include a thermosenstive polymer. The solidified polymer network may be solidified in situ. All or part of the in situ-generated isolation structure may consist of the solidified polymer network.
The in situ-generated isolation structure may be a fully enclosed structure, a structure open at a portion of its periphery large enough to admit passage of a micro-object, a barrier, or any combination thereof. In some embodiments, the in situ-generated isolation structure can be configured like a pen. Some nonlimiting examples are shown in
An in situ-generated isolation structure may also be an in situ-generated barrier. The in situ-generated pen or barrier may include a plurality of in situ-generated modules which together form the pen or barrier. In various embodiments, the at least one in situ-generated isolation structure may include a plurality of in situ-generated isolation modules disposed in the flow region, where the in situ-generated isolation modules may be configured to substantially restrict passage of micro-objects into, out of, and/or through the at least one in situ-generated isolation structure in a size dependent manner. In some embodiments, each of the plurality of in situ-generated isolation modules may be spaced apart from each other such that micro-objects having a diameter of 5 microns or greater may be substantially prevented from passing into, out of, and/or through the at least one in situ-generated isolation structure. In some embodiments, the plurality of in situ-generated isolation modules may be configured to discriminate between two different types of biological micro-objects, allowing a first type of biological micro-object to pass in and out of the at least one in situ-generated isolation structure and substantially preventing a second type of biological micro-object from passing into, out of, and/or through the at least one in situ-generated isolation structure. In various embodiments, the plurality of in situ-generated isolation modules may be configured to substantially prevent passage of a microbead into, out of, and/or through the at least one in situ-generated isolation structure.
In some embodiments, more than one in situ-generated isolation structure may be generated in the microfluidic device. The microfluidic device may have a plurality of in situ-generated isolation structures. When more than one in situ-generated isolation structure is generated in a microfluidic device, there may be more than one kind of in situ-generated isolation structure generated, and in any combination.
The in situ-generated isolation structure may be designed to be temporary or it may be kept in place until the conclusion of the experiment/assay/sorting/cloning process being performed in the microfluidic device. The solidified polymer network of the in situ-generated isolation structure may be at least partially removable by application of increased fluid flow through the flow region, hydrolysis, proteolysis, osmotic change, temperature change, or optical illumination. In some embodiments, at least a portion of the in situ-generated isolation structure may be removable using a flow of a fluidic medium in the flow region, for one non-limiting example.
In some embodiments, the microfluidic device may further include a plurality of in situ-generated pens. Each of the plurality of in situ-generated pens may be disposed to be arranged adjacent to each other. Each of the plurality of in situ-generated pens may have the proximal opening disposed contiguously to each other. In some embodiments, there may be more than one plurality of in situ-generated pens formed within a flow region or there may be multiple channels having in situ-generated pens disposed along each channel.
The microfluidic (or nanofluidic) device may further include at least one sequestration pen, which may include an isolation region and a connection region, where the connection region has a proximal opening to the flow region and a distal opening to the isolation region. In some embodiments, the sequestration pen may be an in situ-generated isolation structure. In various embodiments, the at least one sequestration pen is not an in situ-generated isolation structure. In some embodiments, the in situ-generated isolation structure may include an in situ-generated barrier. In some embodiments, the microfluidic device may further include a plurality of sequestration pens. The device may further include a microfluidic channel. The plurality of sequestration pens may be located adjacent to each other along the channel. Each of the plurality of sequestration pens may be aligned in a row, with each sequestration pen of the plurality opening off of one side of the microfluidic channel (e.g., opening in a common direction from a wall defining the microfluidic channel). In some embodiments, there may be more than one plurality of sequestration pens within a flow region or there may be multiple channels having sequestration pens disposed along each channel. When more than one plurality of sequestration pens is present within a flow region of a microfluidic device, one or more of the pluralities of sequestration pens may be an in situ-generated isolation structure. Alternatively, within each plurality of sequestration pens, some or all of the sequestration pens may be in situ-generated sequestration pens.
The proximal opening of the sequestration pen to the flow region may be oriented substantially parallel to a flow of fluidic medium in the flow region. In some embodiments, the proximal opening of the sequestration pen to the flow region may be oriented to not directly receive a flow of fluidic medium. Fluidic medium in the flow region (or flow channel) may exchange with the fluidic medium in the isolation region of the sequestration pen substantially only by diffusion. The proximal opening may be oriented at an angle to the fluidic flow such that a micro-object is not removed from the sequestration pen, even if it receives some flow. As an in situ-generated isolation structure may be generated in real time, orientation may not be square to the flow or may be chosen to not be square to the flow.
In some embodiments, the solidified polymer network may be configured to be porous to a flow of fluidic medium. The solidified polymer network may not be porous to at least a subset of a plurality of micro-objects. In some embodiments, the solidified polymer network is substantially non-porous to micro-object having a diameter of greater than about 500 nm, 600 nm, 700 nm, 800 nm, 900 nm, 1 micron, 2 microns, 3 microns, 4 microns, 5 microns, 6 microns, 7 microns, 8 microns, 9 microns, 10 microns, 11 microns, 12 microns, 13 microns, 14 microns, 15 microns, or more.
The solidified polymer network may further have at least a portion formed from photoinitiated polymer. In some embodiments, all of the solidified polymer network may be formed from photoinitiated polymer. In other embodiments, the solidified polymer network may have at least a portion formed from thermosensitive polymer. In some embodiments, the polymer of the solidified polymer network may be a synthetic polymer, a modified synthetic polymer, or a biological polymer. The biological polymer may be light or thermally activatable. The synthetic polymer modifications may include size modification motifs, cleavage motifs, or cell recognition motifs. In some embodiments, the polymer may be a modified polyethylene glycol. The solidified polymer network may be any suitable polymer described herein and more fully discussed below
The microfluidic device may further include a thermal pad. The thermal pad may be disposed on the substrate at a location of the in situ-generated isolation structure. The thermal pad may include a material that has a high thermal conductivity, and optionally, absorbs visible and/or infrared electromagnetic radiation. The thermal pad may be created by deposing a metal shape onto the substrate. The thermal pad can comprise any type of metal that can be excited by a light source to produce heat. Suitable metals include chromium, gold, silver, aluminum, indium tin oxide, or any combination thereof. Metals may be combined in a multi-layered thermal pad, e.g., a layer of chromium, a layer of titanium, a layer of gold. Other metals (and alloys) are known in the art. The thermal pad can comprise a continuous metal surface or can comprise a pattern of metal (e.g. metal shapes such as dots, squares, lines, cones, irregular forms). In some embodiments, a thermal pad may be located beneath all or part of a location where an in situ-generated isolation will be/has been generated. The thermal pad may be used to generate heat to gel, swell, reduce, or remove an in situ-generated isolation structure. Heat may be generated by directing light into the microfluidic device at the location where such gelling, swelling, reduction or removal is desired. Alternatively, the heat may be generated electrically (e.g., by an electrical resistor that is part of or coupled to the thermal pad).
The microfluidic device may include a cover, which may be substantially transparent to illumination having wavelengths in the range for photoactivation of the polymer to form the solidified polymer network of the in situ-generated isolation structures. The cover may also be substantially transparent to illumination in the range suitable for photocleavage and degradation of an in situ-generated isolation structure, thereby allowing the reduction and/or removal of the structure. In various embodiments, the cover may transmit more than about 40%, 50%, 60%, 70%, 80%, or 90% of the light directed through it. A cover may have a lower percentage of light transmission and still be utilizable by increasing the time of exposure.
The enclosure of the microfluidic (or nanofluidic) device may further include a selection sector. In some embodiments, the enclosure may also include an isolation sector. The flow region may be part of the selection sector and may further extend into the isolation sector. The flow region may be configured as a channel which may be disposed in either the selection sector, the isolation sector, or both. In some embodiments, the flow region may not have a channel in the selection sector but may have a channel in the isolation sector. In other embodiments, the flow region occupies both the selection sector and the isolation sector. An in situ-generated isolation structure may be disposed in the selection sector.
In other embodiments, an in situ-generated isolation structure may be disposed in the isolation sector.
An in situ-generated isolation structure may have a plurality of in situ-generated isolation modules disposed in the flow region and configured to prevent exit of at least one of a plurality of micro-objects. The plurality of in situ-generated isolation modules may be referred to interchangeably as in situ-generated barrier modules and the overall in situ-generated isolation structure formed by the in situ-generated isolation modules may be a member of a group of in situ-generated isolation structures referred to herein as in situ-generated barriers.
In some embodiments, the enclosure may include a flow region, at least one sequestration pen having a proximal opening to the microfluidic channel, and an in situ-generated barrier, where the flow region further is or further has a microfluidic channel. The in situ-generated barrier may be at least part of an in situ-generated isolation structure, and may act to isolate a micro-object within the sequestration pen or to isolate selected sequestration pens from other sequestration pens.
The in situ-generated barrier may be located within the enclosure, in a selection sector or an isolation sector, if present, to provide at least a partial blockade of one of the microfluidic channel or the sequestration pen. In some embodiments, the in situ-generated barrier may be located in the isolation region of the sequestration pen.
The barrier may further include a capture moiety configured to capture at least one subset of micro-objects disposed in a sequestration pen or a sector that the barrier surrounds.
In other embodiments, the in situ-generated barrier may be disposed within the connection region of the sequestration pen.
In some embodiments, a width of the in situ-generated barrier is about ¼ to about ¾, about ¼ to about ½, or about ¼ to about ⅝ of a width of the connection region. A width of the in situ-generated barrier across the connection region may be about 3 microns to about 50 microns about 5 microns to about 40 microns, about 5 microns to about 30 microns, about 5 microns to about 20 microns, or about 7 microns to about 25 microns. A width of the connection region may be about 30 microns to about 50 microns, about 20 microns to about 40 microns, about 30 microns to about 60 microns, or about 30 microns to about 90 microns. In some embodiments, the in situ-generated barrier may be configured have a first state and a second state, wherein when the in situ-generated barrier is in the first state, it is configured to prevent exit of at least one subset of the plurality of micro-objects from the sequestration pen and when the in situ-generated barrier is in the second state it is configured to permit the at least one subset to pass out of the sequestration pen. In various embodiments, the in situ-generated barrier is configured have a first state and a second state, where when the in situ-generated barrier is in the first state, it has a size configured to prevent exit of at least one subset of the plurality of micro-objects having a diameter of between 1 microns to 20 microns from the sequestration pen, and when the in situ-generated barrier is in the second state it has a size configured to permit the at least one subset of the plurality of micro-objects to pass out of the sequestration pen. A size of the in situ-generated barrier may be reduced by temperature change or optical illumination sufficiently to permit the isolated micro-object to exit past the reduced barrier.
In other embodiments, the in situ-generated barrier is disposed in the microfluidic channel.
In some embodiments, the in situ-generated barrier may be located close to or at a proximal opening of a sequestration pen.
In some embodiments, where a plurality of sequestration pens is present, the plurality of sequestration pens may form a row along the channel. The in situ-generated barrier may prevent at least one subset of a plurality of micro-objects having a diameter of between 1 microns to 20 microns from moving past the in situ-generated barrier in the channel.
In some embodiments, the in situ-generated barrier may include a plurality of in situ-generated barrier modules disposed in the channel. The in situ-generated barrier may be porous to a flow of fluidic medium, but still prevent at least one subset of micro-objects from moving past the barrier. The in situ-generated barrier may include a plurality of in situ-generated barrier modules disposed in the microfluidic channel, which permits fluidic medium to pass through the gaps between the plurality of in situ-generated barrier modules. Alternatively, the barrier may extend from one wall of the microfluidic channel (or proximal openings of sequestration pens) to the opposing wall of the microfluidic channel, while being porous to a fluidic medium.
The in situ-generated barrier may be disposed at one edge of the proximal opening of a selected pen of the plurality of pens.
In some embodiments, there may be a first plurality of pens and a first channel, and additionally, at least a second plurality of pens disposed along a second channel.
In other embodiments, the in situ-generated barrier may block the proximal openings of at least two contiguous sequestration pens. In some embodiments, a portion of the in situ-generated barrier may extend from the channel into the connection region.
The in situ-generated barrier blocking the proximal openings may have a dimension of at least 50 microns to about 500 microns, 50 microns to about 300 microns, 50 microns to about 200 microns, 70 microns to about 500 microns or about 70 microns to about 400 microns. In some embodiments, the barrier may have a dimension of about 50 microns, 70 microns, 90 microns, 100 microns, 120 microns, 140 microns, 160 microns, 180 microns, 200 microns, 220 microns, 250 microns, 290 microns, 300 microns, 320 microns, 340 microns, 360 microns, 380 microns, 400 microns, 420 microns, 440 microns, 460 microns, 480 microns, 500 microns, or any range defined by two of the foregoing dimensions.
In various embodiments, a microfluidic device is provided, including an enclosure comprising: a substrate; a flow region including a microfluidic channel configured to contain a fluidic medium; a first plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the first plurality opens off a first side of the microfluidic channel; and a second plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the second plurality opens off a second opposing side of the microfluidic channel. One nonlimiting example is shown in
The microfluidic device so configured may be used for culturing and assaying clonal populations of cells, but is not so limited, and may be used for any method of culturing, sorting or assaying. The microfluidic device is configured such that a clonal population may be disposed in at least one of the sequestration pens of the first plurality of pens and one or more cells of the clonal population may be disposed in the respective sequestration pen of the second plurality of sequestration pens.
The microfluidic device may further include a barrier dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of sequestration pens, wherein the barrier is punctuated by at least one gap aligned between a proximal opening (to the first sub-channel) of the first pen of the first plurality of pens and a proximal opening (to the second sub-channel) of a first pen of the second plurality of pens. The barrier may further include a plurality of gaps along a length of the barrier in the microfluidic channel. In some embodiments, each gap may be aligned between a proximal opening (to the first sub-channel) of each pen of the first plurality of pens and a proximal opening (to the second sub-channel) of each respective pen of the second plurality of pens. Other arrangements of the plurality of gaps along the length of the barrier are possible. For example, each of the plurality of gaps along the barrier may be offset from the proximal opening (to the first sub-channel) of each sequestration pen of the first plurality of sequestration pens and the proximal opening (to the second sub-channel) of the respective sequestration pen of the second plurality of sequestration pens. The barrier may have a length that extends from a first end of the channel to a second end of the channel. The barrier may be a permanent barrier and may be formed from the same microfluidic circuit materials that form the sequestration pens and/or channel walls. The one or more cells of the clonal population may be moved from the sequestration pen of the parent clonal population to the respective pen of the second plurality of sequestration pens by being transported through the gap aligned with the pen of the first plurality and the pen of the second plurality. When the barrier is a permanent barrier having one or more gaps along its length in the channel, polymerization may be activated at the one or more gaps, to introduce one or more in situ-generated barriers closing the one or more gaps along its length, where the in situ-generated barriers may comprise a solidified polymer network like any described herein. The solidification of the one or more gaps may separate the first sub-channel from the second sub-channel, and prevent cells from moving from the first sub-channel to the second sub-channel, and vice versa. In some embodiments, the microfluidic device comprises a plurality of in situ-generated barriers, closing a plurality of gaps in the barrier punctuated by a plurality of gaps.
In other embodiments, the microfluidic device includes an in situ-generated barrier, wherein the in situ-generated barrier is disposed along a length of the microfluidic channel, dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of sequestration pens. In some embodiments, the in situ-generated barrier prevents cells from moving from the first sub-channel to the second sub-channel, and vice versa.
Processing of the one or more cells (e.g., one or more cells taken from a clonal population) may be performed in a sequestration pen of the second plurality of sequestration pens. The processing may be performed without disruption of the ongoing culture conditions of the parent clonal population located in the corresponding sequestration pen of the first plurality of sequestration pens.
In other embodiments, a microfluidic device is provided, which includes an enclosure having: a substrate; a channel; at least one sequestration pen; and an in situ-generated barrier. The sequestration pen may include an isolation region and a connection region, the connection region having a proximal opening to the channel and a distal opening to the isolation region.
The in situ-generated barrier may be disposed in the isolation region of the sequestration pen. The in situ-generated barrier disposed in an isolation region of a sequestration pen may have a size as described above. In some embodiments, the size of the in situ-generated barrier may be reduced by temperature change or optical illumination. The in situ-generated barrier may further include a capture moiety configured to capture at least one micro-object disposed in the sequestration pen.
The in situ-generated barrier may be disposed within the connection region of the sequestration pen. The in situ-generated barrier may have a dimension across a width of the connection region of the sequestration pen sized to block exit of at least one subset of a plurality of micro-objects disposed in the isolation region of the sequestration pen. The in situ-generated barrier may be sized to block exit of a biological micro-object. The in situ-generated barrier may be sized to permit exit of a bead. The in situ-generated barrier may further include a capture moiety configured to capture at least one micro-object disposed in the sequestration pen. The in situ-generated barrier disposed in a connection region of a sequestration pen may have a size as described above. A portion of the in situ-generated barrier may extend from the connection region into the channel. The portion of the in situ-generated barrier extending into the channel may be less than 50% of a volume of the barrier
In some embodiments, the in situ-generated barrier may be configured have a first state and a second state, wherein when the in situ-generated barrier is in the first state, it is configured to prevent exit of at least one subset of the plurality of micro-objects from the sequestration pen and when the in situ-generated barrier is in the second state it is configured to permit the at least one subset to pass out of the sequestration pen. In the first state, the in situ-generated barrier may have a larger size to prevent exit of the subset of micro-objects. In the second state, the size of the in situ-generated barrier may be at least reduced to permit exit of the at least one subset of the plurality of micro-objects. A size of the in situ-generated barrier may be at least reduced by application of increased fluid flow through the flow region, hydrolysis, proteolysis, osmotic change, temperature change, or optical illumination.
In various embodiments, the in situ-generated barrier may be disposed in the microfluidic channel. The barrier may be located at one edge of the proximal opening of the sequestration pen, and may extend from the proximal opening across the microfluidic channel. The in situ-generated barrier may prevent at least one subset of a plurality of micro-objects having a diameter of between 1 micron to 20 microns from moving past the barrier in the microfluidic channel. In various embodiments, the in situ-generated barrier may include a plurality of in situ-generated barrier modules disposed in the microfluidic channel. The in situ-generated barrier may be porous to a fluidic medium. The at least one sequestration pen may further include a plurality of sequestration pens. The plurality of sequestration pens may form a row along the microfluidic channel. The in situ-generated barrier may be disposed at the distal edge of the proximal opening of a selected sequestration pen of the plurality of sequestration pens. The pen selected to be the site of solidification of the in situ-generated barrier may be the sequestration pen located at the end of the row of sequestration pens. The barrier may be disposed at a distal edge of the proximal opening of a first sequestration pen of the plurality of sequestration pens. The barrier may prevent at least one subset of a plurality of micro-objects from moving into, out of, and/or through the barrier in the microfluidic channel.
The in situ-generated barrier may include a plurality of in situ-generated barrier modules disposed in the microfluidic channel, which permits fluidic medium to pass through the gaps between the plurality of in situ-generated barrier modules.
The plurality of pens may be a first plurality of pens and the channel is a first channel, and the device further comprises a second plurality of pens disposed along a second channel. The in situ-generated barrier may be located at a distal edge of the proximal opening of the first sequestration pen of the first plurality of sequestration pens. When configured in this manner, the barrier may block the entry of any micro-objects into the first channel, and direct flow of fluidic medium and any micro-objects contained therein to a different portion of the enclosure. The in situ-generated barrier may also or alternatively be formed proximal to the first pen of the second plurality of sequestration pens, where it may block entry of any micro-objects to the second channel.
The in situ-generated barrier may block the proximal openings of at least two contiguous sequestration pens. The barrier blocking the proximal openings may have a dimension of at least 50 microns to about 500 microns across the proximal openings.
In yet another embodiment, the microfluidic device may include a first plurality of sequestration pens disposed in a row, wherein each sequestration pen of the first plurality opens off a first side of the microfluidic channel; and a second plurality of sequestration pens disposed in a row, wherein each sequestration pen of the second plurality opens off a second opposing side of the microfluidic channel, wherein the in situ-generated barrier is disposed along a length of the microfluidic channel, dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of sequestration pens, wherein the barrier prevents cells from moving from the first sub-channel to the second sub-channel, and vice versa. The in situ-generated barrier may include a plurality of in situ-generated barrier modules. The in situ-generated barrier modules may be spaced apart from each other such that the openings between two modules is smaller than the size of a selected micro-object, which may have a size of about 1-20 microns. The in situ-generated barrier may be porous to a flow of fluidic medium. The in situ-generated barrier may be porous to a fluidic medium but not permit at least one type of micro-object to pass into, out of, and/or through the barrier.
In any of the embodiments of the microfluidic device having at least one in situ-generated isolation structure, the substrate may be configured to generate dielectrophoresis (DEP) forces within the enclosure as described herein for microfluidic devices 100, 200, 230, 250, 28, 290, 300 and the like. The DEP forces may be optically actuated. In other embodiments, the substrate of the microfluidic device may be configured to comprise an opto-electrowetting surface, as described herein, and described in more detail in International Application No. PCT/US2016/059234, filed on Oct. 27, 2016, and its disclosure is herewith incorporated in its entirety by reference. The opto-electrowetting surface may be photoresponsive and be optically actuated. In some embodiments, the opto-electrowetting surface may be photoconductive.
In any of the embodiments, at least one inner surface of the enclosure of the microfluidic device may include a conditioned surface. The at least one inner surface may include a surface of the substrate. In some embodiments, all the internal surfaces of the enclosure of the microfluidic device may include a conditioned surface. In various embodiments, the conditioned surface may be a covalently modified surface. In various embodiments, the covalently modified surface may be hydrophilic.
A fuller understanding of the invention may be had by referring to some of the embodiments described in the following Figures.
For the embodiments of
The in situ-generated barrier trap (1020+1024) can be formed by copolymerizing two polymers, one having, for example, an RGD peptide motif, or by modifying a precursor prepolymer to have such motif. Another alternative is to immobilize antibodies within the in situ-generated barrier trap or immobilizing the antibodies after the barrier trap has been formed. In one example, biotinylated or streptavidin sites can be introduced either throughout the trap or just on the surface of the in situ-generated barrier 1020, and streptavidin or biotin labeled antibodies may associate with the biotin. Alternatively, modified antibodies may be devised, containing a photoactivatable functionality, such as benzophenone, which may be subjected to photoinitiated insertion into the surface of the polymer barrier at the same time, or after formation of the in situ-generated barrier.
In another variation, microfluidic device 1300 may include thermal pads (not shown) at the points where one wishes to introduce in situ-generated barriers 1320 at channels 1302, 1304, 1306. Heating the thermal pads with a laser to locally increase the temperature, in the presence of a temperature sensitive polymer, can form a hydrogel in the area defined by the thermal pad and laser. As the light is removed, it cools and the hydrogel may dissolve.
In some embodiments, the in situ-generated barrier may be removed, and a second set of one or more cell(s) derived from each or a selected number of the clonal populations of the first plurality of sequestration pens may be introduced to the opposing pens. A second in-situ-generated barrier may be introduced and subsequent assaying or other processing may be performed upon them.
In some embodiments, the microfluidic device may have a barrier present when cells are introduced, wherein the barrier is punctuated with one or more gaps (not shown). The barrier punctuated with one or more gaps may not be an in situ-generated barrier, but may be formed from the same microfluidic circuit material that forms the sequestration pens and the microfluidic channel wall. The gap(s) are aligned adjacent to the opening of a first pen (e.g., 830) of the first plurality of sequestration pens and also aligned with the opening of the respective first pen (e.g., 830′) of the second plurality of sequestration pens. The one or more gaps have a size configured to permit the one or more cell of the first clonal population to be selected and moved from the first pen of the first plurality of pens on the first side of the microfluidic channel to the first pen of the second plurality of pens on the opposing second side of the microfluidic channel. After delivery of the cells 631′, 633′, 635′, the one or more gaps may be closed with one or more in situ-generated barriers as described above. The cells 631′, 633′, 635′ may be further processed in any suitable method as described herein and may be assayed to identify desirable clonal populations of cells. The desirable clonal population of cells may be exported for further expansion or development, or may be cultured in place in the sequestration pens of microfluidic device 1400. Clonal populations identified as not desirable may be exported from the sequestration pens and may further be exported from the microfluidic device 1400.
Any of these laminar in situ-generated barriers (
The microfluidic device 400, 500, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000 may have any combination of features, components or dimensions as described for microfluidic devices 100, 200, 230, 250, 280, 290, 300 and may be suitably used for any method described. Microfluidic device 400, 500, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000 may further be combined with any feature described for a respective other of microfluidic device 400, 500, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2100, 2200, in any suitable combination and used in any suitable method described herein, as one of skill would select.
Polymers for Use in the Solidified Polymer Network of the In Situ-Generated Isolation Structure.
In various embodiments of the solidified polymer network of an isolation structure, the solidified polymer network may be a synthetic polymer, a modified synthetic polymer, or a light or temperature activatable biological polymer. The biological polymer may be configured to be temperature or light activatable to form a solidified polymer network. In some embodiments, the biological polymer may be modified to incorporate moieties providing the ability to be temperature or light activatable. The synthetic polymer modifications may include size modification motifs, cleavage motifs, reactive terminal moieties, and/or cell recognition motifs in any combination.
In some embodiments of the solidified polymer network of an isolation structure, the solidified polymer network may include at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyacrylamide (PAM), modified polyacrylamide, poly-N-isopropylacrylamide (PNIPAm), modified poly-N-isopropylacrylamide, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination. In other embodiments, the polymer may include at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination. In yet other embodiments, the polymer may include at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, or a co-polymer in any combination. In some embodiments, the solidified polymer network does not include a silicone polymer. In some embodiments, the solidified polymer network may not include a polylactic acid (PLA) or a modified polylactic acid polymer. In other embodiments, the solidified polymer network may not include a polyglycolic acid (PGA) or a modified polyglycolic polymer. In some embodiments, the solidified polymer network may not include a polyacrylamide or a modified polyacrylamide polymer. In yet other embodiments, the solidified polymer network may not include a polyvinyl alcohol (PVA) or a modified polyvinyl alcohol polymer. In some embodiments, the solidified polymer network may not include a polyacrylic (PAA) or modified PAA polymer. In some other embodiments, the solidified polymer network may not include a polycaprolactone (PCL) or a modified polycaprolactone polymer. In other embodiments, the solidified polymer network may not be formed from a fibronectin or a modified fibronectin polymer. In some other embodiments, the solidified polymer network may not be formed from a collagen or a modified collagen polymer. In some other embodiments, the solidified polymer network may not be formed from a laminin or a modified laminin polymer.
Physical and chemical characteristics determining suitability of a polymer for use in the solidified polymer network may include molecular weight, hydrophobicity, solubility, rate of diffusion, viscosity (e.g., of the medium), excitation and/or emission range (e.g., of fluorescent reagents immobilized therein), known background fluorescence, characteristics influencing polymerization, and pore size of a solidified polymer network. The solidified polymer network is formed upon polymerization or thermal gelling of a flowable polymer (e.g., a pre-polymer solution,)
One type of polymer, amongst the many polymers that may be used, is polyethylene glycol diacrylate (PEGDA). The mechanism of light initiated polymerization is shown in Equation 1. The free radical initiator Igracure® 2959 (BASF), a highly efficient, non-yellowing radical, alpha hydroxy ketone photoinitiator, is typically used for initiation at wavelengths in the UV region (e.g., 365 nm), but other initiators may be used. An example of another useful photoinitiator class for polymerization reactions is the group of lithium acyl phosphinate salts, of which lithium phenyl 2, 4, 6,-trimethylbenzolylphosphinate has particular utility due to its more efficient absorption at longer wavelengths (e.g., 405 nm) than that of the alpha hydroxy ketone class.
Other types of PEG that may be photopolymerized include PEG dimethylacrylate, and/or multiarm PEG (n-PEG) acrylate (n-PEG-Acr). Other polymer classes that may be used include poly vinyl alcohol (PVA), polylactic acid (PLA) polyacrylic acid (PAA), polyacrylamide (PAM), polyglycolic acid (PGA) or polycaprolactone (PCL).
The molecular weight range of the polymer may be varied as required for the performance of the isolation structures of the invention. A wide range of molecular weights of the flowable polymer may be suitable, depending upon the structure of the polymer. A useful star type polymer may have Mw (weight average molecular weight) in a range from about 500 Da to about 20 kDa (e.g., four arm polymer), or up to about 5 kDa for each arm or for a linear polymer, or any value therebetween. In some embodiments, a polymer having a higher molecular weight range, may be used at lower concentrations in the flowable polymer, and still provide an in situ-generated barrier or isolation structure that may be used in the methods described herein.
Various co-polymer classes may be used, including but not limited to: any of the above listed polymer, or biological polymers such as fibronectin, collagen or laminin. Polysaccharides such as dextran or modified collagens may be used. Biological polymers having photoactivatable functionalities for polymerization may also be used.
Crosslinking may be performed by radiation of linear or branched PEG polymers, free radical polymerization of PRG acrylates, and specifically tailored chemical reactions such as Michael addition, condensation, Click chemistry, native chemical ligation and/or enzymatic reactions.
The polymers may be selected to have a desired range of crosslinking based on the nature of the polymer (configuration of the flowable polymers such as star, multiarm or comb polymers, length of polymer segments between crosslinkable functionalities) and polymerization conditions (extent of temperature or photoinitiation, amount of photoactivatable initiator present, amount of radical terminator species present, and the like).
In some embodiments, the polymer of the solidified polymer network may be a modified PEG polymer. The polymer may be a star, 4-arm or 2-arm PEG diacrylate polymer.
Swellable Polymers.
PEG polymers may be swellable under various conditions and may be reversed by reverting back to the original media/temperature. Poly-N-isopropylacrylamide (PNIPAm) may be swelled by increasing temperature, and de-swelled by cooling.
Size Modification Motifs.
Some hydrogels, including poly-N-isopropylacrylamide (PNIPAm) or poly acrylamide (PAM), may also incorporate specific moieties such as azobenzene which changes cis/trans orientation upon exposure to light at the surface of the functionalized polymer. This shift can provide significant change in size of the portion of polymer such as an isolation structure within a pen. These polymers may alternatively include cinnamic acid functionalities that cross link upon exposure to UV light, which is reversible upon removal of the light. The cross-linked polymer is elongated compared to the non-crosslinked state. Another moiety which may be introduced to these polymers includes triphenyl leucomethane, which forms ion pairs upon application of light, reversibly, upon exposure to light. The wavelength of activating light can be brought into the visible range if trisodium copper chlorophyllin is incorporated into the polymer.
Other Modifications for Functionalization.
A polymer (e.g., PEG) may be modified by incorporating one or more different motifs within the (PEG) polymer. The motifs may include size modification motifs, cleavage motifs, reactive terminal motifs, and/or cell recognition motifs, in any combination. A size modification motif may include susceptibility to changes in temperature, ionic strength or pH of a surrounding medium that may cause a change in physical size of the solidified polymer network, thereby causing a change in size of the isolation structure. A non-limiting example may include a Lower Critical Solution Temperature (LCST) or an Upper Critical Solution Temperature (UCST) polymer, such as poly N-isopropylacrylamide (PNIPAm). Another example is the incorporation of disulfide bonds within a polymer such as PEB.
A cleavage motif may include a peptide sequence inserted into the polymer that is a substrate for one or more proteases, including but not limited to a matrix metalloproteinase, a collagenase, or a serine proteinase such as Proteinase K. Another category of cleavage motif may include a photocleavable motif such as a nitrobenzyl photocleavable linker which may be inserted into selected locations of the prepolymer. In some embodiments, a nitrobenzyl photocleavable linker may include a 1-methinyl, 2-nitrobenzyl moiety configured to be photocleavable. In other embodiments, the photocleavable linker may include a benzoin moiety, a 1, 3 nitrophenolyl moiety, a coumarin-4-ylmethyl moiety or a 1-hydroxy 2-cinnamoyl moiety. A cleavage motif may be utilized to remove the solidified polymer network of an isolation structure. In other embodiments, the polymer may include cell recognition motifs including but not limited to a RGD peptide motif, which is recognized by integrins.
Reversing/Removing/Minimizing the In Situ-Generated Isolation Structure.
A number of mechanisms may be used to remove or reduce the in situ-generated isolation structure when there is no further purpose for it. For example, once an assay is completed and desirable biological cells have been identified, it may be useful to remove the isolation structure in order to continue culturing and expanding the biological cell demonstrating desirable activities or properties.
Mechanical force. Increasing flow can be used if at least a portion of the isolation structure is located within a flow region as opposed to an isolation region of a pen. For example, the at least one isolation structure may be located within an isolation region of a sequestration pen, and after the assay is complete, the sequestration pen or the isolation region therein may be modified to bring flow through the isolation region.
Hydrolytic susceptibility: Porogens, including polymers which are incapable of being chemically linked to the photoinitiated polymer(s), may be including when forming the isolation structure. The degree/size of openings within the formed hydrogel can customize the hydrolysis rate via accessibility within the isolation structure). In other embodiments, the pores formed may be employed to permit secreted materials or chemical reagents to pass through the isolation structure but prevent a cell from moving into, out of, and/or through the isolation structure. In other embodiments, degradability of these polymers may be increased by introducing degradable segments such as polyester, acetal, fumarate, poly(propylene fumarate) or polyhydroxyacids into polymers (e.g., PEG polymers).
Reducing agents: PEG may be formed with disulfide linkages at intervals along the macromere, which may be random or predetermined. The disulfide bonds may be broken by Dithiothreitol (DTT), mercaptoethanol, or TCEP.
Thermal: poly N-isopropylacrylamide (PNIPAm) or other suitable LCST polymers may be used to introduce isolation structures upon heating. They may be removed by decreasing the temperature of the formed polymer isolation structure. The polymers may include ELPs or other motifs that also permit removal by other mechanisms such as hydrolysis or proteolysis. In particular, PNIPAm may be used to create a surface for adherent cells, but then switched to permit export.
Proteolytic susceptibility: Hydrogels may have any sort of peptide sequence engineered in, such that selective proteolysis upon a selected motif by a selected protease can remove/reverse/or minimize a hydrogel isolation structure. Some classes of modified PEG include PEG having elastin like peptide (ELP) motifs and/or having peptide motifs for susceptibility to a variety of proteases (enzyme sensitive peptide ESP). A large number of these motifs are known. One useful motif is RGD which may be constrained to be cyclic.
Osmotic susceptibility: Calcium concentration/other osmotic strategies can be employed to degrade and remove an isolation structure. As above, changes of media flowed through the channel or flow region may dimensionally swell or de-swell isolation structures.
Photocleavage: As described above, if a polymer of the solidified polymer network includes a photocleavable moiety, directing illumination of an exciting wavelength to the solidified polymer network will cause cleavage within sections of the solidified polymer network. This cleavage may provide complete or partial disruption of the solidified polymer network, thereby removing or reducing the isolation structure. If a partial disruption of the solidified polymer network is provided by the photocleavage, complete disruption (e.g., complete removal of this isolation structure) may be effected by flowing a fluidic medium in the channel or flow region to sweep partially disrupted portions of the solidified polymer network away from the isolated one or more micro-objects.
In some applications, the isolation structure may not be removed but may simply be swelled or de-swelled using light or media\solvent changes. Some types of hydrogels may incorporate moieties that respond reversibly to light (for example, change regiochemistry about a rigid bond; form reversible crosslinks within the polymer, or form/break ion pairs).
Microfluidic (or Nanofluidic) Device Assisted Heating.
The microfluidic device may further include a metal pad disposed on the substrate at a location of the in situ-generated isolation structure. The metal pad may be created by deposing a contiguous metal shape or a pattern of metal shapes onto the substrate. The thermal pad can comprise any type of metal that can be excited by a light source to produce heat. Suitable metals include chromium, gold, silver, aluminum, indium tin oxide, or any combination thereof. Metals may be combined in a multi-layered thermal pad, e.g., a layer of chromium, a layer of titanium, a layer of gold. Other metals (and alloys) are known in the art. The thermal pad can comprise a continuous metal surface or can comprise a pattern of metal (e.g. metal shapes such as dots, squares, lines, cones, irregular forms). In some embodiments, a gold pad may be disposed on the substrate at a location where an in situ-generated isolation structure will be/has been generated. The thermal pad may be used to generate heat to gel, swell, reduce, or remove an in situ-generated isolation structure. Heat may be generated by directing light into the microfluidic device at the location where such gelling, swelling, reduction or removal is desired. In some embodiments, the solidified polymer network may include a thermosensitive polymer. When a solidified polymer network of an isolation structure includes a thermosensitive polymer, the device may further include a thermal pad disposed on the substrate at a location beneath the at least one in situ-generated isolation structure will be introduced.
Methods.
In situ-generated isolation structures, which may fully enclose a region within the microfluidic device or partially enclose a region in the manner of a pen or sequestration pen, and which may be an in situ-generated barrier, may be introduced either before or after introduction of cells to the microfluidic (or nanofluidic) device. The in situ-generated isolation structures may be designed to be temporary or may be kept in place for at least the duration of a sorting and/or concentrating and/or processing procedure.
The in situ-generated isolation structures may be introduced by photoactivation, temperature change, or osmotic change which can cause a polymer solution present within the microfluidic to form an isolation structure capable of preventing a biological cell or a bead from crossing the isolation structure. Depending on the mesh size of the polymeric in situ-generated barrier/isolation structure, different categories of chemical species may be permitted to pass through the barrier. If the mesh size is chosen to be about 2 nm, only small molecule components may be permitted to pass, but proteins, etc. may sequestered by the isolation structure/barrier. The in situ-generated isolation structure/barrier may be formed of a polymer having a larger mesh size that may not prevent smaller substances such as proteins, nucleic acids, organelles, or signaling molecules from crossing the barrier. The in situ-generated isolation structure/barrier may permit media to pass through while not permitting a cell or a bead to enter, exit and/or pass through the in situ-generate structure/barrier. The in situ-generated isolation structure/barrier may have a mesh size (effective size of openings or voids between crosslinked polymer strands) that permits a bead (including but not limited to a magnetic bead, polystyrene bead or glass bead) to enter, exit and/or pass through the isolation structure/barrier while retaining a biological cell.
The process of introducing light activated polymerization can be performed within the microfluidic device, and may additionally be performed in the presence of cells. A photoactivatable polymerization initiator may be introduced before, contemporaneously, or after addition of the flowable polymer. Diffusion can compete with the polymerization process, so the ability to quickly create free radicals may be useful. Additionally, free radicals can quickly combine with free oxygen. While photopolymerization may be very efficient and quick in the absence of oxygen in the media, when biological cells are present (thus requiring the presence of oxygen), adjustments to the number of initiating radicals may be made to compensate. In fact, for the introduction of many of the types of barriers useful within a microfluidic device, the limiting effect of oxygen may be helpful as chain termination may happen more quickly and may limit the amount of extraneous polymer formed, particularly when introducing limited amounts of polymer to form small barriers that do not entirely block a pen or a channel.
In the methods of isolating micro-objects with in situ generated isolation structures, including any variations described herein, a microfluidic environment is provided where micro-objects may be sorted, concentrated, and/or selectively disposed in preselected regions or sequestration pens of a microfluidic device. Micro-objects isolated by the in situ-generated isolation structures described herein may be selectively retained within the microfluidic device while non-isolated micro-objects are exported, and may further be selectively released thereafter for further processing in the absence of the micro-objects not selected by the isolation process. Additionally, either isolated micro-objects or non-isolated micro-objects may further be selectively processed in the microfluidic device, which may include any type of assay or preparation for further processing such as lysis, gene editing or genotyping.
In one aspect, a method of isolating a micro-object in a microfluidic device is provided, including the steps of: providing the microfluidic device, where the microfluidic device includes an enclosure including a substrate and a flow region; introducing a first fluidic medium into the enclosure of the microfluidic device; introducing a plurality of micro-objects in the fluidic medium into the enclosure; introducing a flowable polymer into the enclosure before or after the introducing of the plurality of micro-objects; activating solidification of the flowable polymer at at least one selected area of the flow region, thereby forming an in situ-generated isolation structure; and isolating at least one of the plurality of micro-objects with the in situ-generated isolation structure.
In various embodiments of the method, the method may further include exporting a remainder of the plurality of micro-objects from the microfluidic device. The remainder of the plurality of micro-objects may be a selected portion of the plurality of micro-objects. In other embodiments, the at least one micro-object isolated by the in situ-generated isolation structure may be the selected portion of the plurality of micro-objects.
In various embodiments of the method, the method may further include the step of reducing or removing the in situ-generated isolation structure (which may include an in situ-generated barrier, one or more in situ-generated barrier modules, and/or one or more in situ-generated isolation modules) by increasing flow of a fluidic medium, introducing a hydrolytic agent, introducing a proteolytic agent, increasing/decreasing osmolality of the fluidic medium, changing temperature of the in situ-generated isolation structure, or optically illuminating the in situ-generated isolation structure, thereby releasing the at least one micro-object from being isolated. The step of changing the temperature may further include optically illuminating a thermal pad on the substrate adjacent to or under the in situ-generated isolation structure. In various embodiments of the method, the method may further include the step of exporting the at least one released micro-object from the microfluidic device. In various embodiments of the method, exporting the selected portion of the plurality of micro-objects from the microfluidic device may further include moving the selected portion of the plurality of micro-objects to a different portion of the substrate of the microfluidic device.
In various embodiments of the method, the in situ-generated isolation structure may be porous to a flow of a fluidic medium, while preventing some or all subsets of micro-objects from entering, exiting and/or passing through the in situ-generated isolation structure.
In various embodiments of the method, the step of activating solidification of the flowable polymer may form an in situ-generated isolation structure that may be an in situ-generated pen.
The step of activating solidification of the flowable polymer may further include forming an in situ-generated pen having a plurality of in situ-generated pen modules, each of the plurality of sub-units spaced apart from each other at a distance preventing the at least one isolated micro-object from exiting the pen. In some embodiments, the plurality of in situ-generated pen modules may be spaced apart from each other at a distance preventing at least one subset of micro-objects of the plurality of micro-objects from passing through the in situ-generated pen. The micro-objects may have a diameter between about 1-20 microns. In some embodiments, the at least one subset of micro-objects includes at least one type of biological cell.
In some embodiments, the step of activating solidification of the flowable polymer may form an in situ-generated isolation structure including an in situ-generated barrier configured to prevent the at least one micro-object from passing through the barrier. In some embodiments, a plurality of barriers may be introduced, and the plurality of barriers may be configured to allow isolation of respective sub-sets of at least one micro-object of the plurality of micro-objects. The method may include a step of reducing a size or removing the in-situ generated isolation structure, thereby releasing the at least one micro-object.
In various embodiments of the method, the method may further include the step of exporting the one or more sub-sets of the at least one released micro-object from the microfluidic device. Exporting the one or more sub-sets of the at least one micro-object may include moving the one or more sub-sets of the at least one micro-object to a different portion of the microfluidic device. The other portion of the microfluidic device may include a sequestration pen.
In various embodiments of the method, the step of activating solidification may further include forming an in situ-generated barrier having a plurality of in situ-generated barrier modules, each of the plurality of in situ-generated modules spaced apart from each other at a distance preventing the at least one micro-object from passing through the in situ-generated barrier. In various embodiments of the method, the method may further include the step of spacing the plurality of in situ-generated barrier modules apart from each other thereby forming an in situ-generated barrier preventing at least one subset of micro-objects of the plurality of micro-objects from passing through the in situ-generated barrier. The at least one subset of micro-objects may include at least one type of biological cell.
In various embodiments of the method, the enclosure of the microfluidic device may further include at least one sequestration pen including an isolation region and a connection region, the connection region having a proximal opening to the flow region and a distal opening to the isolation region. The enclosure may include a plurality of sequestration pens. The plurality of sequestration pens may be aligned in a row, and the proximal opening of each of the plurality of sequestration pens may be disposed contiguously to each other. In some embodiments, the flow region may include a channel and the proximal opening of each of the plurality of sequestration pens may open off one side of the channel.
In various embodiments of the method, the step of activation of solidification may be performed inside a sequestration pen. In some embodiments, the step of activating solidification may be performed within the isolation region or the connection region.
In some embodiments, the step of activating solidification of the flowable polymer may generate an in situ-generated barrier in the connection region. The method may further include the step of modifying the in situ-generated barrier to include a capture moiety configured to capture at least one micro-object disposed in the sequestration pen. The in situ-generated barrier may have a width across the connection region that may be about ¼ to about ¾ of a width of the connection region. In some embodiments, the width of the in situ-generated barrier across the connection region may be about 5 microns to about 20 microns.
In some embodiments, the method may further include the step of exporting a remainder of the plurality of micro-objects not isolated by the in situ-generated barrier from the microfluidic device.
In various embodiments of the method, the method may further include a step of reducing or removing one or more of the plurality of in situ-generated barriers, thereby releasing the at least one micro-object from isolation. In various embodiments, the method may further include the step of exporting the at least one micro-object from the microfluidic device, after it has been released from isolation by the in situ-generated barrier.
In some embodiments, the step of activating solidification of the flowable polymer may form an in situ-generated barrier in the channel. In various embodiments, the step of activating solidification of the flowable polymer may dispose the in situ-generated barrier adjacent to a proximal opening of at least one sequestration pen of the plurality of sequestration pens. In some embodiments, where a plurality of sequestration pens may be present and the plurality of sequestration pens form a row, and the step of activating solidification of the flowable polymer may dispose the in situ-generated barrier adjacent to a distal edge of the proximal opening of a sequestration pen located at the end of the row of sequestration pens. In some embodiments of the method, the isolating step may include preventing the at least one micro-object of the plurality of micro-objects from moving past the in situ-generated barrier in the channel. In other embodiments, the isolating step may include preventing at least one subset of the plurality of micro-objects from moving past the in situ-generated barrier in the channel.
In various embodiments of the method, the step of activating solidification of the flowable polymer may further include forming an in situ-generated barrier having a plurality of in situ-generated barrier modules, each of the plurality of modules spaced apart from each other at a distance preventing the at least one micro-object of the plurality of micro-objects from moving past the barrier in the channel. In some embodiments, the step activating solidification of the flowable polymer may further include forming the plurality of in situ-generated barrier modules at a distance preventing at least one subset of micro-objects of the plurality of micro-objects from moving past the barrier. In some embodiments, where a plurality of sequestration pens may be present and the plurality of sequestration pens form a row, and the step of activating solidification of the flowable polymer may dispose the barrier adjacent to a distal edge of the proximal opening of a sequestration pen located at the end of the row of sequestration pens. In various embodiments, the isolating step may include preventing the at least one micro-object from passing the selected sequestration pen.
In some embodiments, the step of activating solidification of the flowable polymer may form an in situ-generated barrier sized to block the proximal openings of at least two contiguous sequestration pens. The in situ-generated barrier blocking the proximal openings may have a dimension of at least 50 microns to about 500 microns.
In some embodiments, the step of activating solidification of the flowable polymer may form the barrier at a distal edge of the proximal opening of a first sequestration pen of the plurality of pens.
In various embodiments of the method, the microfluidic device may include a first plurality of sequestration pens disposed adjacent to each other on a first side of the channel and the microfluidic device further includes a second plurality of sequestration pens disposed adjacent to each other on a second opposing side of the microfluidic channel.
In some embodiments, the step of activating solidification of the flowable polymer may include activating solidification of the flowable polymer along a length of the microfluidic channel, thereby forming an in situ-generated isolation structure including an in situ-generated barrier dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of a fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of pens, wherein the in situ-generated barrier prevents micro-objects from moving from the first sub-channel to the second sub-channel, and vice versa.
In other embodiments, the microfluidic device may further include a barrier dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of a fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of pens, the barrier punctuated by at least one gap aligned with a proximal opening to the first sub-channel of a first sequestration pen of the first plurality of sequestration pens and aligned with a proximal opening to a proximal opening to the second sub-channel of a first pen of the second plurality of sequestration pens; and further wherein the step of activating polymerization may include activating polymerization at the at least one gap to form at least one in situ-generated barrier in the at least one gap, thereby preventing micro-objects from moving from the first sub-channel to the second sub-channel, and vice versa. In some embodiments, when the microfluidic device includes a barrier punctuated by at least one gap, the step of moving the at least one cell of each clonal population in the first plurality of sequestration pens comprises moving the at least one cell to the respective sequestration pen of the second plurality of pens through the at least one gap. In some embodiments, the barrier has a plurality of gaps. Each gap may be aligned across from the proximal opening (to the microfluidic channel) of each sequestration pen of the first plurality of sequestration pens and, optionally, also aligned with the proximal opening of each respective sequestration pen of the second plurality of sequestration pens to the microfluidic channel. The step of activating solidification can include forming a one or more in situ-generated barriers closing the one or more of the plurality of gaps. In various embodiments of the method, the method may further include the step of introducing a second fluidic medium into the second sub-channel. The method may further include the step of flowing the first fluidic medium in the first sub-channel and flowing the second fluidic medium in the second sub-channel along the in situ-generated barrier to respective first and second outputs of the device. In some embodiments, the isolating step may further include preventing the first medium from mixing with the second medium in the second sub-channel. In yet further embodiments, the isolating step may further include growing each of the first biological micro-objects of each respective clonal populations in the second fluidic medium, whereby the first biological micro-objects in the second plurality of sequestration pens grow differently from the respective clonal populations in the first plurality of sequestration pens. The method may further include the step of expanding each of the first biological micro-objects in each of the second plurality of sequestration pens to provide new clonal populations of biological micro-objects. In various embodiments, the step of activating solidification of the flowable polymer may further include forming a barrier having a plurality of in situ-generated barrier modules, each of the plurality of modules spaced apart from each other at a distance preventing the at least one micro-object from passing through the barrier. The step of activating solidification of the flowable polymer may further include spacing the plurality of in situ-generated barrier modules apart from each other thereby forming an in situ-generated barrier preventing at least one subset of micro-objects of the plurality of micro-objects from passing through the barrier. The in situ-generated barrier has a length along the microfluidic channel. In some embodiments, the step of activating solidification of the flowable polymer may further include forming a first module of the plurality of in situ-generated modules having a length of at least 40% of the length of the in situ-generated barrier.
In various embodiments of the method, the method may further include the step of reducing a dimension of or removing the in situ-generated barrier. In some embodiments, when the in situ-generated barrier includes a plurality of modules, the in situ-generated barrier may be reduced by removing at least a portion of the plurality of barrier modules. Fewer or more of the in situ-generated barrier modules may be removed to reduce the barrier. In various embodiments of the method, the method may further include the step of growing each of the first biological micro-objects of each respective clonal populations in a differing composition of fluidic medium depending on an extent of the first fluidic medium and the second fluidic medium mixing.
In any of the embodiments of the method, the method may include a step of processing an isolated micro-object. Alternatively, the method may include a step of processing a micro-object that has not been isolated, while another micro-object in the microfluidic device is isolated.
In another aspect, a method of isolating a micro-object in a microfluidic device is provided, including the steps of: providing a microfluidic device including an enclosure having a substrate, a flow region including a channel, and a plurality of sequestration pens; disposing a fluidic medium including a plurality of micro-objects into the channel of the microfluidic device, where the fluidic medium includes a flowable polymer; disposing select micro-objects of the plurality of micro-objects in at least a portion of the plurality of sequestration pens thereby forming a plurality of populated sequestration pens, each containing at least one micro-object; selecting at least one of the plurality of populated sequestration pens; initiating polymerization of the flowable polymer at a selected point within the connection region, the isolation region, or at the proximal opening of the connection region of the at least one selected sequestration pen, where the polymerized polymer of the flowable polymer generates at least a partial in situ-generated barrier; and prevents the at least one micro-object from exiting the at least one selected sequestration pen.
The method may further include the step of permitting the at least one micro-object to exit the at least one selected sequestration pen further includes at least reducing the at least partial in situ-generated barrier, thereby releasing the at least one micro-object. Reducing an in situ-generated barrier can include shrinking a size of the in situ-generated barrier or can include shifting the in situ-generated barrier into a second state that has a smaller size. Reducing may also include increasing porosity of the remaining portion(s) of the barrier. Reducing may further include removing a portion of the modules of an in situ-generated barrier such that the reduced in situ-generated barrier may permit more types of micro-objects to pass in and out through the reduced in situ-generated barrier. In some embodiments, the method may further include the step of reducing or removing the at least partial in situ-generated barrier by increasing flow of a fluidic medium, introducing a hydrolytic agent, introducing a proteolytic agent, increasing/decreasing osmolality of the fluidic medium, changing temperature of the at least partial barrier, or optically illuminating the in situ-generated barrier, thereby releasing the at least one micro-object from isolation. The step of changing temperature may further include optically illuminating a thermal pad on the substrate adjacent or under the barrier. In some embodiments, the step of forming an in situ-generated barrier may further include forming a substantially complete in situ-generated barrier. In various embodiments, the substantially complete in situ-generated barrier may be formed at the proximal opening to the channel of the at least one sequestration pen. The forming step may further include forming the substantially complete in situ-generated barrier at the proximal opening of more than one sequestration pen. In some embodiments, the enclosure of the microfluidic device may further include a plurality of contiguous sequestration pens. In various embodiments, the substantially complete in situ-generated barrier may be removed by an increased flow of fluidic medium in the channel.
Directing Fluidic Flow which May Include Micro-Objects.
In another aspect, a method of directing fluidic flow within a microfluidic device is provided, including the steps of: providing a microfluidic device including an enclosure having a substrate and a flow region configured to contain a fluidic medium that divides into at least a first flow region and a second flow region; generating an in situ-generated barrier in situ that blocks fluid flow into the first flow region; introducing the fluidic medium into the flow region; and flowing the fluidic medium through the enclosure, such that the in situ-generated barrier directs the flow of the fluidic medium through the second flow region. In various embodiments, the fluidic medium may include at least one micro-object. In some embodiments, the at least one micro-object may be directed into the second flow region.
In various embodiments of the method, the method may further include the step of disposing the at least one micro-object within a sequestration pen disposed within the second flow region. The sequestration pen may include an isolation region and a connection region, the connection region having a proximal opening to the second flow region and a distal opening to the isolation region. The at least first micro-object may be disposed within the isolation region of the sequestration pen.
In various embodiments of the method, the method may further include the step of removing the in situ-generated barrier to substantially unblock the first flow region. The step of substantially unblocking the first portion of the flow region may further include allowing flow of the fluidic medium containing a micro-object into the first flow region. In some embodiments, at least a portion of the in situ-generated barrier may be removable by application of increased flow in the flow region, hydrolysis, proteolysis, osmotic change, temperature change of the barrier, or optical illumination.
In various embodiments of the method, the method may further include the step of introducing a second in situ-generated barrier configured to block the second flow region.
In some embodiments, the method may further include the step of introducing at least one micro-object into the first flow region. The method may further include the step of flowing the fluidic medium through the flow region, thereby directing the at least one micro-object to the first flow region. In some embodiments, the directing step may further include disposing the at least one micro-object within a sequestration pen disposed within the first flow region. The sequestration pen may include an isolation region and a connection region, the connection region having a proximal opening to the flow region and a distal opening to the isolation region, and further where the at least one micro-object is disposed within the isolation region of the sequestration pen. In various embodiments of the method, the method may further include the step of removing the second in situ-generated barrier.
In various embodiments of the method, the method may further include the step of processing the at least one micro-object. The further processing step may include assaying, sorting, permeabilizing, transfecting or exporting the at least one micro-object.
In various embodiments, the generating step may include initiating solidification of a flowable polymer present in the fluidic medium.
In various embodiments of the method, the at least first micro-object and/or the at least second micro-object may be a biological micro-object.
Concentrating micro-objects, which may include concentrating biological cells.
In another aspect, a method of concentrating micro-objects in a microfluidic device may be provided, including the steps of: providing a microfluidic device including an enclosure having a substrate and a flow region configured to contain a fluidic medium; introducing an in situ-generated isolation structure in a first sector of the flow region, where the in situ-generated isolation structure is configured to permit the fluidic medium to flow through the in situ-generated isolation structure but does not permit at least one micro-object in the fluidic medium to pass through the isolation structure; introducing a first plurality of micro-objects in a first volume of the fluidic medium into the first sector of the flow region; and concentrating at least a first subset of the first plurality of micro-objects in the first sector of the flow region.
In some embodiments, the in situ-generated isolation structure may not permit a first subset of the first plurality of micro-objects to flow through the isolation structure but may permit a second subset of the first plurality of micro-objects to flow through the in situ-generated isolation structure. In some embodiments, the step of concentrating the at least first subset of the first plurality of micro-objects in the first sector may further include sorting the second subset of micro-objects from the first subset of micro-objects of the first plurality of micro-objects.
In various embodiments of the method, the method may further include the step of disposing the at least first subset of the first plurality of micro-objects within at least one sequestration pen located within the first sector. Each sequestration pen may include an isolation region and a connection region, the connection region having a proximal opening to the flow region and a distal opening to the isolation region.
In various embodiments of the method, the method may further include the step of introducing a second plurality of micro-objects into the flow region, and flowing the second volume of fluidic medium through the first sector of the flow region; and concentrating at least a first subset of the second plurality of micro-objects along with the at least first subset of the first plurality in the first sector of the flow region. The method may further include the step of disposing the at least first subset of the first plurality and the at least first subset of the second plurality of micro-objects within at least one sequestration pen located within the first sector.
In various embodiments of the method, the method may further include the step of introducing a second plurality of micro-objects in a second volume of fluidic medium into the first sector of the flow region, thereby sorting a first subset of micro-objects from a second subset of micro-objects of the second plurality of micro-objects and concentrating the at least first subset of the first plurality of micro-objects and the at least first subset of the second plurality of micro-objects in the first sector of the substrate.
In some embodiments, the method may further include the step of disposing the at least first subset of the first plurality of micro-objects and the first subset of the second plurality of micro-objects into at least one sequestration pen located within the first sector, where each sequestration pen includes an isolation region and a connection region, the connection region having a proximal opening to the flow region and a distal opening to the isolation region.
In various embodiments of the method, the method may further include the step of removing or reducing at least a portion of the isolation structure, thereby permitting a volume of fluidic medium containing micro-objects to flow to at least a second sector of the flow region. In various embodiments of the method, the method may further include the step of introducing a second in situ-generated isolation structure in the second sector of the flow region. In some embodiments of the method, the method may further include the step of introducing a second plurality of micro-objects in a second volume of fluidic medium into the first sector of the flow region; and concentrating the at least first subset of the plurality of micro-objects within the second sector of the flow region. The method may further include the step of disposing the at least first subset of the second plurality of micro-objects within at least one sequestration pen located within the second sector of the flow region. The method may further include the step of removing or reducing at least a portion of the second isolation structure, thereby permitting unrestricted flow throughout the flow region.
In various embodiments of the method, the in situ-generated isolation structure may be a fully enclosed pen encompassing a selected micro-object, a pen open at a portion of its periphery large enough to admit passage of a micro-object, a sequestration pen including an isolation region and a connection region, the connection region having a proximal opening to the flow region and a distal opening to the isolation region, or a barrier. In some embodiments, the in situ-generated barrier may include a plurality of in situ-generated barrier modules, each spaced from the remainder of the plurality such that a size of an opening between two in situ-generated modules is smaller than a size of a selected micro-object. The micro-objects may have a diameter from between about 1-20 μm.
In some embodiments, the in situ-generated isolation structure may be an in situ-generated barrier and may be substantially disposed within the isolation region or connection region of the sequestration pen. In other embodiments, the in situ-generated isolation structure may be an in situ-generated barrier and may be substantially disposed within the flow region.
In various embodiments, the first plurality of micro-objects may include a biological micro-object. In some embodiments, the first subset and the second subset of the first plurality of micro-objects may include different types of micro-objects. In various embodiments, the second plurality of micro-objects may include a biological micro-object. When both pluralities of micro-objects are biological micro-objects, the first subset and the second subset of the second plurality of micro-objects may include different types of micro-objects.
Assaying Cells of a Clonal Population.
In another aspect, a method of assaying cells of a clonal population in a microfluidic device is provided; and includes the steps of: introducing a first fluidic medium including a plurality of cells into an enclosure of the microfluidic device, the enclosure including a substrate, a flow region including a microfluidic channel configured to contain a fluidic medium, a first plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the first plurality opens off a first side of the microfluidic channel, and a second plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the second plurality opens off a second opposing side of the microfluidic channel; flowing the first fluidic medium and the plurality of cells into the channel of the microfluidic device; introducing a clonal population of cells in each of the sequestration pens of the first plurality of sequestration pens; for each clonal population of cells in the first plurality of sequestration pens, moving at least one cell to a respective sequestration pen of the second plurality of sequestration pens; introducing a flowable polymer into the channel; activating solidification of the flowable polymer along a length of the microfluidic channel, thereby forming an in situ-generated barrier dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of sequestration pens, wherein the in situ-generated barrier prevents cells from moving from the first sub-channel to the second sub-channel, and vice versa; flowing a second fluidic medium into the second sub-channel, wherein the second fluidic medium includes reagents for assaying the cells in the second plurality of sequestration pens; and assaying the cell(s) in each sequestration pen of the second plurality.
In various embodiments, the flowable polymer may be introduced before or after the step of introducing of the plurality of cells to the first plurality of sequestration pens.
In some embodiments, the step of introducing the clonal population may include introducing a single cell to each of the first plurality of sequestration pens, and may further include expanding the single cell to a clonal population of cells.
In various embodiments of the method, the method may further include the step of flowing fluidic medium in the first sub-channel and flowing fluidic medium in the second sub-channel to respective first and second outputs of the microfluidic device. The fluidic medium in the first sub-channel may be different from the fluidic medium in the second sub-channel. In some embodiments, the in situ-generated barrier may prevent the first sub-flow of fluidic medium in the first sub-channel from mixing with the second sub-flow of fluidic medium in the second sub-channel.
In some embodiments, the step of assaying may include preparing the cells in the second plurality of sequestration pens for genotyping. In some other embodiments, the step of assaying may include determining a level of production of a biological product by the cell(s) in each sequestration pen of the second plurality and/or by the clonal population in each sequestration pen of the first plurality.
In some embodiments, the reagents for assaying may include one or more of the group including chemical reagents, biological reagents, feeder cells, stimulatory cells, reporter cells, reporter molecules, and beads. The beads may include chemical reagents, biological reagents, stimulatory reagents, or reporter molecules.
In various embodiments, the assaying step further includes identifying at least one cell of the cells in the second plurality of sequestration pens, the at least one cell including a selected characteristic. The method may further include a step of exporting at least one cell of the cells in the second plurality of sequestration pens, wherein the at least one cell includes a selected characteristic s. In various embodiments, the method may further include the step of exporting the clonal population from the respective pen of the first plurality of sequestration pens. In other embodiments, the method may further include a step of exporting the cells in the second plurality of sequestration pens and/or clonal populations of cells in the first plurality of sequestration pens that do not include a selected characteristic.
In various embodiments of the method, the method may further include the step of removing the in situ-generated barrier before exporting a cell.
In various embodiments, the step of activating solidification of the flowable polymer along a length of the microfluidic channel includes activating solidification of the flowable polymer at gaps of a barrier extending from a first end of the microfluidic channel to a second end of the microfluidic channel, the barrier separating the microfluidic channel into the first sub-channel and the second sub-channel, wherein the gaps are aligned with the proximal opening of each pen of the first plurality of sequestration pens and the proximal opening of the respective pen of the second plurality of sequestration pens, thereby forming an in situ-generated barrier preventing cells from moving from the first sub-channel to the second sub-channel, and vice versa. The barrier may have at least one gap aligned with the proximal opening of one pen of the first plurality of sequestration pens and the proximal opening of the respective pen of the second plurality of sequestration pens. In some embodiments, the barrier has a plurality of gaps. Each gap may be aligned across from the proximal opening (to the microfluidic channel) of each sequestration pen of the first plurality of sequestration pens and, optionally, also aligned with the proximal opening of each respective sequestration pen of the second plurality of sequestration pens to the microfluidic channel. In some embodiments, the step of activating solidification along the length of the barrier may include forming a plurality of in situ-generated barriers closing the plurality of gaps in the barrier.
Cell Line Evolution.
In another aspect, a method of cell line evolution in a microfluidic device is provided, including the steps of: providing the microfluidic device, where the device includes an enclosure comprising a substrate, a flow region including a channel configured to contain a fluidic medium, a first plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the first plurality opens off a first side of the microfluidic channel, and a second plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the second plurality opens off a second opposing side of the microfluidic channel; introducing a first fluidic medium into the channel of the microfluidic device; introducing one or more cells of a clonal population into each of the first plurality of sequestration pens; introducing one or more cells of the clonal population into each of the second plurality of sequestration pens; introducing a flowable polymer into the channel; activating solidification of the flowable polymer along a length of the microfluidic channel, thereby forming an in situ-generated barrier dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of sequestration pens, wherein the in situ-generated barrier prevents cells from moving from the first sub-channel to the second sub-channel, and vice versa; introducing a second fluidic medium into the second side of the channel; and growing each of the one or more cells in each sequestration pen of the second plurality of sequestration pens in the presence of the second fluidic medium. The step of introducing a flowable polymer may be performed before or after the introducing of cells.
In some embodiments, the second fluidic medium may include chemical or biological components differing from those of the first fluidic medium. The chemical or biological components of the second fluidic medium may apply selective pressure upon the growth of the one or more cells of the clonal population in each of the second plurality of sequestration pens.
In various embodiments of the method, the method may further include the step of flowing the first fluidic medium in the first side of the channel and flowing the second fluidic medium in the second side of the channel along the in situ-generated barrier to respective first and second outputs of the device. In some embodiments, the isolating step may further include preventing the first medium from mixing with the second medium on the second side of the channel.
In various embodiments of the method, the method may further include the step of expanding each of the single cells in each of the second plurality of sequestration pens to provide new clonal populations in each sequestration pen of the second plurality of sequestration pens.
In some embodiments, the step of forming an in situ-generated barrier may further include forming an in situ-generated barrier having a plurality of in situ-generated barrier modules, each of the plurality of in situ-generated modules spaced apart from each other at a distance preventing the at least one micro-object from passing through the barrier. In some embodiments, the micro-objects prevented from passing through the in situ-generated barrier may have a diameter from 1-20 microns. In other embodiments, the step of forming an in situ-generated barrier may further include spacing the plurality of in situ-generated barrier modules apart from each other thereby forming an in situ-generated barrier preventing at least one subset of micro-objects of the plurality of micro-objects from passing through the in situ-generated barrier. In some embodiments, the patterning step may further include forming a first module of the plurality of in situ-generated modules having a length of at least 40% of the length of the in situ-generated barrier, where the in situ-generated barrier has a length along the length of the channel. The in situ-generated barrier further has a first end and a second end. The first end of the in situ-generated barrier may be proximal to a first fluidic inlet and/or a second fluidic inlet. In some embodiments, the step of forming an in situ-generated barrier may further include forming each of a remainder of the plurality of in situ-generated barrier modules having a length no greater than 20% of the length of the in situ-generated barrier. In yet other embodiments, the step of forming an in situ-generated barrier may further include forming the in situ-generated barrier, where the in situ-generated barrier is not porous to a flow of the first or second fluidic medium at the first end and is porous to at least a portion of the flow of the first or the second fluidic medium at a point that is at least 40% of the length of the in situ-generated barrier.
In various embodiments of the method, the method may further include the step of reducing at least a portion of the in situ-generated barrier by application of increased fluidic flow in the flow region, hydrolysis, proteolysis, osmotic change, temperature change of the in situ-generated barrier, or optical illumination. The at least a portion of the in situ-generated barrier may be reduced by reducing a size of the barrier. In various embodiments, when the in situ-generated barrier includes the plurality of in situ-generated modules, the in situ-generated barrier may be at least reduced by removing at least a portion of the plurality of in situ-generated barrier modules. Removing at least a portion of the plurality of the in situ-generated barrier modules may include removing one or any number of the plurality of in situ-generated barrier modules.
In various embodiments of the method, the method may further include mixing the first fluidic medium and the second fluidic medium to an extent dependent upon a location along the microfluidic channel, thereby forming a plurality of differing compositions for each of the first fluidic medium and the second fluidic medium. In some embodiments, the method may further include the step of growing each of the one or more cells in each of the first plurality and the second plurality of sequestration pens clonal in the presence of a differing composition of fluidic medium depending on a location of the one or more cells along the microfluidic channel.
In various embodiments of the method, the method may further include the step of assaying the one or more cells in each sequestration pen of the second plurality of sequestration pens. In various embodiments of the method, the method may further include the step of assaying the new clonal populations in each sequestration pen of the second plurality of sequestration pens.
The assaying step may include flowing in a third fluidic medium into the second side of the channel, where the third fluidic medium includes reagents for assaying the one or more cells in each respective pen of the second plurality of sequestration pens. The reagents for assaying may include one or more of chemical reagents, biological reagents, feeder cells, stimulatory cells, reporter cells, reporter molecules, and beads. The beads may include chemical reagents, biological reagents, stimulatory reagents, or reporter molecules.
In various embodiments, the assaying step may further include identifying at least one cell in the second plurality of sequestration pens having a selected characteristic. In other embodiments, the assaying step may further include identifying at least one new clonal population having the selected characteristic and exporting the new clonal population so identified.
In various embodiments of the method, the method may further include the step of exporting the at least one cell having a selected characteristic s from the microfluidic device. The method may further include exporting the clonal population from the pens of the first plurality of sequestration pens from the microfluidic device. The method may further include the step of exporting cells that do not have the selected characteristic in the second plurality of sequestration pens from the microfluidic device. In various embodiments of the method, the method may further include the step of removing the in situ-generated barrier before exporting a cell.
Prototyping.
In another aspect, a method of rapid microfluidic device prototyping is provided, including the steps of: providing the microfluidic device, where the device includes an enclosure including a substrate and a flow region; introducing a first fluidic medium into the enclosure of the microfluidic device; introducing a flowable polymer into the enclosure; selecting at least one area of the enclosure; activating solidification of the polymer at each selected area, such that a pattern of activation results in the formation of an in situ-generated test structure; and testing the in situ-generated test structure for use in manipulating micro-objects in the microfluidic device. In some embodiments, when the test structure does not pass the testing, then the test structure may be removed. In some embodiments, at least a portion of the test structure may be removable by application of increased fluidic flow in the flow region, hydrolysis, proteolysis, osmotic change, temperature change to the test structure, or optical illumination. In some embodiments, when the at least a portion of the test structure is removable by temperature change, then temperature change may be performed by optically illuminating a thermal pad on the substrate underlying the in situ-generated test structure. In various embodiments of the method, the method may further include the step of patterning a second in situ-generated test structure having adjusted properties based on a result of the testing step.
For all Methods:
In various embodiments of any of the methods described herein, the flowable polymer may include a synthetic polymer, a modified synthetic polymer, or a biological polymer. The biological polymer may be light or temperature activatable. The synthetic polymer modifications may include size modification motifs, cleavage motifs, reactive terminal moieties, and/or cell recognition motifs, in any combination. In various embodiments, the polymer may include at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyacrylamide (PAM), modified polyacrylamide, poly-N-isopropylacrylamide (PNIPAm), modified poly-N-isopropylacrylamide, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination. In other embodiments, the polymer may include at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination. In some embodiments, the flowable polymer may include at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
For all Methods:
In various embodiments of any of the methods described herein, the flowable polymer may include a modified polyethylene glycol polymer. In other embodiments, the modified polyethylene glycol polymer may include a star polymer. In some embodiments, the modified polyethylene glycol polymer may include diacrylate moieties. In various embodiments, the modified polyethylene glycol polymer may include photocleavable moieties.
For all Methods:
In various embodiments of any of the methods described herein, the step of activating solidification of the flowable polymer may include optically illuminating a selected area of the substrate, thereby polymerizing the polymer. Polymerizing the flowable polymer may form a solidified polymer network. The step of activating solidification of the flowable polymer may further include introducing a photoactivatable polymerization initiator.
For all Methods:
In various embodiments of any of the methods described herein, the step of activating solidification of the flowable polymer may include changing a temperature at a selected area of the substrate, and thereby gelling the polymer. Gelling the flowable polymer may form a solidified polymer network. The step of changing temperature at the selected area of substrate may further include optically illuminating a thermal pad on the substrate.
For all Methods:
In various embodiments of any of the methods described herein, at least a portion of the in situ-generated isolation structure/isolation modules/barrier/barrier modules may be removable by increasing flow of a fluidic medium through the flow region; introducing a hydrolytic agent into the flow region; introducing a proteolytic agent into the flow region; introducing a fluidic medium into the flow region that increases/decreases an osmolality within the flow region; changing a temperature of the in situ-generated isolation structure; or optically illuminating the isolation structure. In some embodiments when the at least a portion of the in situ-generated isolation structure/isolation modules/barrier/barrier modules is removable by temperature change, then the temperature may be changed by optical illumination of a thermal pad on the substrate underlying the barrier.
For all Methods:
In various embodiments of any of the methods described herein, the substrate may be configured to generate a dielectrophoretic (DEP) force upon a micro-object in a fluidic medium within the enclosure. The substrate configured to generate the DEP force may be optically actuated. In various embodiments of the method, the substrate may be configured to generate an electro-wetting force on a droplet within the enclosure. The electro-wetting forces may be optically actuated.
For all Methods:
In various embodiments, at least one inner surface of the enclosure of the microfluidic device may include a conditioned surface. The at least one inner surface may include a surface of the substrate. In some embodiments, substantially all the inner surface of the enclosure may include a conditioned surface. The conditioned surface may be a covalently modified surface. In some embodiments, the covalently modified surface may be hydrophilic. In some embodiments of the method, the method may further include a step of providing a conditioned surface to at least one inner surface of the enclosure. The step of providing a conditioned surface may be performed before introducing any micro-objects, biological cells or a flowable polymer.
Kits.
In yet another aspect, a kit is provided, for isolating a micro-object within a microfluidic device, comprising a microfluidic device comprising an enclosure comprising a substrate and a flow region located within the enclosure and a flowable polymer solution, wherein the polymer is capable of polymerization and/or thermally induced gelling. The microfluidic device may be any microfluidic device described herein and may have any combination of features, components and dimensions. The kit may further include a photoactivatable polymerization initiator.
In another aspect, a kit for assaying cells of a clonal population is provided, including a microfluidic device having an enclosure having a substrate; a flow region comprising a channel located within the enclosure; a first plurality of sequestration pens disposed adjacent to each other on a first side of the channel; and a second plurality of sequestration pens disposed adjacent to each other on a second opposing side of the channel, and a flowable polymer solution, wherein the polymer is capable of polymerization and/or thermally induced gelling. In various embodiments, the microfluidic device may further include a barrier separating the first side of the channel from the second side of the channel. The barrier may be an in situ-generated barrier. In various embodiments, the barrier may not be an in situ-generated barrier and may be punctuated by at least one gap aligned between a proximal opening to the channel of the first pen of the first plurality of pens and a proximal opening to the channel of a first pen of the second plurality of pens. This kit including a microfluidic device having a substrate; a flow region comprising a channel located within the enclosure; a first plurality of sequestration pens disposed adjacent to each other on a first side of the channel; and a second plurality of sequestration pens disposed adjacent to each other on a second opposing side of the channel may have any combination of features, components or dimensions for the microfluidic device as described herein.
In various embodiments of any of the kits described herein, the polymer may include a synthetic polymer, a modified synthetic polymer, or a biological polymer. The biological polymer may be light or temperature activatable. The synthetic polymer modifications may include size modification motifs, cleavage motifs, reactive terminal moieties, and/or cell recognition motifs, in any combination. In various embodiments, the polymer may include at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyacrylamide (PAM), modified polyacrylamide, poly-N-isopropylacrylamide (PNIPAm), modified poly-N-isopropylacrylamide, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination. In other embodiments, the polymer may include at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination. In some embodiments, the flowable polymer may include at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
In various embodiments of any of the kits described herein, the flowable polymer may include a modified polyethylene glycol polymer. In other embodiments, the modified polyethylene glycol polymer may include a star polymer. In some embodiments, the modified polyethylene glycol polymer may include diacrylate moieties. In various embodiments, the modified polyethylene glycol polymer may include photocleavable moieties.
In various embodiments of any of the kits described herein, the kit may further include a reagent configured to covalently modify at least one internal surface of the microfluidic device, which may produce any covalently modified internal surface as described herein. The various components of the kit may be packaged in separate containers.
System and Microfluidic Device: System and Microfluidic Device:
Manufactured by Berkeley Lights, Inc. The system included at least a flow controller, temperature controller, fluidic medium conditioning and pump component, light source for light activated DEP configurations, microfluidic device, mounting stage, and a camera. The sequestration pens have a volume of about 2×107 cubic microns.
Priming Procedure:
250 microliters of 100% carbon dioxide was flowed in at a rate of 3 microliters/sec. This was followed by 250 microliters of PBS, flowed in at 3 microliters per second. The final step of priming included 250 microliters of culture medium containing 0.1% Pluronic® F27 (Life Technologies® Cat #P6866), flowed in at 3 microliters/sec.
Hydrogel preparation: A prepolymer solution was made combining polyethylene glycol diacrylate (PEGDA), 5 kDa (Laysan Bio, Cat. #ACRL-PEG_ACRL-5000-1 g), 10% w/v, and 1.2% w/v IGRACURE® 2959 (Ciba®, Sigma Aldrich Cat. #410896) photoinitiator in Dulbecco's phosphate buffer saline.
Culture medium: Hybridoma-SFM (Life Technologies, Cat. #12045-076); 10% Fetal Bovine Serum; 1% Penicillin-streptomycin (100000 U/mL, Life Technologies Cat #15140-163); 1 mM MEM Non-Essential Amino Acid (Life Technologies Cat #10370-088); 2 mM GlutaMAX (Life Technologies Cat #35050-079); 1 mM Sodium Pyruvate (Life Technologies Cat #11360-070).
The microfluidic device was primed according to the general procedure above. Culture medium was then flowed in for 5 minutes. Cells were loaded into the microfluidic device and then introduced into the sequestration pens using gravity.
Prepolymer solution (60 microliters) was flowed into the microfluidic device at 2 microliter/sec and allowed to exchange with media present within the sequestration pens for 5 minutes. Photoinitiated polymerization of selected regions (25×600 microns) within the channel, just above selected sequestration pens containing cells, was performed using 100 microW at 340 nm+/−20 nm, introducing isolation structures over the openings of several pens, for 7.5 sec. After completion of photopolymerization, culture medium was perfused at 1 microliter/sec for 10 minutes to remove remaining prepolymer from the sequestration pens and flow channel.
The entire microfluidic device was then maintained over 2 days with continued perfusion of media at 0.02 microliters/sec. At the end of the culturing period, the sequestration pens having an isolation structure preventing exit of cells within the pens was visualized again, using a FITC overlay to the brightfield illumination, which is shown in
A photocleavable PEG diacrylate having a structure of Formula 1 was synthesized.
The synthesis protocol of Kloxin et al. (Kloxin, A. M.; Tibbitt, M. W.; Anseth, K. S. Synthesis of photodegradable hydrogels as dynamically tunable cell culture platforms. Nat. Protoc. 2010, 5 (12), 1867-1887) was used to synthesize the compound of Formula I, with modifications to more rigorously exclude oxygen. Preparation and handling of solutions of the photocleavable PEG diacrylate was performed under low light conditions for all experiments. The reaction product was used as is for all procedures.
Prepolymer solution: The prepolymer solution was prepared using 7.5% w/v PEG diacrylate Mn 700 (Sigma Aldrich Cat. #455008), 3.5% w/v photodegradable PEG diacryrlate (Formula I); and 1% v/v H-NU 605 IL photoinitiator (Spectra group Ltd) in phosphate buffered saline/deionized water (1:3 ratio).
Introduction of Barriers:
A microfluidic device having sequestration pens as above was primed prior to introduction of the prepolymer solution. The prepolymer solution was flowed in and allowed to diffuse into the sequestration pens from the flow channel. Introduction of precisely and selectively placed in situ-generated barriers was performed using exposure to 458 nm illumination (458 filtered visible light), with a power of approximately 4.5 nW/cm2. As shown in
Gels sufficiently formed to prevent cells from exiting the pen were observed for all timepoints greater than 10 sec exposure. Gels formed with approximately 60 sec of exposure were very dense.
Removal of Barriers:
Barriers formed as above with in a microfluidic device, and stored overnight at 4 C, were exposed to illumination from an Omnicure Series 2000 lamp having a 383 short pass filter installed, for two minute exposures. As shown in
Cells.
OKT3 mouse myeloma (ATCC®, CRL-8001™).
Culture Medium.
IMDM (LifeTech™, 12440-061), 20% FBS (Seradigm), 10000 U/ml penicillin-streptomycin (LifeTech™, 15140-163).
Cell Penning.
OKT3 cells were introduced into a primed microfluidic device and placed into sequestration pens using optically actuated dielectrophoresis forces (optoelectronic tweezers (OET)), 5 volts applied field, moving at 8 microns/sec. The device was kept at 37° C. until the start of prepolymer introduction. The microfluidic device was flushed ×3 with culture medium (250 microliters at 3 microliters/sec).
Prepolymer Solution Preparation.
All photosensitive compounds prepared in low light conditions. 160 microliters of prepolymer hydrogel solution was prepared to a final concentration of 3.75% w/v Ac star PEG star solid (4 arm PEG acrylate (10 k MW) from Laysan Bio (#4arm-PEG-ACRYL-10 k-1 g), 1.25% w/v photodegradable PEG diacrylate (Formula I, synthesized as described above in Example 2); and 1% v/v H-NU 605 IL photoinitiator (Spectra group Ltd) in culture medium containing 0.1% Pluronic® F27 (Life Technologies® Cat #P6866).
A solution of H-NU 605 IL photoinitiator at 1% v/v in culture medium containing 0.1% Pluronic® F27 (Life Technologies® Cat #P6866) was made by vortexing and warming at 35° C. until fully solubilized.
Introducing In Situ-Generated Barriers for Isolation of Selected Cells.
In low light conditions a primed microfluidic device was loaded with 140 microliters prepolymer solution at 0.05 microliter/sec. This rate allowed diffusion of prepolymer into pens of the microfluidic device. After loading the prepolymer, a 60 sec or 120 sec exposure to UV light (Omnicure® Series 2000, Lumen Dynamics) was used to initiate polymer solidification at the top of selected pens containing cells.
After solidification was initiated, a set of rinses with culture medium containing 0.1% Pluronic® F27 (Life Technologies® Cat #P6866) were used to remove excess soluble polymers and initiator in the channel of the microfluidic device, including 1×250 microliters at 3 microliters/sec at room temperature; 3×250 microliters at 3 microliters/sec at 37° C. The photograph of
As depicted in
Recitation of Some Embodiments of the Microfluidic Devices, Methods and Kits.
1. A microfluidic device including: an enclosure including: a substrate; a flow region located within the enclosure; and at least one in situ-generated isolation structure disposed on the substrate, wherein the at least one in situ-generated structure includes a solidified polymer network.
2. The microfluidic device of embodiment 1, wherein the solidified polymer network includes a photoinitiated polymer.
3. The microfluidic device of embodiment 1 or 2, wherein the solidified polymer network does not include a silicone polymer.
4. The microfluidic device any one of embodiments 1 to 3, wherein all or at least part of the at least one in situ-generated isolation structure consists of the solidified polymer network.
5. The microfluidic device of any one of embodiments 1-4, wherein the solidified polymer network includes a thermosensitive polymer.
6. The microfluidic device of embodiment 5, wherein the device further includes a thermal pad disposed on the substrate at a location beneath the at least one in situ-generated isolation structure.
7. The microfluidic device of any one of embodiments 1 to 6, wherein the device further includes at least one sequestration pen.
8. The microfluidic device of embodiment 7, wherein the at least one sequestration pen includes an isolation region and a connection region, the connection region having a proximal opening to the flow region and a distal opening to the isolation region.
9. The microfluidic device of embodiment 8, wherein the proximal opening of the sequestration pen to the flow region is oriented substantially parallel to a flow of fluidic medium in the flow region.
10. The microfluidic device of any one of embodiments 1 to 9, wherein the flow region includes a microfluidic channel.
11. The microfluidic device of any one of embodiments 1 to 10, wherein the device includes a plurality of sequestration pens.
12. The microfluidic device of embodiment 11, wherein the flow region includes a microfluidic channel, and wherein the plurality of sequestration pens is aligned in a row, with each sequestration pen of the plurality opening off a common side of the microfluidic channel.
13. The device of any one of embodiments 1-12, wherein the in situ-generated isolation structure is porous to a flow of fluidic medium.
14. The microfluidic device of any one of embodiments 1-13, wherein the in situ-generated isolation structure is configured to retain one or more of a plurality of micro-objects.
15. The microfluidic device of any one of embodiments 1-14, wherein the at least one in situ-generated isolation structure includes a plurality of in situ-generated isolation modules disposed in the flow region, wherein the in situ-generated isolation modules of the plurality are configured to substantially restrict passage of micro-objects into, out of, and/or through the at least one isolation structure in a size dependent manner.
16. The microfluidic device of embodiment 15, wherein each in situ-generated isolation module of the plurality is spaced apart from the other in situ-generated isolation modules of the plurality such that micro-objects having a diameter of 5 microns or greater are substantially prevented from passing into, out of, and/or through the at least one in situ-generated isolation structure.
17. The microfluidic device of embodiment 16, wherein the in situ-generated isolation modules of the plurality are configured to allow a first type of biological micro-object to pass into, out of, and/or through the at least one isolation structure and substantially prevent a second type of biological micro-object from passing into, out of, and/or through the at least one isolation structure.
18. The microfluidic device of any one of embodiments 1-17, wherein the microfluidic device further includes a plurality of in situ-generated isolation structures.
19. A microfluidic device including: an enclosure including: a flow region including a microfluidic channel; a sequestration pen, wherein the sequestration pen opens off of the microfluidic channel; and an in situ-generated isolation structure comprising an in situ-generated barrier disposed on the substrate, the in situ-generated barrier including a solidified polymer network.
20. The microfluidic device of embodiment 19, wherein the solidified polymer network includes a photoinitiated polymer.
21. The microfluidic device of embodiment 19 or 20, wherein the solidified polymer network does not include a silicone polymer.
22. The microfluidic device of any one of embodiments 19 to 21, wherein the in situ-generated barrier at least partially blocks the microfluidic channel and/or the sequestration pen.
23. The microfluidic device of any one of embodiments 19 to 22, wherein the in situ-generated barrier is disposed within the connection region of the sequestration pen.
24. The microfluidic device of embodiment 23, wherein the in situ-generated barrier has a width that extends across at least part of a width Wcon of the connection region, and wherein the in situ-generated barrier is configured to substantially block entry and/or exit of at least one micro-object into and/or from the sequestration pen.
25. The microfluidic device of embodiment 24, wherein the width of the in situ-generated barrier is about 5 microns to about 20 microns.
26. The microfluidic device of any one of embodiments 23 to 25, wherein a portion of the in situ-generated barrier extends from the connection region into the microfluidic channel.
27. The microfluidic device of embodiment 26, wherein the portion of the in situ-generated barrier extending into the channel includes less than 50% of a volume of the barrier.
28. The microfluidic device of any one of embodiments 19 to 27, wherein the in situ-generated barrier is disposed in the channel.
29. The microfluidic device of embodiment 28, wherein the in situ-generated barrier is located adjacent to one edge of the proximal opening of the sequestration pen.
30. The microfluidic device of embodiment 28 or 29 further including a plurality of sequestration pens, wherein the plurality of sequestration pens form a row, and wherein the in situ-generated barrier is located adjacent to a distal edge of the proximal opening of a sequestration pen located at the end of the row of sequestration pens.
31. The microfluidic device of any one of embodiments 28 to 30, wherein the barrier prevents at least one subset of a plurality of micro-objects from moving past the in situ-generated barrier in the channel, wherein the plurality of micro-objects have a diameter in a range from 1 micron to 20 microns.
32. The microfluidic device of embodiment 31, wherein the in situ-generated barrier includes a plurality of in situ-generated barrier modules disposed on the substrate in the channel.
33. The microfluidic device of any one of embodiments 19 to 32, wherein the in situ-generated barrier is porous to a flow of fluidic medium.
34. The microfluidic device of embodiment 28 or 29 further including a plurality of sequestration pens, wherein the plurality of sequestration pens form a row, and wherein the in situ-generated barrier is disposed adjacent to an edge of the proximal opening of a selected sequestration pen of row of sequestration pens.
35. The microfluidic device of any one of embodiments 19 to 28 further including a plurality of sequestration pens, wherein the plurality of sequestration pens form a row, and wherein the in situ-generated barrier blocks the proximal openings of at least two contiguous sequestration pens.
36. The microfluidic device of any one of embodiments 19 to 21, further including: a first plurality of sequestration pens disposed in a row, wherein each sequestration pen of the first plurality opens off a first side of the microfluidic channel; and a second plurality of sequestration pens disposed in a row, wherein each sequestration pen of the second plurality opens off a second opposing side of the microfluidic channel, wherein the in situ-generated barrier is disposed along a length of the microfluidic channel, dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of sequestration pens, wherein the in situ-generated barrier prevents cells from moving from the first sub-channel to the second sub-channel, and vice versa.
37. The microfluidic device of embodiment 36, wherein the in situ-generated barrier includes a plurality of in situ-generated barrier modules.
38. The microfluidic device of embodiment 37, wherein the in situ-generated barrier modules are configured to fill one or more gaps in a barrier that is not in situ-generated.
39. The microfluidic device of any one of embodiments 36 to 38, wherein the in situ-generated barrier is porous to a flow of fluidic medium.
40. The microfluidic device of any one of embodiments 36 to 39, wherein the first side of the microfluidic channel is configured to receive a first fluidic medium, and the second side of the microfluidic channel is configured to receive a second fluidic medium.
41. The microfluidic device of any one of embodiments 36 to 40, wherein the in situ-generated barrier prevents a micro-object having a diameter greater than 1 μm from moving from the first side of the microfluidic channel to the second side of the microfluidic channel, or vice versa.
42. The microfluidic device of any one of embodiments 1-41, wherein the solidified polymer network includes a synthetic polymer, a modified synthetic polymer, or a biological polymer.
43. The microfluidic device of embodiment 42, wherein the synthetic polymer modifications include size modification motifs, cleavage motifs, reactive terminal moieties, or cell recognition motifs.
44. The microfluidic device of any one of embodiments 1 to 43, wherein the solidified polymer network includes at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyacrylamide (PAM), modified polyacrylamide, poly-N-isopropylacrylamide (PNIPAm), modified poly-N-isopropylacrylamide, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
46. The microfluidic device of any one of embodiments 1 to 45, wherein the solidified polymer network includes at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
47. The microfluidic device of any one of embodiments 1-46, wherein the solidified polymer network includes a modified polyethylene glycol polymer.
48. The microfluidic device of embodiment 47, wherein the modified polyethylene glycol polymer includes a star polymer.
49. The microfluidic device of embodiment 47 or 48, wherein the modified polyethylene glycol polymer includes diacrylate moieties.
50. The microfluidic device of any one of embodiments 47 to 49, wherein the modified polyethylene glycol polymer includes photocleavable moieties.
51. The microfluidic device of any one of embodiments 42 to 50, wherein the solidified polymer network is susceptible to degradation by hydrolysis, proteolysis, osmotic change, temperature change or optical illumination.
52. The microfluidic device of any one of embodiments 42 to 51, wherein the solidified polymer network is susceptible to displacement by increased fluidic flow.
53. The microfluidic device of any one of embodiments 1 to 52, wherein at least one inner surface of the enclosure includes a conditioned surface.
54. The microfluidic device of embodiment 53, wherein the at least one inner surface includes a surface of the substrate.
55. The microfluidic device of embodiment 53 or 54, wherein the conditioned surface is a covalently modified surface.
56. The microfluidic device of embodiment 55, wherein the covalently modified surface is hydrophilic.
57. The microfluidic device of any one of embodiments 1-56, wherein the substrate is configured to generate dielectrophoresis (DEP) forces within the enclosure.
58. The microfluidic device of embodiment 57, wherein the DEP forces are optically actuated.
59. The microfluidic device of any one of embodiments 1 to 59, wherein a cover of the microfluidic device is transparent.
60. A method of isolating a micro-object in a microfluidic device, including the steps of: introducing a first fluidic medium including a plurality of micro-objects into an enclosure of the microfluidic device, the enclosure including a substrate and a flow region; introducing a solution including a flowable polymer into the enclosure; activating solidification of the flowable polymer at at least one selected area of the flow region, thereby forming an in situ-generated isolation structure; and isolating at least one of the plurality of micro-objects with the in situ-generated isolation structure.
61. The method of embodiment 60, wherein the step of introducing a solution including a flowable polymer is performed before the step of introducing the first fluidic medium including the plurality of micro-objects
62. The method of embodiment 61 wherein the step of initiating solidification of the flowable polymer includes optically illuminating the at least one selected area of the flow region, and further wherein the step of solidification of the flowable polymer includes polymerizing polymers of the flowable polymer to form a polymer network.
63. The method of any one of embodiments 60 to 62, wherein the step of introducing a flowable polymer further includes introducing a photoactivatable polymerization initiator.
64. The method of any one of embodiments 60 to 62, wherein the step of initiating solidification of the flowable polymer includes changing a temperature at the at least one selected area of the substrate, and further wherein the step of solidification of the polymer includes gelling the polymer to form a polymer network.
65. The method of any one of embodiments 60 to 64, further including processing a remainder of the plurality of micro-objects.
66. The method of any one of embodiments 60 to 65, further including exporting a remainder of the plurality of micro-objects from the microfluidic device.
67. The method of any one of embodiments 60 to 66, wherein the at least one micro-object isolated by the in situ-generated isolation structure is a selected portion of the plurality of micro-objects.
68. The method of any one of embodiments 60 to 67, further including the step of: reducing or removing the in situ-generated isolation structure by: increasing flow of a fluidic medium through the flow region; introducing a hydrolytic agent into the flow region; introducing a proteolytic agent into the flow region; introducing a fluidic medium into the flow region that increases/decreases an osmolality within the flow region; changing a temperature of the in situ-generated isolation structure; or optically illuminating the isolation structure, and thereby releasing the at least one micro-object from the in situ-generated isolation structure.
69. The method of embodiment 68, wherein the step of changing the temperature further includes optically illuminating a thermal pad on the substrate adjacent to or under the in situ-generated isolation structure.
70. The method of embodiment 68 or 69, further including the step of exporting the at least one released micro-object from the microfluidic device.
71. The method of any one of embodiments 60 to 70, wherein the in situ-generated isolation structure is at least partially porous to a flow of a fluidic medium.
72. The method of any one of embodiments 60 to 71, wherein the step of activating solidification of the flowable polymer includes forming an in situ-generated isolation structure comprising an in situ-generated barrier configured to prevent passage of the at least one micro-object into, out of, or through the in situ-generated isolation structure.
73. The method of any one of embodiments 60 to 72, wherein the step of activating solidification of the flowable polymer includes forming a plurality of in situ-generated barriers configured to prevent passage of sub-sets of the plurality of micro-objects into, out of, or through the in situ-generated isolation structure.
74. The method of embodiment 73, further including the step of reducing or removing one or more of the plurality of in situ-generated barriers by: increasing flow of a fluidic medium through the flow region; introducing a hydrolytic agent into the flow region; introducing a proteolytic agent into the flow region; introducing a fluidic medium into the flow region that increases/decreases an osmolality within the flow region; changing a temperature of the in situ-generated barriers; or optically illuminating the in situ-generated barriers, and thereby releasing one or more sub-sets of the at least one micro-object from the in situ-generated isolation structure.
75. The method of embodiment 74, wherein the step of reducing or removing one or more of the in situ-generated barriers includes optically illuminating the in situ-generated barrier.
76. The method of embodiment 74, wherein the step of changing the temperature of the one or more in situ-generated barriers further includes optically illuminating a thermal pad on the substrate adjacent or under the one or more in situ-generated barriers.
77. The method of any one of embodiment 74 to 76, further including the step of exporting the one or more sub-sets of the at least one released micro-object from the microfluidic device.
78. The method of any one of embodiments 72 to 77, wherein the step of activating solidification further includes forming an in situ-generated isolation structure comprising an in situ-generated barrier including a plurality of in situ-generated barrier modules, each of the plurality of in situ-generated barrier modules spaced apart from each other at a distance preventing the at least one micro-object from passing through the in situ-generated isolation structure.
79. The method of embodiment 78, further including the step of spacing the plurality of in situ-generated barrier modules apart from each other thereby preventing at least one subset of micro-objects of the plurality of micro-objects from passing through the in situ-generated isolation structure.
80. The method of embodiment 79, wherein the at least one subset of micro-objects includes at least one type of biological cell.
81. The method of any one of embodiments 60-80, wherein the enclosure of the microfluidic device further includes at least one sequestration pen including an isolation region and a connection region, the connection region having a proximal opening to the flow region and a distal opening to the isolation region.
82. The method of embodiment 81, wherein the enclosure includes a plurality of sequestration pens.
83. The method of embodiment 82, wherein the plurality of sequestration pens is disposed in a row, and the proximal opening of each of the plurality of sequestration pens are disposed contiguously to each other.
84. The method of embodiment 82 or 83, wherein the flow region includes a microfluidic channel and the proximal opening of each of the plurality of sequestration pens opens off of one side of the microfluidic channel.
85. The method of any one of embodiments 81 to 84, wherein the step of activating solidification is performed inside a sequestration pen.
86. The method of embodiment 85, wherein the step of activation of solidification is performed within the isolation region or the connection region.
87. The method of embodiment 85 or 86, wherein the step of activating solidification of the flowable polymer generates an in situ-generated isolation structure including an in situ-generated barrier in the connection region.
88. The method of any one of embodiments 81 to 87, further including the step of processing a remainder of the plurality of micro-objects not isolated by the in situ-generated barrier.
89. The method of any one of embodiments 81 to 87, further including the step of exporting a remainder of the plurality of micro-objects not isolated by the in situ-generated barrier from the microfluidic device.
90. The method of embodiment 89, further including the step of reducing or removing the in situ-generated barrier by increasing flow of a fluidic medium through the flow region, introducing a hydrolytic agent into the flow region, introducing a proteolytic agent into the flow region, introducing a fluidic medium into the flow region that increases or decreases an osmolality of the fluidic medium, changing a temperature of the in situ-generated barrier, or optically illuminating the barrier, thereby releasing the at least one micro-object from isolation.
91. The method of embodiment 90, wherein the step of reducing or removing the in situ-generated barrier includes optically illuminating the in situ-generated barrier.
92. The method of embodiment 90, wherein changing temperature further includes optically illuminating a thermal pad on the substrate adjacent or under the in situ-generated barrier.
93. The method of any one of embodiments 90 to 92, further including a step of exporting the at least one micro-object from the microfluidic device.
94. The method of embodiment 84, wherein the step of activating solidification of the flowable polymer forms an in situ-generated isolation structure including an in situ-generated barrier in the channel.
95. The method of embodiment 94, wherein the step of activating solidification of the flowable polymer disposes the in situ-generated barrier at a proximal opening of at least one sequestration pen of the plurality of sequestration pens.
96. The method of embodiment 94 or 95, wherein the step of activating solidification of the flowable polymer forms an in situ-generated barrier sized to block the proximal openings of at least two contiguous sequestration pens.
97. The method of embodiment 96, further including a step of exporting a remainder of the plurality of micro-objects not isolated by the in situ-generated barrier from the microfluidic device.
98. The method of embodiment 94, wherein the microfluidic device further includes a second plurality of sequestration pens disposed adjacent to each other such that each sequestration pen opens off a second side of the microfluidic channel; and the step of activating solidification of the flowable polymer further includes activating solidification of the flowable polymer along a length of the microfluidic channel, thereby forming an in situ-generated isolation structure comprising an in situ-generated barrier dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of a fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of pens, wherein the in situ-generated barrier prevents micro-objects from moving from the first sub-channel to the second sub-channel, and vice versa.
99. The method of embodiment 98, wherein the microfluidic device further includes a barrier dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of a fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of pens, the barrier punctuated by at least one gap aligned with a proximal opening to the first sub-channel of a first sequestration pen of the first plurality of sequestration pens and aligned with a proximal opening to a proximal opening to the second sub-channel of a first pen of the second plurality of sequestration pens; and further wherein the step of activating polymerization includes activating polymerization at the at least one gap to form at least one in situ-generated barrier in the at least one gap, thereby preventing micro-objects from moving from the first sub-channel to the second sub-channel, and vice versa.
100. The method of embodiment 98 or 99, wherein the step of introducing the plurality of micro-objects further includes introducing a clonal population of cells in each of the sequestration pens of the first plurality of sequestration pens; and, for each clonal population of cells in the first plurality of sequestration pens, moving at least one cell to a respective sequestration pen of the second plurality of pens.
101. The method of embodiment 100, wherein when the microfluidic device includes the barrier punctuated by at least one gap, the step of moving the at least one cell of each clonal population in the first plurality of sequestration pens includes moving the at least one cell to the respective sequestration pen of the second plurality of pens through the at least one gap.
102. The method of embodiment 100 or 101, wherein the method further includes a step of processing the cell(s) in the second plurality of sequestration pens.
103. The method of any one of embodiments 60 to 102, wherein the flowable polymer includes a synthetic polymer, a modified synthetic polymer, or a biological polymer.
104. The method of embodiment 103, wherein the synthetic polymer modifications include size modification motifs, cleavage motifs, reactive terminal moieties, or cell recognition motifs.
105. The method of any one of embodiments 60 to 104, wherein the flowable polymer includes at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyacrylamide (PAM), modified polyacrylamide, poly-N-isopropylacrylamide (PNIPAm), modified poly-N-isopropylacrylamide, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
106. The method of any one of embodiments 60 to 105, wherein the flowable polymer includes at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
107. The method of any one of embodiments 60 to 106, wherein the solidified polymer network includes a modified polyethylene glycol polymer.
108. The method of embodiment 107, wherein the modified polyethylene glycol polymer includes a star polymer.
109. The method of embodiment 107 or 108, wherein the modified polyethylene glycol polymer includes diacrylate moieties.
110. The method of any one of embodiments 107 to 109, wherein the modified polyethylene glycol polymer includes photocleavable moieties.
111. The method of any one of embodiments 60 to 110, wherein at least one inner surface of the enclosure includes a conditioned surface.
112. The method of embodiment 111, wherein the at least one inner surface includes a surface of the substrate.
113. The method of any one of embodiments 110 to 112, wherein the conditioned surface is a covalently modified surface.
114. The method of embodiment 113, wherein the covalently modified surface is hydrophilic.
115. The method of any one of embodiments 60 to 114, wherein the step of introducing the plurality of micro-objects further includes using dielectrophoresis (DEP) forces.
116. The method of any one of embodiments 66 to 115, wherein the step of exporting one or more micro-objects of the plurality of micro-objects further includes using dielectrophoresis (DEP) forces.
117. The method of embodiment 115 or 116, further including optically actuating the DEP forces.
118. A method of assaying a cell of a clonal population in a microfluidic device, the method including the steps of: introducing a first fluidic medium including a plurality of cells into an enclosure of the microfluidic device, the enclosure including: a substrate; a flow region including a microfluidic channel configured to contain a fluidic medium; a first plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the first plurality opens off a first side of the microfluidic channel; and a second plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the second plurality opens off a second opposing side of the microfluidic channel; flowing the first fluidic medium and the plurality of cells into the channel of the microfluidic device; introducing a clonal population of cells in each of the sequestration pens of the first plurality of sequestration pens; for each clonal population of cells in the first plurality of sequestration pens, moving at least one cell to a respective sequestration pen of the second plurality of sequestration pens; introducing a flowable polymer into the channel; activating solidification of the flowable polymer along a length of the microfluidic channel, thereby forming an in situ-generated barrier dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of sequestration pens, wherein the in situ-generated barrier prevents cells from moving from the first sub-channel to the second sub-channel, and vice versa; flowing a second fluidic medium into the second sub-channel, wherein the second fluidic medium includes reagents for assaying the cells in the second plurality of sequestration pens; and, assaying the cell(s) in each sequestration pen of the second plurality.
119. The method of embodiment 118, wherein the in situ-generated barrier has a length from a first end of the channel to a second end of the microfluidic channel.
120. The method of embodiment 118 or 119, wherein each sequestration pen of the first plurality of sequestration pens and of the second plurality of sequestration pens has a proximal opening to its respective side of the microfluidic channel.
121. The method of any one of embodiments 118 to 120, wherein the step of introducing the clonal population includes introducing a single cell to each of the first plurality of sequestration pens, and further includes expanding the single cell to a clonal population of cells.
122. The method of embodiment 121 further including flowing fluidic medium in the first sub-channel and flowing fluidic medium in the second sub-channel to respective first and second outputs of the microfluidic device.
123. The method of any one of embodiments 118 to 122, wherein the step of assaying includes preparing the cells in the second plurality of sequestration pens for genotyping.
124. The method of any one of embodiments 118 to 123, wherein the step of assaying includes determining a level of production of a biological product by the cell(s) in each sequestration pen of the second plurality and/or by the clonal population in each sequestration pen of the first plurality.
125. The method of any one of embodiments 118 to 124, wherein the in situ-generated barrier prevents the first sub-flow of fluidic medium in the first sub-channel from mixing with the second sub-flow of fluidic medium in the second sub-channel.
126. The method of any one of embodiments 118 to 125, wherein the reagents for assaying include one or more of the group including chemical reagents, biological reagents, feeder cells, stimulatory cells, reporter cells, reporter molecules, and beads.
127. The method of embodiment 126 wherein the beads include chemical reagents, biological reagents, stimulatory reagents, or reporter molecules.
128. The method of any one of embodiments 118 to 127, wherein the assaying step further includes identifying at least one cell of the cells in the second plurality of sequestration pens, the at least one cell including a selected characteristic.
129. The method of any one of embodiments 118 to 128, further including a step of exporting at least one cell of the cells in the second plurality of sequestration pens, wherein the at least one cell includes a selected characteristic.
130. The method of embodiment 128 or 129, further including a step of exporting the respective clonal population from the respective pen of the first plurality of sequestration pens.
131. The method of any one of embodiments 118 to 130, further including a step of exporting the cells in the second plurality of sequestration pens and/or clonal populations of cells in the first plurality of sequestration pens that do not include a selected characteristic.
132. The method of any one of claims 129 to 131, further including the step of removing the in situ-generated barrier before exporting a cell.
133. The method of any one of embodiments 118 to 132, wherein the step of activating solidification the polymer includes optically illuminating a selected area of the substrate, thereby polymerizing the polymer.
134. The method of embodiment 133, wherein the step of activating solidification of the flowable polymer further includes introducing a photoactivatable polymerization initiator.
135. The method of any one of embodiments 118 to 134, wherein the step of activating solidification of the flowable polymer along a length of the microfluidic channel includes activating solidification of the flowable polymer at gaps of a barrier extending from a first end of the microfluidic channel to a second end of the microfluidic channel, the barrier separating the microfluidic channel into the first sub-channel and the second sub-channel, wherein the gaps are aligned with the proximal opening of each pen of the first plurality of sequestration pens and the proximal opening of the respective pen of the second plurality of sequestration pens, thereby forming an in situ-generated barrier preventing cells from moving from the first sub-channel to the second sub-channel, and vice versa.
136. The method of any one of embodiments 118 to 130, wherein the step of activating solidification of the polymer includes changing a temperature at a selected area of the substrate, and thereby gelling the polymer.
137. The method of any one of embodiments 118 to 136, wherein the flowable polymer includes a synthetic polymer, a modified synthetic polymer, or a biological polymer.
138. The method of embodiment 137, wherein the synthetic polymer modifications include size modification motifs, cleavage motifs, reactive terminal moieties, and/or cell recognition motifs.
139. The method of any one of embodiments 118 to 138, wherein the flowable polymer includes at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyacrylamide (PAM), modified polyacrylamide, poly-N-isopropylacrylamide (PNIPAm), modified poly-N-isopropylacrylamide, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
140. The method of any one of embodiments 118 to 139, wherein the flowable polymer includes at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
141. The method of any one of embodiments 118 to 140, wherein the solidified polymer network includes a modified polyethylene glycol polymer.
142. The method of embodiment 141, wherein the modified polyethylene glycol polymer includes a star polymer.
143. The method of embodiment 141 or 142, wherein the modified polyethylene glycol polymer includes diacrylate moieties.
144. The method of any one of embodiments 141 to 143, wherein the modified polyethylene glycol polymer includes photocleavable moieties.
145. The method of any one of embodiments 116 to 144, wherein the step of introducing the clonal population of micro-objects or moving the single cell is performed using dielectrophoretic (DEP) forces.
146. The method of embodiment 145, further including optically actuating the DEP forces.
147. The method of any one of embodiments 118-146, wherein at least one inner surface of the enclosure includes a conditioned surface.
148. The method of embodiment 147, wherein the at least one inner surface includes a surface of the substrate.
149. The method of embodiment 147 or 148, wherein the conditioned surface is a covalently modified surface.
150. The method of embodiment 149, wherein the covalently modified surface is hydrophilic.
151. A kit including a microfluidic device of any one of embodiments 1 to 59, and a flowable polymer solution, wherein the polymer is capable of polymerization and/or thermally induced gelling.
152. The kit of embodiment 151, further including a photoactivatable polymerization initiator.
153. The kit of embodiment 151 or 152, wherein the flowable polymer includes a synthetic polymer, a modified synthetic polymer, or a biological polymer.
154. The kit of embodiment 153, wherein the modified synthetic polymer includes size modification motifs, cleavage motifs, reactive terminal moieties, or cell recognition motifs.
155. The kit of any one of embodiments 151 to 154, wherein the flowable polymer includes at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyacrylamide (PAM), modified polyacrylamide, poly-N-isopropylacrylamide (PNIPAm), modified poly-N-isopropylacrylamide, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
156. The kit of any one of embodiments 151 to 155, wherein the flowable polymer includes at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
157. The kit of any one of embodiments 151 to 156, wherein the flowable polymer includes a modified polyethylene glycol polymer.
158. The kit of embodiment 157, wherein the modified polyethylene glycol polymer includes a star polymer.
159. The kit of embodiment 157 or 158, wherein the modified polyethylene glycol polymer includes diacrylate moieties.
160. The kit of any one of embodiments 153 to 154, wherein the modified polyethylene glycol polymer includes photocleavable moieties.
161. The kit of any one of embodiments 151 to 161, further including a reagent configured to covalently modify at least one internal surface of the microfluidic device.
162. A microfluidic device including: an enclosure including: a substrate; a flow region including a microfluidic channel configured to contain a fluidic medium; a first plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the first plurality opens off a first side of the microfluidic channel; and a second plurality of sequestration pens disposed adjacent to each other such that each sequestration pen of the second plurality opens off a second opposing side of the microfluidic channel.
163. The microfluidic device of embodiment 162, wherein the first side of the microfluidic channel is configured to receive a first fluidic medium, and the second side of the microfluidic channel is configured to receive a second fluidic medium.
164. The microfluidic device of embodiment 163, wherein the first fluidic medium is introduced into the first side of microfluidic the channel via a first fluidic inlet and the second fluidic medium is introduced into the second side of the microfluidic channel via a second fluidic inlet.
165. The microfluidic device of embodiment 163 or 164, wherein the first fluidic medium flows out of the first side of the microfluidic channel via a first outlet and the second fluidic medium flows out of the second side of the microfluidic channel via a second outlet.
166. The microfluidic device of any one of embodiments 162-165, wherein each sequestration pen of the first plurality and the second plurality of sequestration pens includes an isolation region and a connection region, the connection region having a proximal opening to the channel and a distal opening to the isolation region.
167. The microfluidic device of embodiment 166, wherein the proximal opening of the sequestration pen to the channel is oriented substantially parallel to a flow of fluidic medium in the channel.
168. The microfluidic device of any one of embodiments 162-167, wherein at least one inner surface of the enclosure includes a conditioned surface.
169. The microfluidic device of embodiment 168, wherein the at least one inner surface includes a surface of the substrate.
170. The microfluidic device of embodiment 168 or 169, wherein the conditioned surface is a covalently modified surface.
171. The microfluidic device of any one of embodiments 168-169, wherein the covalently modified surface is hydrophilic.
172. The microfluidic device of any one of embodiments 162-171, wherein the substrate is configured to generate dielectrophoresis (DEP) forces within the enclosure.
173. The microfluidic device of embodiment 172, wherein the DEP forces are optically actuated.
174. The microfluidic device of any one of embodiments 162-173, wherein a cover of the microfluidic device is substantially transparent.
175. The microfluidic device of any one of embodiments 162-174, further including a barrier dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of sequestration pens, wherein the barrier is punctuated by at least one gap aligned between a proximal opening to the first sub-channel of the first pen of the first plurality of pens and a proximal opening to the second sub-channel of a first pen of the second plurality of pens.
176. The microfluidic device of embodiment 175, wherein the barrier has a length that extends from a first end of the channel to a second end of the channel.
177. The microfluidic device of embodiment 175 or 176, wherein the barrier of the microfluidic device further includes a gap aligned between a proximal opening to the first sub-channel of each pen of the first plurality of pens and a proximal opening to the second sub-channel of each respective pen of the second plurality of pens, wherein the barrier thereby includes a plurality of gaps along a length of the barrier in the microfluidic channel.
178. The microfluidic device of embodiment 175 or 176, further including an in situ-generated barrier closing the gap in the barrier separating the first sub-channel from the second sub-channel.
179. The microfluidic device of embodiment 178, further including an in situ-generated barrier closing each of the plurality of gaps of the barrier separating the first sub-channel from the second sub-channel, wherein the barrier thereby includes a plurality of in situ-generated barriers.
180. The microfluidic device of any one of embodiments 162-174, further including an in situ-generated barrier, wherein the in situ-generated barrier is disposed along a length of the microfluidic channel, dividing the microfluidic channel into a first sub-channel configured to provide a first sub-flow of fluidic medium past the first plurality of sequestration pens and a second sub-channel configured to provide a second sub-flow of fluidic medium past the second plurality of sequestration pens, wherein the in situ-generated barrier prevents cells from moving from the first sub-channel to the second sub-channel, and vice versa.
181. The microfluidic device of any one of embodiments 178-180, wherein the in situ-generated barrier includes a solidified polymer network.
182. The microfluidic device of embodiments 181, wherein the solidified polymer network includes a synthetic polymer, a modified synthetic polymer, or a biological polymer.
183. The microfluidic device of embodiment 182, wherein the synthetic polymer modifications include size modification motifs, cleavage motifs, reactive terminal moieties, or cell recognition motifs.
184. The microfluidic device of any one of embodiments 181-183, wherein the solidified polymer network includes at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyacrylamide (PAM), modified polyacrylamide, poly-N-isopropylacrylamide (PNIPAm), modified poly-N-isopropylacrylamide, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
185. The microfluidic device of any one of embodiments 181-184, wherein the solidified polymer network includes at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
186. The microfluidic device of any one of embodiments 176-180, wherein the solidified polymer network includes a modified polyethylene glycol polymer.
187. The microfluidic device of embodiment 186, wherein the modified polyethylene glycol polymer includes a star polymer.
188. The microfluidic device of embodiment 186 or 187, wherein the modified polyethylene glycol polymer includes diacrylate moieties.
189. The microfluidic device of any one of embodiments 186 to 188 wherein the modified polyethylene glycol polymer includes photocleavable moieties.
190. A kit for assaying cells of a clonal population, including a microfluidic device of any one of embodiments 162-177, and a flowable polymer solution, wherein the polymer is capable of polymerization and/or thermally induced gelling.
191. The kit of embodiment 190, further including a photoactivatable polymerization initiator.
192. The kit of embodiment 190 or 191, wherein the flowable polymer includes a synthetic polymer, a modified synthetic polymer, or a biological polymer.
193. The kit of embodiment 192, wherein the modified synthetic polymer includes size modification motifs, cleavage motifs, reactive terminal moieties, or cell recognition motifs.
194. The kit of any one of embodiments 190-193, wherein the flowable polymer includes at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyacrylamide (PAM), modified polyacrylamide, poly-N-isopropylacrylamide (PNIPAm), modified poly-N-isopropylacrylamide, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
195. The kit of any one of embodiments 190-194, wherein the flowable polymer includes at least one of a polyethylene glycol, modified polyethylene glycol, polylactic acid (PLA), modified polylactic acid, polyglycolic acid (PGA), modified polyglycolic acid, polyvinyl alcohol (PVA), modified polyvinyl alcohol, polyacrylic acid (PAA), modified polyacrylic acid, polycaprolactone (PCL), modified polycaprolactone, fibronectin, modified fibronectin, collagen, modified collagen, laminin, modified laminin, polysaccharide, modified polysaccharide, or a co-polymer in any combination.
196. The kit of any one of embodiments 190-195, wherein the flowable polymer includes a modified polyethylene glycol polymer.
197. The kit of embodiment 196, wherein the modified polyethylene glycol polymer includes a star polymer.
193. The kit of embodiment 191 or 192, wherein the modified polyethylene glycol polymer includes diacrylate moieties.
194. The kit of any one of embodiments 191 to 193, wherein the modified polyethylene glycol polymer includes photocleavable moieties.
195. The kit of any one of embodiments 185 to 194, further including a reagent configured to covalently modify at least one internal surface of the microfluidic device.
This application is a non-provisional application claiming the benefit under 35 U.S.C. 119(e) of U.S. Provisional Application No. 62/258,957 filed on Nov. 23, 2015, and of U.S. Provisional Application No. 62/423,627 filed on Nov. 17, 2016, each of which disclosures is herein incorporated by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 6294063 | Becker | Sep 2001 | B1 |
| 6387707 | Seul et al. | May 2002 | B1 |
| 6408878 | Unger et al. | Jun 2002 | B2 |
| 6488872 | Beebe | Dec 2002 | B1 |
| 6685344 | Lin et al. | Feb 2004 | B1 |
| 6942776 | Medoro | Sep 2005 | B2 |
| 7090759 | Seul | Aug 2006 | B1 |
| 7442339 | Sundararajan et al. | Oct 2008 | B2 |
| 7790631 | Sharma et al. | Sep 2010 | B2 |
| 20030008364 | Wang | Jan 2003 | A1 |
| 20030047456 | Medora | Mar 2003 | A1 |
| 20030175947 | Liu et al. | Sep 2003 | A1 |
| 20030224528 | Chiou et al. | Dec 2003 | A1 |
| 20040072278 | Chou | Apr 2004 | A1 |
| 20040115838 | Quake et al. | Jun 2004 | A1 |
| 20040191789 | Manaresi et al. | Sep 2004 | A1 |
| 20040197905 | Hafeman | Oct 2004 | A1 |
| 20050020846 | Ujita | Jan 2005 | A1 |
| 20050112548 | Segawa | May 2005 | A1 |
| 20050129581 | McBride et al. | Jun 2005 | A1 |
| 20050175702 | Muller-Schulte | Aug 2005 | A1 |
| 20050175981 | Voldman | Aug 2005 | A1 |
| 20050274456 | Roitman et al. | Dec 2005 | A1 |
| 20050274612 | Segawa et al. | Dec 2005 | A1 |
| 20060091015 | Lau | May 2006 | A1 |
| 20060154361 | Wikswo et al. | Jul 2006 | A1 |
| 20060240545 | Tomida et al. | Oct 2006 | A1 |
| 20060240548 | Deutsch et al. | Oct 2006 | A1 |
| 20060263612 | Chen et al. | Nov 2006 | A1 |
| 20070095669 | Lau | May 2007 | A1 |
| 20070183934 | Diercks et al. | Aug 2007 | A1 |
| 20070242105 | Srinivasan et al. | Oct 2007 | A1 |
| 20070264481 | DeSimone | Nov 2007 | A1 |
| 20070292941 | Handique et al. | Dec 2007 | A1 |
| 20080014575 | Nelson | Jan 2008 | A1 |
| 20080153134 | Wiyatno et al. | Jun 2008 | A1 |
| 20080193536 | Khademhosseini et al. | Aug 2008 | A1 |
| 20080302732 | Soh | Dec 2008 | A1 |
| 20090023608 | Hung et al. | Jan 2009 | A1 |
| 20090170186 | Wu | Jul 2009 | A1 |
| 20100003666 | Lee | Jan 2010 | A1 |
| 20100009335 | Joseph et al. | Jan 2010 | A1 |
| 20100068706 | Pourahmadi et al. | Mar 2010 | A1 |
| 20100101960 | Ohta | Apr 2010 | A1 |
| 20100263599 | Yanik | Oct 2010 | A1 |
| 20100273681 | Cerrina et al. | Oct 2010 | A1 |
| 20100285490 | Dees et al. | Nov 2010 | A1 |
| 20110003325 | Durack | Jan 2011 | A1 |
| 20110053151 | Hansen et al. | Mar 2011 | A1 |
| 20110108422 | Heller et al. | May 2011 | A1 |
| 20110117634 | Halamish | May 2011 | A1 |
| 20110143964 | Zhou | Jun 2011 | A1 |
| 20110186165 | Borenstein et al. | Aug 2011 | A1 |
| 20110195527 | O'Neill et al. | Aug 2011 | A1 |
| 20110262906 | Dimov et al. | Oct 2011 | A1 |
| 20120009671 | Hansen et al. | Jan 2012 | A1 |
| 20120015347 | Singhal et al. | Jan 2012 | A1 |
| 20120024708 | Chiou et al. | Feb 2012 | A1 |
| 20120118740 | Garcia | May 2012 | A1 |
| 20120156675 | Lueerssen et al. | Jun 2012 | A1 |
| 20120208266 | Bookbinder et al. | Aug 2012 | A1 |
| 20120325665 | Chiou et al. | Dec 2012 | A1 |
| 20130059322 | Hung et al. | Mar 2013 | A1 |
| 20130115606 | Hansen et al. | May 2013 | A1 |
| 20130118905 | Morimoto | May 2013 | A1 |
| 20130130232 | Weibel | May 2013 | A1 |
| 20130146459 | Bazant et al. | Jun 2013 | A1 |
| 20130171628 | DiCarlo | Jul 2013 | A1 |
| 20130190212 | Handique | Jul 2013 | A1 |
| 20130204076 | Han | Aug 2013 | A1 |
| 20130261021 | Bocchi et al. | Oct 2013 | A1 |
| 20130277218 | Mudrik et al. | Oct 2013 | A1 |
| 20130288065 | Chen et al. | Oct 2013 | A1 |
| 20140057311 | Kamm et al. | Feb 2014 | A1 |
| 20140116881 | Chapman | May 2014 | A1 |
| 20140124370 | Short | May 2014 | A1 |
| 20140154703 | Skelley et al. | Jun 2014 | A1 |
| 20140154791 | North et al. | Jun 2014 | A1 |
| 20140299472 | Chang et al. | Oct 2014 | A1 |
| 20150018226 | Hansen et al. | Jan 2015 | A1 |
| 20150151298 | Hobbs | Apr 2015 | A1 |
| 20150151307 | Breinlinger | Apr 2015 | A1 |
| 20150165436 | Chapman | Apr 2015 | A1 |
| 20150148264 | Esfandyarpour | May 2015 | A1 |
| 20150167043 | Goluch et al. | Jun 2015 | A1 |
| 20150306598 | Khandros et al. | Oct 2015 | A1 |
| 20150306599 | Khandros et al. | Oct 2015 | A1 |
| 20150352547 | Breinlinger et al. | Dec 2015 | A1 |
| 20160184821 | Hobbs et al. | Jun 2016 | A1 |
| 20160199837 | Breinlinger et al. | Jul 2016 | A1 |
| 20160222224 | Haag et al. | Aug 2016 | A1 |
| 20160252495 | Ricicova et al. | Sep 2016 | A1 |
| 20160257918 | Chapman et al. | Sep 2016 | A1 |
| 20160312165 | Lowe | Oct 2016 | A1 |
| 20160370266 | White et al. | Dec 2016 | A1 |
| 20170021366 | Chapman et al. | Jan 2017 | A1 |
| 20180298318 | Kurz et al. | Oct 2018 | A1 |
| 20190240665 | Lionberger et al. | Aug 2019 | A1 |
| 20190275516 | Lowe, Jr. et al. | Sep 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 103477222 | Aug 2016 | CN |
| 104838273 | Jan 2018 | CN |
| 0421380 | Dec 1995 | EP |
| 1065378 | Jan 2001 | EP |
| 2397224 | Dec 2011 | EP |
| 2647434 | May 2017 | EP |
| 2004532310 | Oct 2004 | JP |
| 2007108087 | Apr 2007 | JP |
| 2007197609 | Aug 2007 | JP |
| 2008-539711 | Nov 2008 | JP |
| 2011000079 | Jan 2011 | JP |
| 2011-101626 | May 2011 | JP |
| 2018-538531 | Dec 2018 | JP |
| 20100008222 | Jan 2010 | KR |
| 0046595 | Aug 2000 | WO |
| 2002081183 | Oct 2002 | WO |
| 2002088702 | Nov 2002 | WO |
| 03095088 | Nov 2003 | WO |
| 2004089810 | Oct 2004 | WO |
| 2005007796 | Jan 2005 | WO |
| 2005095963 | Oct 2005 | WO |
| 2005100541 | Oct 2005 | WO |
| 2007008609 | Jan 2007 | WO |
| 2007024701 | Mar 2007 | WO |
| WO 2007074756 | Jul 2007 | WO |
| 2007092713 | Aug 2007 | WO |
| 2008119066 | Oct 2008 | WO |
| 2008131048 | Oct 2008 | WO |
| 2009-061392 | May 2009 | WO |
| 2009130694 | Oct 2009 | WO |
| 2010040851 | Apr 2010 | WO |
| 2010115167 | Oct 2010 | WO |
| 2010147078 | Dec 2010 | WO |
| 2011149032 | Dec 2011 | WO |
| 2011160430 | Dec 2011 | WO |
| 2012037030 | Mar 2012 | WO |
| 2012072823 | Jun 2012 | WO |
| 2012162779 | Dec 2012 | WO |
| 2013019491 | Feb 2013 | WO |
| 2013130714 | Sep 2013 | WO |
| 2014070873 | May 2014 | WO |
| 2015061462 | Apr 2015 | WO |
| 2015061497 | Apr 2015 | WO |
| 2015061506 | Apr 2015 | WO |
| 2015095623 | Jun 2015 | WO |
| 2015164846 | Oct 2015 | WO |
| 2015164847 | Oct 2015 | WO |
| 2015188171 | Dec 2015 | WO |
| 2016090295 | Jun 2016 | WO |
| Entry |
|---|
| European Patent Office, International Search Report by the International Searching Authority for related PCT/US2016/063387, dated Mar. 31, 2017, 7 pgs. |
| European Patent Office, Written Opinion by the International Searching Authority for related PCT/US2016/063387, dated May 29, 2018, 12 pgs. |
| European Patent Office, International Report on Patentability by the International Searching Authority for related PCT/US2016/063387, dated , 13 pgs. |
| Beebe et al., Functional Hydrogel Structures for Autonomous Flow Control inside Microfluidic Channels, Nature 404:588-90 (2000). |
| Betre et al., Characterization of a Genetically Engineered Polypeptide for Cartilaginous Tissue Repair, Biomacromolecules 3:910-16 (2002). |
| Folk et al., Hydrogel Microvalves with Short Response Time, 226 American Chemical Society National Meeting, New York (2003). |
| Chiou et al., Massively parallel manipulation of single cells and microparticles using optical images, Nature 436:370-73 (2005). |
| Fuchs, Lab on a Chip 6:121-26 (2006). |
| Nevill et al., Integrated microfluidic cell culture and lysis on a chip, Lab on a Chip 7:1689-95 (2007). |
| Jongpaiboonkit et al., An adaptable hydrogel array format for 3-dimensional cell culture and analysis , Biomaterials 29:3346-3356 (2008). |
| Chow et al., Peptide-based polymers in biomedicine and biotechnology , Materials Science and Engineering 62:125-155 (2008). |
| Valley et al., Optoelectronic Tweezers as a Tool for Parallel Single-Cell Manipulation and Stimulation, IEEE Transactions on Biomedical Circuits and Systems 3(6):424-30 (2009). |
| Fairbanks et al., Photoinitiated Polymerization of Peg-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility, Biomaterials, 30(35): 6702-6707 (2009). |
| Lee et al., Development of Macroporous PEG Hydrogel Arrays within Microfluidic Channels , Biomacromolecules 13:11(12): 3316-3324 (2010). |
| Chung et al., Imaging single-cell signaling dynamics with a deterministic high-density single-cell trap array, Anal. Chem.83(18):7044-7052 (2011). |
| Meng et al., A Review of Stimuli-responsive shape memory polymer composites , Polymer 54:2199-2221 (2013). |
| Vats et al., Dynamic Manipulation of Hydrogels to Control Cell Behavior: A Review, Tissue Engineering: Part B 19(6): 455-469 (2013). |
| Zhang et al., “Azide Functional Monolayers Grafted to a Germanium Surface: Model Substrates for ATR-IR Studies of Interfacial Click Reactions,” Langmuir, Vo. 28, No. 1, Nov. 14, 2011, abstract (2 pages). |
| Zhang, Z. et al. “‘Click’ chemistry-based surface modification of poly(dimethylsiloxane) for protein separation in a microfluidic chaip” ELECTROPHORESIS, Sep. 20, 2010, vol. 31, No. 18, pp. 3129-3136. |
| Kleparnik, K. et al., “Recent advances in the development of single cell analysis—A review,” Analytica Chimica Acta, 2013, 800, pp. 12-21. |
| JP2007108087A, Sugiura et al. (machine translation), publication date Apr. 26, 2007, Photo-Responsive Gel Material, Micro Valve, and Microchip, 8 pages. |
| Chen et al., Microfluidic approaches for cancer cell detection, characterization, and separation, Lab on a Chip 12:1753 (2012). |
| Chiou_DisseilaLion UC Berkeley “Massively Parallel Optical Manipulation of Single Cells, Micro- and Nano-particles an Optoelectronic Devices” 2005. |
| Dicarlo et al., “Dynamic Single Cell Analysis for Quantitative Biology,” Analytical Chemistry (Dec. 1, 2006), pp. 7918-7925. |
| Gascoyne, Peter et al., “Dielectrophoretic Separation of Cancer Cells from Blood”, IEEE Trans Ind Appl. 1997, vol. 33(3), pp. 67-678, Dec. 2009. |
| Hsu, Hy et al., “Sorting of Differentiated Neurons Using Phototransistor-Based Optoelectronic Tweezers for Cell Replacement Therapy of Neurodegenerative Diseases”, Transducers 2009, Denver, CO USA Jun. 2009, download fated Nov. 23, 2009 from IEEE Xplore, 4 pages. |
| Hulkower, Keren I and Renee L. Herber “Cell Migration and Invasion Assays as Tools for Drug Discovery” Pharmaceutics (2011) 3, 107-124; doi:10.3390/pharmaceutics3010107. |
| Hung et al., Continuous Perfusion Microfluidic Cell Culture Array for High-Throughput Cell-Based Assays, Biotech and Bioengineering 89(1): 1-8 (2004). Dec. 3, 2004. |
| Liescu et al., Continuous Field-Flow Separation of Particle Populations in a Dielectrophoretic Chip with Three Dimensional Electrodes, Applied Physics Letters 90:234104 (2007). |
| Jamshidi, Arash and Wu, Ming C.; Optoelectronic Manipulation, Assembly, and Patterning of Nanoparticles Dissertation (University of California, Berkeley); Technical Report No. UCB/EECS-2009-165 (Dec. 10, 2009). |
| Kim et al., “A practical guide to microfluidic perfusion culture of adherent mammalian” Lab on a Chip 11(7): 681-684. Jun. 7, 2007. |
| KIPO computer-generated English language translation of KR 20100008222A_Kyun, Nov. 3, 2010. |
| Lee et al., Microfluidic Chemostat and Turbidostat with Flow Rate, Oxygen and Temperature Control for Dynamic Continuous Culture , Lab on a Chip 11:1730-39 (2011). |
| Lee, Gi-Hun et al. “Separation and sorting of cells in microsystems using physical principles”, Journal of Micromechanics & Microengineering, Institute of Physics Publishing, Bristol, GB, vol. 26, No. 1, Dec. 16, 2015 (Dec. 16, 2015), p. 13003. |
| Papageorgiou, D.P. et al. “Superior performance of multilayered fluoropolymer films in low voltage electrowetting” Journal of Colloid Interface Science, Oct. 25, 2011, vol. 368, No. 1, pp. 592-598. |
| Sajeesh, P. et al., “Particle separation and sorting in microfluidic devices: a review” Microfluid Nanofluid (2014) vol. 17, pp. 1-52. |
| Sochol, et al. (2013). Single-layer “domino” diodes via optofluidic lithography for ultra-low Reynolds number applications. Proceedings of the IEEE International Conference on Micro Electro Mechanical Systems (MEMS). 2. 153-156. 10.1109/MEMSYS.2013.6474200. |
| Somaweera H. et al., Generation of a Chemical Gradient Across an Array of 256 Cell Cultures in a Single Chip. Analyst, Oct. 7, 2013, vol. 138, No. 19, pp. 5566-5571. |
| Sun, Jinchen and Tan, Huaping; “Alginate-Based Biomaterials for Regenerative Medicine Applications”; Materials (2013) 6, 1285-1309. |
| WO2010147078, University of Tokyo, Machine Translation, Dec. 23, 2010, 12 pages. |
| Xu, Guoling et al.,. Recent Trends in Dielectrophoresis, Informacije MIDEM, 2010, vol. 40, Issue No. 4, pp. 253-262. |
| Yi et al., “Microfluidics technology for manipulation and analysis of biological cells,” Analytica Chimica Acta 560 (2006), pp. 1-23. |
| Zustiak, Silviya P. and Leach, Jennie B.; Hydrolytically degradable poly(ethylene glycol) hydrogelscaffolds with tunable degradation and mechanical properties; Biomacromolecules May 1, 20100; 11(5): 1348-1357. |
| Decision to Grant issued in corresponding Japanese Patent Application No. 2021-193586 dated Jan. 5, 2023 (with Machine Translation). |
| Number | Date | Country | |
|---|---|---|---|
| 20170165667 A1 | Jun 2017 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62423627 | Nov 2016 | US | |
| 62258957 | Nov 2015 | US |
